fast-twitch rat hind limb skeletal muscle phenotypes 8 months after spinal cord transection and olfactory ensheathing glia transplantation Pilar Negredo1 , Jos ' e-Luis L. Rivero2 , Beatriz Gonz ' alez1 , Almudena Ram ' on-Cueto3 and Rafael Manso1 1Centre of Molecular Biology ` Severo Ochoa ' -LRB- CSIC-UAM -RRB- , Autonomous University of Madrid , E-28049 Cantoblanco , Madrid , Spain 2Laboratory of Muscular Biopathology , Department of Comparative Anatomy and Pathological Anatomy , Faculty of Veterinary Science , University of Cordoba , E-14014 Cordoba , Spain 3Neural Regeneration Laboratory , Institute of Biomedicine -LRB- CSIC -RRB- , E-46010 Valencia , Spain Paralysed skeletal muscle of rats with spinal cord injury -LRB- SCI -RRB-	11
fast-twitch rat hind limb	11
skeletal muscle phenotypes 8 months after spinal cord transection and olfactory ensheathing glia transplantation Pilar Negredo1 , Jos ' e-Luis L. Rivero2 , Beatriz Gonz ' alez1 , Almudena Ram ' on-Cueto3 and Rafael Manso1 1Centre of Molecular Biology ` Severo Ochoa ' -LRB- CSIC-UAM -RRB- , Autonomous University of Madrid , E-28049 Cantoblanco , Madrid , Spain 2Laboratory of Muscular Biopathology , Department of Comparative Anatomy and Pathological Anatomy , Faculty of Veterinary Science , University of Cordoba , E-14014 Cordoba , Spain 3Neural Regeneration Laboratory , Institute of Biomedicine -LRB- CSIC -RRB- , E-46010 Valencia , Spain Paralysed skeletal muscle of rats with spinal cord injury -LRB- SCI -RRB-	37
skeletal muscle phenotypes	37
8 months	64
spinal cord transection and olfactory ensheathing glia transplantation Pilar Negredo1 , Jos ' e-Luis L. Rivero2 , Beatriz Gonz ' alez1 , Almudena Ram ' on-Cueto3 and Rafael Manso1 1Centre of Molecular Biology	78
spinal cord transection	78
olfactory ensheathing glia transplantation Pilar Negredo1 , Jos ' e-Luis L. Rivero2 , Beatriz Gonz ' alez1 , Almudena Ram ' on-Cueto3 and Rafael Manso1 1Centre of Molecular Biology	106
olfactory ensheathing glia transplantation Pilar Negredo1	106
Jos ' e-Luis L. Rivero2	166
Jos '	166
Beatriz Gonz ' alez1	189
Beatriz Gonz '	189
Almudena Ram ' on-Cueto3	209
Almudena Ram '	209
Rafael Manso1 1Centre of Molecular Biology	236
Rafael Manso1 1Centre	236
Molecular Biology	261
` Severo Ochoa ' -LRB- CSIC-UAM -RRB- , Autonomous University of Madrid , E-28049 Cantoblanco , Madrid , Spain 2Laboratory of Muscular Biopathology , Department of Comparative Anatomy and Pathological Anatomy , Faculty of Veterinary Science , University of Cordoba , E-14014 Cordoba , Spain 3Neural Regeneration Laboratory , Institute of Biomedicine -LRB- CSIC -RRB- , E-46010 Valencia , Spain Paralysed skeletal muscle of rats	279
Severo Ochoa ' -LRB- CSIC-UAM -RRB-	280
Severo Ochoa '	280
-LRB- CSIC-UAM -RRB-	294
Autonomous University of Madrid	306
Autonomous University	306
Madrid	331
E-28049 Cantoblanco , Madrid , Spain 2Laboratory of Muscular Biopathology	339
E-28049 Cantoblanco , Madrid , Spain 2Laboratory	339
Muscular Biopathology	389
Department of Comparative Anatomy and Pathological Anatomy , Faculty of Veterinary Science	412
Department	412
Comparative Anatomy and Pathological Anatomy , Faculty of Veterinary Science	426
Comparative Anatomy and Pathological Anatomy , Faculty	426
Veterinary Science	483
University of Cordoba	503
University	503
Cordoba	517
E-14014 Cordoba , Spain 3Neural Regeneration Laboratory	526
E-14014 Cordoba	526
Spain 3Neural Regeneration Laboratory	543
Institute of Biomedicine -LRB- CSIC -RRB-	582
Institute	582
Biomedicine -LRB- CSIC -RRB-	595
Biomedicine	595
CSIC	608
E-46010 Valencia	615
E-46010	615
Valencia	623
Spain Paralysed skeletal muscle of rats	633
Spain Paralysed skeletal muscle	633
rats	669
spinal cord injury -LRB- SCI -RRB-	679
spinal cord injury	679
SCI	699
atrophy and a switch in gene expression pattern which leads to faster , more fatigable phenotypes	714
atrophy	714
a switch in gene expression pattern which leads to faster , more fatigable phenotypes	726
a switch	726
gene expression pattern which leads to faster , more fatigable phenotypes	738
gene expression pattern which leads to faster	738
gene expression pattern	738
more fatigable phenotypes	785
Olfactory ensheathing glia -LRB- OEG -RRB- transplants	812
Olfactory ensheathing glia	812
OEG	840
axonal regeneration	887
sensory-motor function	922
animals with SCI	948
animals	948
SCI	961
We	966
OEG transplants	987
skeletal muscle phenotypic deterioration	1019
this effect	1069
the functional recovery observed in behavioural tests	1096
the functional recovery	1096
behavioural tests	1132
A variety of morphological , metabolic and molecular markers	1151
A variety	1151
morphological , metabolic and molecular markers	1164
soleus -LRB- SOL -RRB- and extensor digitorum longus -LRB- EDL -RRB-	1228
soleus	1228
SOL	1236
extensor digitorum longus	1245
EDL	1272
muscles of spinal cord transected -LRB- SCT -RRB- , OEG-transplanted rats 8 months after the intervention and compared with non-transplanted SCT rats and sham-operated -LRB- without SCT -RRB- controls -LRB- C -RRB-	1277
muscles	1277
spinal cord transected -LRB- SCT -RRB- , OEG-transplanted rats 8 months after the intervention and compared with non-transplanted SCT rats and sham-operated -LRB- without SCT -RRB- controls -LRB- C -RRB-	1288
spinal cord transected -LRB- SCT -RRB-	1288
spinal cord	1288
SCT	1312
OEG-transplanted rats 8 months after the intervention and compared with non-transplanted SCT rats	1318
OEG-transplanted rats	1318
8 months	1340
the intervention	1354
non-transplanted SCT rats	1389
sham-operated -LRB- without SCT -RRB- controls -LRB- C -RRB-	1419
sham-operated -LRB- without SCT -RRB- controls	1419
SCT	1442
C	1457
A multivariate analysis encompassing all the parameters	1461
A multivariate analysis	1461
all the parameters	1498
OEG-transplanted rats	1532
skeletal muscle phenotypes intermediate between non-transplanted and sham-operated controls , but different	1564
skeletal muscle phenotypes	1564
non-transplanted and sham-operated controls	1612
both	1676
A high correlation	1682
behaviourally tested sensory-motor functional capacity and expression level of slow - and fast-twitch hind limb skeletal muscle phenotypic markers , particularly the histochemical glycerol-3-phosphate dehydrogenase activity -LRB- − 0.843 , P < 0.0001 -RRB- and the fraction of variant 2s of the slow regulatory myosin light chain isoform -LRB- 0.848 , P < 0.0001 -RRB- in SOL	1722
behaviourally tested sensory-motor functional capacity and expression level of slow - and fast-twitch hind limb skeletal muscle phenotypic markers , particularly the histochemical glycerol-3-phosphate dehydrogenase activity -LRB- − 0.843 , P < 0.0001 -RRB- and the fraction of variant 2s of the slow regulatory myosin light chain isoform -LRB- 0.848 , P < 0.0001 -RRB-	1722
behaviourally tested sensory-motor functional capacity and expression level of slow - and fast-twitch hind limb skeletal muscle phenotypic markers , particularly the histochemical glycerol-3-phosphate dehydrogenase activity -LRB- − 0.843 , P < 0.0001 -RRB- and the fraction of variant 2s of the slow regulatory myosin light chain isoform	1722
behaviourally tested sensory-motor functional capacity and expression level of slow - and fast-twitch hind limb skeletal muscle phenotypic markers	1722
sensory-motor functional capacity and expression level of slow - and fast-twitch hind limb skeletal muscle	1743
sensory-motor functional capacity	1743
expression level of slow - and fast-twitch hind limb skeletal muscle	1781
expression level	1781
slow - and fast-twitch hind limb skeletal muscle	1801
particularly the histochemical glycerol-3-phosphate dehydrogenase activity -LRB- − 0.843 , P < 0.0001 -RRB-	1869
particularly the histochemical glycerol-3-phosphate dehydrogenase activity	1869
− 0.843 , P < 0.0001	1945
− 0.843	1945
P < 0.0001	1953
P	1953
0.0001	1956
the fraction of variant 2s of the slow regulatory myosin light chain isoform	1968
the fraction	1968
variant 2s of the slow regulatory myosin light chain isoform	1984
variant 2s	1984
the slow regulatory myosin light chain isoform	1998
0.848 , P < 0.0001	2046
0.848	2046
P < 0.0001	2053
P	2053
0.0001	2056
SOL	2067
the mean overall effect of OEG transplants in patterning skeletalmuscle protein expression towards normal , in 6 out of 9 animals	2080
the mean overall effect	2080
OEG transplants in patterning skeletalmuscle protein expression towards normal , in 6 out of 9 animals	2107
OEG transplants	2107
patterning skeletalmuscle protein expression towards normal , in 6 out	2126
patterning skeletalmuscle protein expression	2126
normal	2179
6	2190
9 animals	2199
they	2209
fibre type switching	2248
a consistent	2284
long-term maintenance of normal skeletal muscle characteristics	2313
long-term maintenance	2313
normal skeletal muscle characteristics	2338
The interplay of OEG and exercise-mediated neurotrophic actions	2378
The interplay	2378
OEG and exercise-mediated neurotrophic actions	2395
a plausible mechanism underlying OEG transplantation effects on paralysed skeletal muscle	2445
a plausible mechanism	2445
OEG transplantation effects	2478
skeletal muscle	2519
Complete spinal cord injury -LRB- SCI -RRB-	2537
Complete spinal cord injury	2537
SCI	2566
long spinal pathways and disconnects	2580
long spinal pathways	2580
disconnects	2605
organs	2624
the brain	2636
failure of neurons to regenerate their axons spontaneously in the mature CNS milieu	2654
failure	2654
neurons to regenerate their axons spontaneously in the mature CNS milieu	2665
their axons	2687
the mature CNS milieu	2716
SCI	2739
disabling , permanent effects that include loss of voluntary movement , appearance of involuntary muscle spasms and loss of somatosensory function below the injury site	2747
disabling	2747
permanent effects that include loss of voluntary movement , appearance of involuntary muscle spasms and loss of somatosensory function below the injury site	2758
permanent effects	2758
loss of voluntary movement , appearance of involuntary muscle spasms and loss of somatosensory function	2789
loss of voluntary movement	2789
loss	2789
voluntary movement	2797
appearance of involuntary muscle spasms	2817
appearance	2817
involuntary muscle spasms	2831
loss of somatosensory function	2861
loss	2861
somatosensory function	2869
the injury site	2898
skeletal muscle experiences	2925
progressive atrophy	2953
reduced fibre cross-sectional area , concurrent with alterations in contractile and metabolic properties resulting from a switch in gene expression programs , particularly those governing the isoforms of the myosin subunits -LRB- see Schiaffino & Reggiani , 1996 ; Pette & Staron , 1997 ; Talmadge , 2000 ; Pette & Staron , 2001 for review -RRB-	2978
reduced fibre cross-sectional area	2978
alterations in contractile and metabolic properties resulting from a switch in gene expression programs , particularly those governing the isoforms of the myosin subunits -LRB- see Schiaffino & Reggiani , 1996 ; Pette & Staron , 1997 ; Talmadge , 2000 ; Pette & Staron , 2001 for review -RRB-	3030
alterations in contractile and metabolic properties resulting from a switch in gene expression programs	3030
alterations	3030
contractile and metabolic properties	3045
a switch in gene expression programs	3097
a switch	3097
gene expression programs	3109
those governing the isoforms of the myosin subunits -LRB- see Schiaffino & Reggiani , 1996 ; Pette & Staron , 1997 ; Talmadge , 2000 ; Pette & Staron , 2001 for review -RRB-	3148
those governing the isoforms of the myosin subunits	3148
those	3148
the isoforms of the myosin subunits	3164
the isoforms	3164
the myosin subunits	3180
Schiaffino & Reggiani , 1996 ; Pette & Staron , 1997 ; Talmadge , 2000 ; Pette & Staron , 2001 for review	3205
Schiaffino & Reggiani , 1996 ; Pette & Staron , 1997 ; Talmadge , 2000 ; Pette & Staron , 2001	3205
Schiaffino & Reggiani , 1996	3205
Schiaffino & Reggiani	3205
1996	3228
Pette & Staron , 1997	3234
Pette & Staron	3234
1997	3250
Talmadge , 2000	3256
Talmadge	3256
2000	3266
Pette & Staron , 2001	3272
Pette & Staron	3272
2001	3288
review	3297
rodentswith a complete spinal cord transection -LRB- SCT -RRB-	3309
rodentswith a complete spinal cord transection	3309
rodentswith	3309
a complete spinal cord transection	3321
SCT	3357
the slow-twitch SOLmuscle	3363
a dramatic reduction in the proportion of the slow myosin heavy chain -LRB- MHC -RRB- isoform -LRB- MHC-I or β/slow -RRB- , the major isoform of this muscle accounting	3401
a dramatic reduction	3401
the proportion of the slow myosin heavy chain -LRB- MHC -RRB- isoform -LRB- MHC-I or β/slow -RRB- , the major isoform of this muscle accounting	3425
the proportion of the slow myosin heavy chain -LRB- MHC -RRB- isoform -LRB- MHC-I or β/slow -RRB-	3425
the proportion	3425
the slow myosin heavy chain -LRB- MHC -RRB- isoform -LRB- MHC-I or β/slow -RRB-	3443
the slow myosin heavy chain -LRB- MHC -RRB- isoform	3443
slow myosin heavy chain -LRB- MHC -RRB-	3447
slow myosin heavy chain	3447
MHC	3472
MHC-I or β/slow	3486
MHC-I	3486
β/slow	3495
the major isoform of this muscle accounting	3504
the major isoform	3504
this muscle accounting	3525
90 % of the MHC content	3558
90 %	3558
the MHC content	3565
The reduced proportion of MHC-I	3582
The reduced proportion	3582
MHC-I	3608
increases in the fast MHC isoforms IIa and IIx/d and , to a limited extent , also IIb -LRB- Talmadge et al. 1995 , 1999 -RRB-	3632
increases in the fast MHC isoforms IIa	3632
increases	3632
the fast MHC isoforms IIa	3645
IIx/d	3675
a limited extent	3689
IIb -LRB- Talmadge et al. 1995 , 1999 -RRB-	3712
IIb	3712
Talmadge	3717
et al. 1995 , 1999	3726
et al.	3726
1995	3733
1999	3739
These transitions in the MHC expression pattern	3746
These transitions	3746
the MHC expression pattern	3767
increases in the maximal speed of shortening , in agreement with the established correlation between the MHC isoform expressed in a fibre and its maximal velocity of contraction -LRB- Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 -RRB-	3813
increases	3813
the maximal speed of shortening , in agreement with the established correlation between the MHC isoform expressed in a fibre and its maximal velocity of contraction -LRB- Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 -RRB-	3826
the maximal speed	3826
agreement	3862
the established correlation between the MHC isoform expressed in a fibre and its maximal velocity of contraction -LRB- Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 -RRB-	3877
the established correlation	3877
the MHC isoform expressed in a fibre and its maximal velocity of contraction -LRB- Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 -RRB-	3913
the MHC isoform	3913
a fibre and its maximal velocity of contraction -LRB- Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 -RRB-	3942
a fibre	3942
its maximal velocity of contraction -LRB- Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 -RRB-	3954
its maximal velocity	3954
contraction -LRB- Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 -RRB-	3978
contraction	3978
Reiser	3991
et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991	3998
et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al.	3998
et al. 1985	3998
et al.	3998
1985	4005
Sweeney et al. 1986	4011
Sweeney	4011
et al.	4019
1986	4026
Bottinelli et al.	4032
Bottinelli	4032
et al.	4043
1991	4050
A shift of intermediary metabolism towards more glycolytic phenotypes	4057
A shift	4057
intermediary metabolism towards more glycolytic phenotypes	4068
intermediary metabolism	4068
more glycolytic phenotypes	4100
Talmadge , 2000 ; Otis et al. 2004	4150
Talmadge , 2000 ; Otis et al.	4150
Talmadge , 2000	4150
Talmadge	4150
2000	4160
Otis et al.	4166
Otis	4166
et al.	4171
2004	4178
Soleus muscle of SCT rats	4185
Soleus muscle	4185
SCT rats	4202
a relatively high proportion of hybrid fibres	4237
a relatively high proportion	4237
hybrid fibres	4269
two or more different MHC isoforms -LRB- Talmadge et al. 1999 -RRB-	4297
two or more different MHC isoforms	4297
Talmadge	4333
et al. 1999	4342
et al.	4342
1999	4349
The persistence of hybrid fibres	4356
The persistence	4356
hybrid fibres	4375
an indication	4401
it	4420
a stable phenotypic characteristic of paralysed skeletal muscle -LRB- Talmadge , 2000 -RRB-	4434
a stable phenotypic characteristic	4434
skeletal muscle -LRB- Talmadge , 2000 -RRB-	4482
skeletal muscle	4482
Talmadge	4499
2000	4509
Myosin light chains -LRB- MLCs -RRB-	4516
Myosin light chains	4516
MLCs	4537
the contractile velocity of fibres	4574
the contractile velocity	4574
fibres	4602
a specified range for each MHC isoform -LRB- Bottinelli et al. 1994 -RRB-	4616
a specified range	4616
each MHC isoform -LRB- Bottinelli et al. 1994 -RRB-	4638
each MHC isoform	4638
Bottinelli	4655
et al. 1994	4666
et al.	4666
1994	4673
The isoform transitions of essential -LRB- eMLCs -RRB- and regulatory -LRB- rMLCs -RRB-	4680
The isoform transitions	4680
essential -LRB- eMLCs -RRB- and regulatory -LRB- rMLCs -RRB-	4707
essential -LRB- eMLCs -RRB-	4707
regulatory -LRB- rMLCs -RRB-	4729
MLCs observed in rat skeletal muscle following SCI -LRB- Lee & Braun , 1990 -RRB- could also contribute to adapt skeletal muscle contractile properties to reduced neuromuscular activity , leading to faster	4748
MLCs	4748
rat skeletal muscle following SCI -LRB- Lee & Braun , 1990 -RRB- could also contribute to adapt skeletal muscle contractile properties to reduced neuromuscular activity , leading to faster	4765
rat skeletal muscle	4765
SCI -LRB- Lee & Braun , 1990 -RRB- could also contribute to adapt skeletal muscle contractile properties to reduced neuromuscular activity , leading to faster	4795
SCI -LRB- Lee & Braun , 1990 -RRB-	4795
SCI	4795
Lee & Braun	4800
1990	4813
skeletal muscle contractile properties	4850
reduced neuromuscular activity , leading to faster	4892
reduced neuromuscular activity	4892
more fatigable phenotypes	4943
Several studies	4970
interventions increasing the neuromuscular activity either by increasing the level of electrical activation or the load bearing , or both ,	5002
interventions	5002
the neuromuscular activity	5027
the level of electrical activation or the load bearing , or both ,	5075
the level	5075
electrical activation or the load bearing , or both ,	5088
electrical activation or the load bearing	5088
electrical activation	5088
the load bearing	5113
both	5134
transitions of MHC expression in the fast-to-slow direction , i.e. opposing the effect of SCI	5150
transitions of MHC expression in the fast-to-slow direction , i.e.	5150
transitions	5150
MHC expression in the fast-to-slow direction	5165
MHC expression	5165
the fast-to-slow direction	5183
the effect of SCI	5225
the effect	5225
SCI	5239
These transitions	5244
an ordered sequence -LRB- MHC-IIb > MHC-IIx/d > MHC-IIa > MHC-I -RRB- that characterizes phenotypic changes in skeletal muscle as proposed by the theory of the continuum of MHC isoformexpression -LRB- Staron & Pette , 1993 -RRB-	5269
an ordered sequence -LRB- MHC-IIb > MHC-IIx/d > MHC-IIa > MHC-I -RRB-	5269
an ordered sequence	5269
MHC-IIb > MHC-IIx/d > MHC-IIa > MHC-I	5290
MHC-IIb > MHC-IIx/d > MHC-IIa	5290
MHC-IIb > MHC-IIx/d	5290
> MHC-IIa	5307
> MHC-I	5315
phenotypic changes	5342
skeletal muscle as proposed by the theory of the continuum of MHC isoformexpression -LRB- Staron & Pette , 1993 -RRB-	5364
skeletal muscle as	5364
the theory of the continuum of MHC isoformexpression -LRB- Staron & Pette , 1993 -RRB-	5395
the theory	5395
the continuum of MHC isoformexpression -LRB- Staron & Pette , 1993 -RRB-	5409
the continuum	5409
MHC isoformexpression -LRB- Staron & Pette , 1993 -RRB-	5426
MHC isoformexpression	5426
Staron & Pette	5449
1993	5463
Low-frequency electrical stimulation , functional overload and resistance or endurance exercise training , amongother interventions ,	5470
Low-frequency electrical stimulation	5470
functional overload and resistance or endurance exercise training , amongother interventions	5508
resistance or endurance exercise training	5532
resistance	5532
endurance exercise training	5546
the expression of MHCs toward slower isoforms -LRB- Talmadge , 2000 ; Baldwin & Haddad , 2001 -RRB-	5626
the expression	5626
MHCs toward slower isoforms -LRB- Talmadge , 2000 ; Baldwin & Haddad , 2001 -RRB-	5644
MHCs	5644
slower isoforms -LRB- Talmadge , 2000 ; Baldwin & Haddad , 2001 -RRB-	5656
slower isoforms	5656
Talmadge , 2000 ; Baldwin & Haddad , 2001	5673
Talmadge	5673
2000 ; Baldwin & Haddad	5683
2000	5683
Baldwin & Haddad	5689
2001	5707
addition to interventions that increase neuromuscular activity	5717
addition	5717
interventions that increase neuromuscular activity	5729
interventions	5729
neuromuscular activity	5757
a switch of MHC isoform expression in the fast-to-slow direction	5781
a switch	5781
MHC isoform expression in the fast-to-slow direction	5793
MHC isoform expression	5793
the fast-to-slow direction	5819
rat	5872
SOL and EDL muscles	5876
conditions of hypothyroidism , glucocorticoid treatment , diabetes and ageing -LRB- see Pette & Staron , 1997 for a review -RRB-	5902
conditions	5902
hypothyroidism , glucocorticoid treatment , diabetes and ageing	5916
hypothyroidism	5916
glucocorticoid treatment	5932
diabetes	5958
ageing	5971
Pette & Staron , 1997 for a review	5983
Pette & Staron	5983
1997 for a review	5999
1997	5999
a review	6008
no known treatment	6030
functional regeneration	6073
a complete spinal cord transection in humans	6104
a complete spinal cord transection	6104
humans	6142
Paraplegic patients	6150
temporal activation of target organs	6180
temporal activation	6180
target organs	6203
means of electrical stimulation for motor rehabilitation and improvement of bladder and bowel function -LRB- Prochazka & Mushahwar , 2001 -RRB-	6220
means	6220
electrical stimulation for motor rehabilitation and improvement of bladder and bowel function -LRB- Prochazka & Mushahwar , 2001 -RRB-	6229
electrical stimulation	6229
motor rehabilitation and improvement	6256
bladder and bowel function -LRB- Prochazka & Mushahwar , 2001 -RRB-	6296
bladder and bowel function	6296
Prochazka & Mushahwar	6324
2001	6347
Passive exercise and arm cranking	6354
Passive exercise and arm	6354
a palliative treatment	6411
motor automatism	6443
Wernig et al. 1999 ; Kjaer , 2000	6487
Wernig	6487
et al. 1999 ; Kjaer , 2000	6494
et al. 1999	6494
et al.	6494
1999	6501
Kjaer , 2000	6507
Kjaer	6507
2000	6514
These palliative strategies	6521
consistentwith experimental observations indicating that exercise or muscle activity induced by electrical stimulation can attenuate or reverse changes in skeletal muscle properties induced by SCI -LRB- Dupont-Versteegden et al. 1998 ; Hartkopp et al. 2003 ; Shields & Dudley-Javoroski , 2006 -RRB-	6553
consistentwith experimental observations	6553
exercise or muscle activity induced by electrical stimulation	6610
exercise or muscle activity	6610
electrical stimulation	6649
changes	6697
skeletal muscle properties induced by SCI	6708
skeletal muscle properties	6708
SCI	6746
Dupont-Versteegden et al. 1998 ; Hartkopp et al. 2003 ; Shields & Dudley-Javoroski , 2006	6751
Dupont-Versteegden	6751
et al. 1998 ; Hartkopp et al. 2003 ; Shields & Dudley-Javoroski , 2006	6770
et al. 1998	6770
et al.	6770
1998	6777
Hartkopp et al. 2003	6783
Hartkopp	6783
et al.	6792
2003	6799
Shields & Dudley-Javoroski , 2006	6805
Shields & Dudley-Javoroski	6805
2006	6833
the neuromuscular activity , as would occur upon re-establishment of functional descending upper motor neuron pathways in SCI individuals ,	6851
the neuromuscular activity	6851
re-establishment of functional descending upper motor neuron pathways in SCI individuals	6899
re-establishment	6899
upper motor neuron pathways	6941
SCI individuals	6972
skeletal muscle protein expression pattern	7002
muscles	7055
the experimental approaches developed in recent years to promote an effective regeneration of the injured spinal cord	7085
the experimental approaches	7085
recent years	7126
an effective regeneration of the injured spinal cord	7150
an effective regeneration	7150
the injured spinal cord	7179
transplantation of olfactory ensheathing glia -LRB- OEG -RRB-	7204
transplantation	7204
olfactory ensheathing glia -LRB- OEG -RRB-	7223
olfactory ensheathing glia	7223
OEG	7251
one of the most promising strategies -LRB- Ramon-Cueto & Valverde , 1995 ; Raisman , 2001 ; Keyvan-Fouladi et al. 2002 ; Wewetzer et al. 2002 ; Santos-Benito & Ramon-Cueto , 2003 ; Barnett & Riddell , 2004 -RRB-	7271
one	7271
the most promising strategies -LRB- Ramon-Cueto & Valverde , 1995 ; Raisman , 2001 ; Keyvan-Fouladi et al. 2002 ; Wewetzer et al. 2002 ; Santos-Benito & Ramon-Cueto , 2003 ; Barnett & Riddell , 2004 -RRB-	7278
the most promising strategies	7278
Ramon-Cueto & Valverde , 1995 ; Raisman , 2001 ; Keyvan-Fouladi et al. 2002 ; Wewetzer et al. 2002 ; Santos-Benito & Ramon-Cueto , 2003 ; Barnett & Riddell , 2004	7309
Ramon-Cueto & Valverde	7309
1995 ; Raisman , 2001 ; Keyvan-Fouladi et al. 2002 ; Wewetzer et al. 2002 ; Santos-Benito & Ramon-Cueto , 2003 ; Barnett & Riddell , 2004	7333
1995	7333
Raisman , 2001 ; Keyvan-Fouladi et al. 2002 ; Wewetzer et al. 2002 ; Santos-Benito & Ramon-Cueto , 2003 ; Barnett & Riddell , 2004	7339
Raisman , 2001	7339
Raisman	7339
2001	7348
Keyvan-Fouladi et al. 2002	7354
Keyvan-Fouladi	7354
et al.	7369
2002	7376
Wewetzer et al. 2002	7382
Wewetzer	7382
et al.	7391
2002	7398
Santos-Benito & Ramon-Cueto , 2003	7404
Santos-Benito & Ramon-Cueto	7404
2003	7433
Barnett & Riddell , 2004	7439
Barnett & Riddell	7439
2004	7458
histological data and behavioural tests	7474
histological data	7474
behavioural tests	7496
OEG transplantation	7515
axonal regeneration	7564
the rat SC and recovery of sensory-motor function -LRB- Ramon-Cueto et al. 2000 -RRB-	7587
the rat SC and recovery	7587
sensory-motor function -LRB- Ramon-Cueto et al. 2000 -RRB-	7614
sensory-motor function	7614
Ramon-Cueto et al. 2000	7638
Ramon-Cueto	7638
et al. 2000	7650
et al.	7650
2000	7657
this context	7667
we	7681
OEG transplantation	7698
the effect of SCT	7734
the effect	7734
SCT	7748
slow - and fast-twitch rat hind limb skeletal muscle phenotypes , thus contributing to preserve normal contractile properties and to favour functional recovery	7755
slow - and fast-twitch rat hind limb skeletal muscle phenotypes	7755
normal contractile properties	7849
functional recovery	7893
the present investigation	7927
the impact of OEG transplants	7988
the impact	7988
OEG transplants	8002
the phenotypic features of fast - and slow-twitch hind limb skeletal muscles of rats with completely transected spinal cords	8021
the phenotypic features	8021
fast - and slow-twitch hind limb skeletal muscles of rats with completely transected spinal cords	8048
fast - and slow-twitch hind limb	8048
skeletal muscles of rats with completely transected spinal cords	8080
skeletal muscles	8080
rats with completely	8100
rats	8100
spinal cords	8132
A second aim of this research	8146
A second aim	8146
this research	8162
motor functional capacity of OEG-transplanted rats , previously determined by means of behavioural tests for the same animals of this study -LRB- Ramon-Cueto et al. 2000 -RRB- ,	8196
motor functional capacity	8196
OEG-transplanted rats	8225
means of behavioural tests for the same animals of this study -LRB- Ramon-Cueto et al. 2000 -RRB-	8273
means	8273
behavioural tests for the same animals of this study -LRB- Ramon-Cueto et al. 2000 -RRB-	8282
behavioural tests	8282
the same animals of this study -LRB- Ramon-Cueto et al. 2000 -RRB-	8304
the same animals	8304
this study -LRB- Ramon-Cueto et al. 2000 -RRB-	8324
this study	8324
Ramon-Cueto et al. 2000	8336
Ramon-Cueto	8336
et al. 2000	8348
et al.	8348
2000	8355
the extent that affected slow -LRB- SOL -RRB- and fast-twitch -LRB- EDL -RRB- skeletal muscle approached normal phenotype	8378
the extent that affected slow -LRB- SOL -RRB-	8378
the extent	8378
SOL	8409
fast-twitch -LRB- EDL -RRB- skeletal muscle approached normal phenotype	8418
fast-twitch	8418
EDL	8431
skeletal muscle	8436
normal phenotype	8463
this investigation	8490
sensitive markers of skeletal muscle phenotype potentially valuable to assess on a quantitative basis changes in the locomotor capacity of SCT animals in response to OEG transplantation	8536
sensitive markers	8536
skeletal muscle phenotype potentially valuable to assess on a quantitative basis changes in the locomotor capacity of SCT animals in response to OEG transplantation	8557
skeletal muscle phenotype	8557
a quantitative basis changes in the locomotor capacity of SCT animals	8617
a quantitative basis changes	8617
the locomotor capacity of SCT animals	8649
the locomotor capacity	8649
SCT animals	8675
response	8690
OEG transplantation	8702
Methods Preparation of adult olfactory bulb OEG for transplantation into damaged spinal cord Preparation of adult rat olfactory bulb OEG	8724
Methods Preparation	8724
adult olfactory bulb OEG for transplantation into damaged spinal cord Preparation of adult rat olfactory bulb OEG	8747
adult olfactory bulb OEG	8747
transplantation into damaged spinal cord Preparation of adult rat olfactory bulb OEG	8776
transplantation	8776
damaged spinal cord Preparation of adult rat olfactory bulb OEG	8797
damaged spinal cord Preparation	8797
adult rat olfactory bulb OEG	8832
a previously described procedure -LRB- Ramon-Cueto & Nieto-Sampedro , 1992 -RRB-	8885
a previously described procedure	8885
Ramon-Cueto & Nieto-Sampedro	8919
1992	8949
Olfactory bulbs	8956
adult Wistar Hannover rats -LRB- 2 -- 2.5 months old , Charles River -RRB- , killed by decapitation under deep ketamine anaesthesia -LRB- Imalgene , Rhone Merieux , Lyon ; 15 mg -LRB- 100 g body weight -RRB- − 1 , i.p.	8992
adult Wistar Hannover rats -LRB- 2 -- 2.5 months old , Charles River -RRB-	8992
adult Wistar Hannover rats	8992
2	9020
2.5 months old , Charles River	9022
2.5 months old	9022
Charles River	9038
decapitation under deep ketamine anaesthesia -LRB- Imalgene , Rhone Merieux , Lyon ; 15 mg -LRB- 100 g body weight -RRB- − 1 , i.p.	9064
decapitation under deep ketamine anaesthesia -LRB- Imalgene , Rhone Merieux , Lyon ; 15 mg -LRB- 100 g body weight -RRB- − 1	9064
decapitation	9064
deep ketamine anaesthesia -LRB- Imalgene , Rhone Merieux , Lyon ; 15 mg -LRB- 100 g body weight -RRB-	9083
deep ketamine anaesthesia	9083
Imalgene , Rhone Merieux	9110
Imalgene	9110
Rhone Merieux	9120
Lyon ; 15 mg -LRB- 100 g body weight	9135
Lyon	9135
15 mg -LRB- 100 g body weight	9141
15 mg	9141
100 g body weight	9147
100 g	9147
body weight	9153
1	9166
The olfactory bulbs of one rat per transplanted animal	9176
The olfactory bulbs	9176
one rat per transplanted animal	9199
one rat	9199
transplanted animal	9211
the heads	9251
sterile conditions	9267
The first two olfactory bulb layers	9287
inHank 's balanced salt solution	9338
inHank 's	9338
calcium and magnesium ions -LRB- HBSS , Gibco -RRB-	9375
calcium and magnesium ions	9375
HBSS	9403
Gibco	9409
10 min at 37 ◦ C	9434
10 min	9434
37 ◦ C	9444
0.25 % trypsin -LRB- w/v , Sigma -RRB-	9454
0.25 % trypsin	9454
w/v	9469
Sigma	9474
a sterile tube containing 5 ml of HBSS	9483
a sterile tube	9483
5 ml of HBSS	9509
5 ml	9509
HBSS	9516
EDTA -LRB- without calcium and magnesium , 1 mm EDTA -RRB-	9521
EDTA	9521
calcium and magnesium , 1 mm EDTA	9535
calcium and magnesium	9535
1 mm EDTA	9558
Treatment with trypsin	9569
Treatment	9569
trypsin	9584
D/F -10 S -LRB- DEMEM and Ham 's F-12 media , 1 : 1 , Gibco , supplemented with 10 % fetal bovine serum , 100 Uml − 1 penicillin and 100 μgml − 1 streptomycin -RRB-	9614
D/F -10 S	9614
DEMEM and Ham 's F-12 media , 1 : 1 , Gibco , supplemented with 10 % fetal bovine serum , 100 Uml − 1 penicillin and 100 μgml − 1 streptomycin	9623
DEMEM and Ham 's F-12 media , 1 : 1 , Gibco , supplemented with 10 % fetal bovine serum , 100 Uml − 1 penicillin	9623
DEMEM and Ham 's F-12 media , 1 : 1	9623
DEMEM	9623
Ham 's F-12 media , 1 : 1	9633
Ham 's F-12 media	9633
Ham 's	9633
1 : 1	9651
Gibco	9658
10 % fetal bovine serum , 100 Uml − 1 penicillin	9683
10 % fetal bovine serum	9683
100 Uml − 1 penicillin	9707
100 Uml −	9707
1 penicillin	9715
100 μgml − 1 streptomycin	9732
100 μgml −	9732
1 streptomycin	9741
several times	9772
D/F -10 S and centrifuging	9791
D/F -10 S	9791
centrifuging	9803
cells	9817
1 ml D/F	9843
-10 S using a fire-polished Pasteur pipette	9850
-10 S	9850
a fire-polished Pasteur pipette	9861
Cells from two olfactory bulbs	9894
Cells	9894
two olfactory bulbs	9905
one poly l-lysine -LRB- 10 000 -- 30 000 MW , Sigma -RRB-	9942
one poly l-lysine	9942
10 000 -- 30 000 MW , Sigma	9961
10 000	9961
30 000 MW , Sigma	9968
30 000 MW	9968
Sigma	9979
coated culture flask -LRB- 25 cm2 , Falcon -RRB-	9986
coated culture flask	9986
25 cm2	10008
Falcon	10016
D/F -10 S	10040
37 ◦ C and 5 % CO2	10051
37 ◦ C	10051
5 % CO2	10060
Culture medium	10068
every 2 -- 3 days	10095
every 2	10095
3 days	10103
Seven days	10111
cells	10137
the flasks using 0.1 % trypsin -LRB- w/v -RRB- in Ca2 + -- Mg2 + - free HBSS medium	10162
the flasks using 0.1 % trypsin -LRB- w/v -RRB- in Ca2 +	10162
the flasks	10162
0.1 % trypsin -LRB- w/v -RRB- in Ca2	10179
0.1 % trypsin -LRB- w/v -RRB-	10179
0.1 % trypsin	10179
w/v	10193
Ca2	10201
+	10204
Mg2 + - free HBSS medium	10206
Mg2 +	10206
Mg2	10206
+	10209
free HBSS medium	10211
P75 receptor-expressing OEG	10229
immunoaffinity	10274
an antibody against p75 -LRB- hybridoma 192 , kindly provided by Dr Patrick Wood , Miami Project to Cure Paralysis -RRB- , as previously described -LRB- Ramon-Cueto et al. 1998 , 2000 -RRB-	10295
an antibody	10295
p75 -LRB- hybridoma 192 , kindly provided by Dr Patrick Wood , Miami Project to Cure Paralysis -RRB- , as previously described	10315
p75 -LRB- hybridoma 192 , kindly provided by Dr Patrick Wood , Miami Project to Cure Paralysis -RRB-	10315
p75	10315
hybridoma 192 , kindly provided by Dr Patrick Wood , Miami Project to Cure Paralysis	10320
hybridoma 192	10320
Dr Patrick Wood , Miami Project	10354
Dr Patrick Wood	10354
Miami Project	10371
Paralysis	10393
Ramon-Cueto	10430
et al. 1998 , 2000	10442
et al.	10442
1998	10449
2000	10455
96 mm Petri dishes	10471
96 mm	10471
Petri dishes	10476
biotinylated anti-mouse IgG -LRB- 1/1000 ; Jackson Immunoresearch -RRB- for 12 h at 4 ◦ C , and thereafter with the supernatant of hybridoma 192 -LRB- 1/5 -RRB- containing mouse anti-p75 , also for 12 h at 4 ◦ C	10507
anti-mouse IgG -LRB- 1/1000 ; Jackson Immunoresearch -RRB- for 12 h at 4 ◦ C	10520
anti-mouse IgG -LRB- 1/1000 ; Jackson Immunoresearch -RRB-	10520
anti-mouse IgG	10520
1/1000 ; Jackson Immunoresearch	10536
1/1000	10536
Jackson Immunoresearch	10544
12 h at 4 ◦ C	10572
12 h	10572
4 ◦ C	10580
the supernatant of hybridoma 192 -LRB- 1/5 -RRB-	10605
the supernatant	10605
hybridoma 192 -LRB- 1/5 -RRB-	10624
hybridoma 192	10624
1/5	10639
mouse anti-p75	10655
12 h at 4 ◦ C	10680
12 h	10680
4 ◦ C	10688
DMEM	10709
Cells detached from culture flasks	10715
Cells	10715
culture flasks	10735
ontotreatedPetri dishes -LRB- at a ratio of twoflasks per Petri dish -RRB-	10762
ontotreatedPetri dishes	10762
a ratio of twoflasks per Petri dish	10790
a ratio	10790
twoflasks per Petri dish	10801
twoflasks	10801
Petri dish	10815
Unbound cells	10828
cells	10864
the dishes with a cell scraper	10889
the dishes	10889
a cell scraper	10905
poly	10936
l-lysine-treated 25 cm2 flasks -LRB- two dishes per flask -RRB-	10941
l-lysine-treated 25 cm2 flasks	10941
25	10958
two dishes per flask	10973
two dishes	10973
flask	10988
P75-OEG	10996
D/F -10 S for no more than 2 weeks	11021
D/F -10 S	11021
no more than 2 weeks	11033
senescence	11063
Two days after plating 2 μm forskolin -LRB- Sigma -RRB- and 20 μgml − 1 bovine pituitary extract -LRB- Biomedical Technologies Inc. -RRB-	11075
Two days	11075
2 μm forskolin -LRB- Sigma -RRB- and 20 μgml − 1 bovine pituitary extract -LRB- Biomedical Technologies Inc. -RRB-	11098
2 μm forskolin	11098
Sigma	11114
20 μgml − 1 bovine pituitary extract -LRB- Biomedical Technologies Inc. -RRB-	11125
20 μgml −	11125
1 bovine pituitary extract -LRB- Biomedical Technologies Inc. -RRB-	11133
1 bovine pituitary extract	11133
Biomedical Technologies Inc.	11161
the culture medium	11205
these components	11229
the whole culture period	11264
Medium	11290
every 2 -- 3 days	11309
every 2	11309
3 days	11317
transplantation	11329
we	11345
only p75 immunoreactive OEG , the only OEG capable of axon enfolding -LRB- Ramon-Cueto et al. 1993 -RRB-	11353
only p75 immunoreactive OEG , the only OEG capable	11353
only p75	11353
immunoreactive OEG	11362
the only OEG	11382
axon enfolding -LRB- Ramon-Cueto et al. 1993 -RRB-	11406
axon enfolding	11406
Ramon-Cueto et al. 1993	11422
Ramon-Cueto	11422
et al. 1993	11434
et al.	11434
1993	11441
transplantation	11460
cells	11477
the flasks	11502
bisbenzimide -LRB- Hoechst 33342 ; Sigma -RRB-	11528
bisbenzimide	11528
Hoechst 33342 ; Sigma	11542
Hoechst 33342	11542
Sigma	11557
DMEM	11584
a density of 105 cells μl − 1	11592
a density	11592
105 cells μl − 1	11605
105 cells μl −	11605
1	11618
Spinal cord transection and OEG transplantation , animal care and post-surgery period For the experiments described in this paper we	11621
Spinal cord transection and OEG transplantation	11621
animal care and post-surgery period	11670
the experiments described in this paper	11710
the experiments	11710
this paper	11739
we	11750
SOL and EDL muscles of the same rats that served as experimental animals in a previous study -LRB- Ramon-Cueto et al. 2000 -RRB-	11758
SOL and EDL muscles	11758
the same rats that served as experimental animals in a previous study -LRB- Ramon-Cueto et al. 2000 -RRB-	11781
the same rats	11781
experimental animals	11810
a previous study	11834
Ramon-Cueto et al. 2000	11852
Ramon-Cueto	11852
et al. 2000	11864
et al.	11864
2000	11871
The experimental details	11878
tissue culture	11914
surgical procedures , analysis of recovery of motor and sensory functions and spinal cord histology ,	11930
surgical procedures	11930
analysis of recovery of motor and sensory functions and spinal cord histology	11951
analysis	11951
recovery of motor and sensory functions and spinal cord histology	11963
recovery of motor	11963
recovery	11963
motor	11975
sensory functions and spinal cord histology	11985
sensory functions	11985
spinal cord histology	12007
detail	12053
OEG	12078
olfactory bulbs of adult Wistar rats -LRB- 2.5 months old , from the animal facilities of the Centre for Molecular Biology , CSIC-Autonomous University of Madrid -RRB- , expanded in culture and p75-positive cells -LRB- p75OEG -RRB- purified as reported previously -LRB- Ramon-Cueto & Nieto-Sampedro , 1992 , 1994 -RRB-	12101
olfactory bulbs	12101
adult Wistar rats -LRB- 2.5 months old , from the animal facilities of the Centre for Molecular Biology , CSIC-Autonomous University of Madrid -RRB- , expanded in culture and p75-positive cells -LRB- p75OEG -RRB- purified as reported previously	12120
adult Wistar rats -LRB- 2.5 months old , from the animal facilities of the Centre for Molecular Biology , CSIC-Autonomous University of Madrid -RRB-	12120
adult Wistar rats	12120
2.5 months old , from the animal facilities of the Centre for Molecular Biology , CSIC-Autonomous University of Madrid	12139
2.5 months old , from the animal facilities of the Centre for Molecular Biology , CSIC-Autonomous University	12139
2.5 months	12139
the animal facilities of the Centre for Molecular Biology	12160
the animal facilities	12160
the Centre for Molecular Biology	12185
the Centre	12185
Molecular Biology	12200
Madrid	12249
culture and p75-positive cells -LRB- p75OEG -RRB- purified as reported previously	12270
culture and p75-positive cells	12270
p75OEG	12302
Ramon-Cueto & Nieto-Sampedro	12343
1992	12372
1994	12378
Three weeks	12385
the primary cultures	12411
2 weeks after OEG purification	12433
2 weeks	12433
OEG purification	12447
p75OEG cells	12465
the flasks	12497
a nuclear fluorochrome	12523
culture medium	12563
transplantation	12591
Twenty-eight adult female Wistar rats -LRB- 2.5 months old , 200 -- 230 g -RRB-	12608
Twenty-eight adult female Wistar rats	12608
2.5 months old , 200 -- 230 g	12647
2.5 months old	12647
200 -- 230 g	12663
200	12663
230 g	12667
a mixture , in the same syringe , of 0.04 ml of medetomidine -LRB- Domtor , Pfizer -RRB- and 0.15 ml of ketamine -LRB- from a stock of 25 mg ml − 1 -RRB-	12699
a mixture , in the same syringe ,	12699
a mixture	12699
the same syringe	12713
0.04 ml of medetomidine -LRB- Domtor , Pfizer -RRB- and 0.15 ml of ketamine -LRB- from a stock of 25 mg ml − 1 -RRB-	12734
0.04 ml of medetomidine -LRB- Domtor , Pfizer -RRB-	12734
0.04 ml	12734
medetomidine -LRB- Domtor , Pfizer -RRB-	12745
medetomidine	12745
Domtor	12759
Pfizer	12767
0.15 ml of ketamine -LRB- from a stock of 25 mg ml − 1 -RRB-	12779
0.15 ml	12779
ketamine -LRB- from a stock of 25 mg ml − 1 -RRB-	12790
ketamine	12790
a stock of 25 mg ml − 1	12805
a stock	12805
25 mg ml − 1	12816
25 mg ml −	12816
1	12825
The need for supplemental doses of anaesthesia	12829
The need	12829
supplemental doses of anaesthesia	12842
supplemental doses	12842
anaesthesia	12864
the withdrawal reflex in both the fore and hind paws , after pin prick/dull stimulation of the wrist and ankle joints , respectively , and the tail	12903
the withdrawal reflex	12903
both the fore and hind paws	12928
the fore	12933
hind paws	12946
pin prick/dull stimulation of the wrist and ankle joints	12963
pin prick/dull stimulation	12963
the wrist and ankle joints	12993
the tail	13039
A laminectomy	13049
all animals	13080
thoracic segments 8 and 9 -LRB- T8 -- T9 -RRB-	13102
thoracic segments 8 and 9	13102
thoracic segments	13102
T8 -- T9	13129
T8	13129
T9	13132
19 rats	13140
the dura	13148
the spinal cords	13172
microscissors	13216
The stumps	13231
completeness of the lesion	13264
completeness	13264
the lesion	13280
Nine paraplegic rats -LRB- SCT+CT animals , n = 9 -RRB-	13292
Nine paraplegic rats	13292
SCT+CT animals , n = 9	13314
SCT+CT animals	13314
n = 9	13330
n	13330
9	13333
stereotaxic injections of Hoechst-labelled OEG	13345
stereotaxic injections	13345
Hoechst-labelled OEG	13371
cord stumps	13400
four sites	13418
the middle line	13433
1 mm from the stump border , using a sterile glass needle as previously described -LRB- Ramon-Cueto et al. 1998 , 2000 -RRB-	13457
1 mm	13457
the stump border	13466
a sterile glass needle as previously described -LRB- Ramon-Cueto et al. 1998 , 2000 -RRB-	13490
a sterile glass needle as previously described	13490
a sterile glass needle	13490
Ramon-Cueto	13538
et al. 1998 , 2000	13550
et al.	13550
1998	13557
2000	13563
Each site	13570
0.5 μl of a suspension containing 50 000 cells -LRB- 200 000 per stump -RRB-	13589
0.5 μl	13589
a suspension containing 50 000 cells -LRB- 200 000 per stump -RRB-	13599
a suspension	13599
50 000 cells -LRB- 200 000 per stump -RRB-	13623
50 000 cells	13623
200 000 per stump	13637
200 000	13637
stump	13649
Spinal cord	13657
non-transplanted animals -LRB- SCT , n = 11 -RRB-	13681
non-transplanted animals	13681
SCT , n = 11	13707
SCT	13707
n = 11	13712
n	13712
11	13715
0.5 μl of medium devoid of cells in the same spinal cord locations	13738
0.5 μl	13738
medium devoid of cells in the same spinal cord locations	13748
cells in the same spinal cord	13765
cells	13765
the same spinal cord	13774
Eight rats	13806
sham operated -LRB- C , control un-injured group , n = 8 -RRB-	13822
sham	13822
C , control un-injured group , n = 8	13837
C	13837
control un-injured group , n = 8	13840
control un-injured group	13840
n = 8	13866
n	13866
8	13869
no spinal cord transection and no injections	13873
no spinal cord transection	13873
no injections	13904
The injury site	13934
gelfoam	13967
the muscles and skin	13976
washedwith antiseptic solution.Animals	14019
a heating pad	14071
they	14091
surgery	14131
all rats	14140
a subcutaneous injectionof 1 mlof lactateRinger solution	14158
andmagnesium metamizol -LRB- Nolotil , Boeringer Ingelheim -RRB- as analgesic	14215
andmagnesium metamizol -LRB- Nolotil , Boeringer Ingelheim -RRB-	14215
andmagnesium metamizol	14215
Nolotil	14239
Boeringer Ingelheim	14248
analgesic	14272
Augmentine -LRB- amoxyciline -- clavulanic acid , 1 g -- 200 mg , GlaxoSmithKline -RRB- ,	14283
Augmentine	14283
amoxyciline	14295
clavulanic acid , 1 g -- 200 mg , GlaxoSmithKline	14307
clavulanic acid	14307
1 g -- 200 mg	14324
1 g	14324
200 mg	14328
GlaxoSmithKline	14336
that time	14374
every 8 h. Bladder expression	14399
twice a day	14443
establishment of reflex voidance	14461
establishment	14461
reflex voidance	14478
approximately 10 days	14495
this period	14525
residual urine	14538
everyday fromthe bladder of all paraplegic rats	14565
everyday fromthe bladder	14565
all paraplegic rats	14593
the risk of infections	14624
the risk	14624
infections	14636
Any complication derived from the spinal cord lesion -LRB- i.e. bladder infection , autonomic disreflexia , ulcers , failure of the kidneys , among others -RRB- that occurred during the post-surgery period	14648
Any complication	14648
the spinal cord lesion -LRB- i.e. bladder infection , autonomic disreflexia , ulcers , failure of the kidneys , among others -RRB- that occurred during the post-surgery period	14678
the spinal cord lesion	14678
i.e. bladder infection , autonomic disreflexia , ulcers , failure of the kidneys , among others	14702
i.e.	14702
bladder infection , autonomic disreflexia , ulcers , failure of the kidneys , among others	14707
bladder infection	14707
autonomic disreflexia	14726
ulcers	14749
failure of the kidneys	14757
failure	14757
the kidneys	14768
others	14787
the post-surgery period	14816
protocols adapted from those used in human patients at the Spinal Cord Injury Unit of the University Hospital La Fe , Valencia , and the National Paraplegics Hospital of Toledo , Spain -LRB- see Santos-Benito et al. -LRB- 2006 -RRB- for a detailed description of the post-operative care of these paraplegic rats -RRB-	14863
protocols	14863
those used in human patients at the Spinal Cord Injury Unit of the University Hospital La Fe , Valencia , and the National Paraplegics Hospital of Toledo , Spain -LRB- see Santos-Benito et al. -LRB- 2006 -RRB- for a detailed description of the post-operative care of these paraplegic rats -RRB-	14886
those	14886
human patients	14900
the Spinal Cord Injury Unit of the University Hospital La Fe , Valencia , and the National Paraplegics Hospital of Toledo , Spain -LRB- see Santos-Benito et al. -LRB- 2006 -RRB- for a detailed description of the post-operative care of these paraplegic rats -RRB-	14918
the Spinal Cord Injury Unit of the University Hospital La Fe	14918
the Spinal Cord Injury Unit	14918
the University Hospital La Fe	14949
Valencia	14980
the National Paraplegics Hospital of Toledo , Spain -LRB- see Santos-Benito et al. -LRB- 2006 -RRB- for a detailed description of the post-operative care of these paraplegic rats -RRB-	14994
the National Paraplegics Hospital of Toledo , Spain	14994
the National Paraplegics Hospital	14994
Toledo , Spain	15031
Santos-Benito	15050
et al. -LRB- 2006 -RRB- for a detailed description of the post-operative care of these paraplegic rats	15064
et al. -LRB- 2006 -RRB-	15064
et al.	15064
2006	15072
a detailed description of the post-operative care of these paraplegic rats	15082
a detailed description	15082
the post-operative care of these paraplegic rats	15108
the post-operative care	15108
these paraplegic rats	15135
recovery from surgery	15165
recovery	15165
surgery	15179
all animals	15188
an open field every day	15244
an open field	15244
every day	15258
20 min	15272
inclined grids of different level of difficulty	15310
inclined grids	15310
different level of difficulty	15328
different level	15328
difficulty	15347
a function of the slope	15361
a function	15361
the slope	15375
3 to 7 months	15391
post-surgery the improvement of motor and sensory function	15404
post-surgery the improvement	15404
motor and sensory function	15436
all rats -LRB- Ramon-Cueto et al. 2000 -RRB-	15479
all rats	15479
Ramon-Cueto	15489
et al. 2000	15501
et al.	15501
2000	15508
Recovery of voluntary movement of the hind limbs	15515
Recovery	15515
voluntary movement of the hind limbs	15527
voluntary movement	15527
the hind limbs	15549
a climbing test that allowed discerning between local reflex activity and real voluntary movement	15583
a climbing test	15583
discerning between local reflex activity and real voluntary movement	15612
discerning	15612
local reflex activity and real voluntary movement	15631
local reflex activity	15631
real voluntary movement	15657
Seven months	15682
animals	15709
a restricted amount of standard laboratory chow	15726
a restricted amount	15726
standard laboratory chow	15749
an individual basis	15789
body weight	15822
a range of 270 -- 300 g	15844
a range of 270	15844
a range	15844
270	15855
300 g	15859
this period	15872
animals	15884
ad libitum	15912
killing	15929
All animals	15938
a second surgery	15960
tracer injection 7 months and 1 week	15981
tracer injection 7 months	15981
tracer injection	15981
7 months	15998
1 week	16011
the first surgery	16024
They	16043
an isoflurane-based gaseous anaesthesia -LRB- induction : 2 l min − 1 O2 , 1 l min − 1 N2O and 3.5 % isoflurane for 2 min ; maintenance : 0.8 l min − 1 O2 , 0.4 l min − 1 N2O and 2.5 % isoflurane -RRB-	16072
an isoflurane-based gaseous anaesthesia	16072
induction : 2 l min − 1 O2 , 1 l min − 1 N2O and 3.5 % isoflurane for 2 min ; maintenance : 0.8 l min − 1 O2 , 0.4 l min − 1 N2O and 2.5 % isoflurane	16113
induction : 2 l min − 1 O2	16113
induction	16113
2 l min − 1 O2	16124
2 l min −	16124
1 O2	16132
1 l min − 1 N2O	16138
1 l min −	16138
1 N2O	16146
3.5 % isoflurane for 2 min ; maintenance : 0.8 l min − 1 O2 , 0.4 l min − 1 N2O and 2.5 % isoflurane	16156
3.5 % isoflurane	16156
2 min ; maintenance : 0.8 l min − 1 O2 , 0.4 l min − 1 N2O and 2.5 % isoflurane	16176
2 min	16176
maintenance	16183
0.8 l min − 1 O2	16196
0.8 l min −	16196
1 O2	16206
0.4 l min − 1 N2O and 2.5 % isoflurane	16212
0.4 l min − 1 N2O	16212
0.4 l min −	16212
1 N2O	16222
2.5 % isoflurane	16232
the same treatments -LRB- antibiotics and analgesics -RRB- described above	16262
the same treatments	16262
antibiotics and analgesics	16283
antibiotics	16283
analgesics	16299
Three weeks later	16328
8 months after the first surgery	16347
8 months	16347
the first surgery	16362
animals	16381
a mixture of Domtor and ketamine as described above , and soleus -LRB- SOL -RRB- and extensor digitorum longus -LRB- EDL -RRB- muscles of both hind limbs were dissected quickly	16420
a mixture of Domtor	16420
a mixture	16420
Domtor	16433
ketamine as described above	16444
ketamine	16444
soleus -LRB- SOL -RRB- and extensor digitorum longus -LRB- EDL -RRB- muscles of both hind limbs were dissected quickly	16477
soleus -LRB- SOL -RRB-	16477
soleus	16477
SOL	16485
extensor digitorum longus -LRB- EDL -RRB- muscles of both hind limbs were dissected quickly	16494
extensor digitorum longus	16494
EDL	16521
muscles of both hind limbs	16526
muscles	16526
both hind limbs	16537
all rats	16601
saline and fixative -LRB- 4 % paraformaldehyde -RRB- and their spinal cords dissected for histological analysis , as previously reported -LRB- Ramon-Cueto et al. 2000 -RRB-	16629
saline and fixative -LRB- 4 % paraformaldehyde -RRB-	16629
saline and fixative	16629
4 % paraformaldehyde	16650
4 %	16650
paraformaldehyde	16653
their spinal cords dissected for histological analysis , as previously reported -LRB- Ramon-Cueto et al. 2000 -RRB-	16675
their spinal cords dissected for histological analysis , as previously reported	16675
their spinal cords	16675
histological analysis , as previously reported	16708
histological analysis	16708
Ramon-Cueto	16755
et al. 2000	16767
et al.	16767
2000	16774
All experimental procedures	16781
the guidelines laid down by the AutonomousUniversity ofMadridand theHigherCouncil of Scientific Research of Spain following the normal procedures directing animal welfare -LRB- Real Decreto 223/88 , BOE of 18 ofMarch -RRB- and adhered to the recommendations	16818
the guidelines	16818
the AutonomousUniversity ofMadridand theHigherCouncil of Scientific Research of Spain	16846
the AutonomousUniversity ofMadridand theHigherCouncil	16846
Scientific Research of Spain	16903
Scientific Research	16903
Spain	16926
the normal procedures directing animal welfare -LRB- Real Decreto 223/88 , BOE of 18 ofMarch -RRB-	16942
the normal procedures	16942
animal welfare -LRB- Real Decreto 223/88 , BOE of 18 ofMarch -RRB-	16974
animal welfare	16974
Real Decreto 223/88 , BOE of 18 ofMarch	16990
Real Decreto	16990
223/88 , BOE of 18 ofMarch	17003
223/88	17003
BOE of 18 ofMarch	17011
BOE	17011
18 ofMarch	17018
the recommendations	17045
the Guide for Care and Use of Laboratory Animals -LRB- US Department of Health and Human Services , NIH -RRB- andEuropean laws and regulations	17077
the Guide for Care and Use of Laboratory Animals -LRB- US Department of Health and Human Services , NIH -RRB- andEuropean	17077
Care	17091
Laboratory Animals	17107
US Department of Health and Human Services , NIH	17127
US Department	17127
Health and Human Services	17144
NIH	17171
laws and regulations	17187
the protection of animals	17211
the protection	17211
animals	17229
the advice of specialized personnel	17244
the advice	17244
specialized personnel	17258
Muscle dissection and preparation of tissue samples Eight months	17281
Muscle dissection and preparation	17281
tissue samples	17318
Eight months	17333
the first intervention	17352
all animals	17376
this section	17443
SOL and EDL muscles of both hind limbs	17457
SOL and EDL muscles	17457
both hind limbs	17480
Tissue blocks	17550
the muscle belly	17583
isopentane chilled with liquid nitrogen	17603
isopentane	17603
liquid nitrogen	17627
− 70 ◦ C	17657
Cryostat serial cross-sections prepared at − 20 ◦ C	17679
Cryostat serial cross-sections	17679
− 20 ◦ C	17721
either gelatin-coated or silanized slides , for immunohistochemistry ,	17742
either gelatin-coated or silanized slides	17742
immunohistochemistry	17789
qualitative and quantitative histochemistry	17831
The remainder of the muscle	17876
The remainder	17876
the muscle	17893
liquid nitrogen	17918
− 70 ◦ C	17952
electrophoresis	17973
Immunohistochemistry and histochemistry Immunohistochemical analysis of myosin heavy chain -LRB- MHC -RRB- isoform expression in individual fibres was performed on 10μm thick serial cryostat cross-sections	17990
Immunohistochemistry and histochemistry Immunohistochemical analysis	17990
myosin heavy chain -LRB- MHC -RRB- isoform expression in individual fibres was performed on 10μm thick serial cryostat cross-sections	18062
myosin heavy chain -LRB- MHC -RRB-	18062
myosin heavy chain	18062
MHC	18082
isoform expression in individual fibres	18087
isoform expression	18087
individual fibres	18109
10μm thick serial cryostat cross-sections	18144
a series of monoclonal antibodies -LRB- Mabs , Table	18199
a series	18199
monoclonal antibodies -LRB- Mabs , Table	18211
monoclonal antibodies	18211
Mabs	18234
Table	18240
1 -RRB- specific for rat MHC isoforms -LRB- Schiaffino et al. 1989 -RRB- as described by Rivero et al. -LRB- 1999 -RRB-	18246
1 -RRB- specific for rat MHC isoforms	18246
specific	18249
rat MHC isoforms	18262
Schiaffino et al. 1989	18280
Schiaffino	18280
et al. 1989	18291
et al.	18291
1989	18298
Rivero	18320
et al. -LRB- 1999 -RRB-	18327
et al.	18327
1999	18335
Localization of the bound primary antibodies	18342
Localization	18342
the bound primary antibodies	18358
biotin-bound secondary antibodies and avidin	18406
biotin-bound secondary antibodies	18406
avidin	18444
biotin complex -LRB- ABC , peroxidase-based kit PK-6102 , for IgG class monoclonal antibodies -LRB- MAbs -RRB- , and alkaline phosphatase-based kit AK-5010 , for IgM class MAbs , Vector Laboratories , Burlingame , CA , USA -RRB-	18451
biotin complex	18451
ABC , peroxidase-based kit PK-6102 , for IgG class monoclonal antibodies -LRB- MAbs -RRB- , and alkaline phosphatase-based kit AK-5010 , for IgM class MAbs	18467
ABC , peroxidase-based kit PK-6102 , for IgG class monoclonal antibodies -LRB- MAbs -RRB- , and alkaline phosphatase-based kit AK-5010 ,	18467
ABC , peroxidase-based kit PK-6102 , for IgG class monoclonal antibodies -LRB- MAbs -RRB-	18467
ABC , peroxidase-based kit PK-6102 , for IgG class monoclonal antibodies	18467
ABC , peroxidase-based kit PK-6102 ,	18467
ABC	18467
peroxidase-based kit PK-6102	18472
IgG class monoclonal antibodies	18506
MAbs	18539
alkaline phosphatase-based kit AK-5010	18550
alkaline	18550
phosphatase-based kit AK-5010	18559
IgM class MAbs	18594
Vector Laboratories , Burlingame , CA , USA	18610
Vector Laboratories	18610
Burlingame	18631
CA	18643
USA	18647
diaminobenzidine -LRB- DAB , kit SK-4100 ; Vector Laboratories -RRB-	18658
diaminobenzidine	18658
DAB , kit SK-4100 ; Vector Laboratories	18676
DAB	18676
kit SK-4100 ; Vector Laboratories	18681
kit SK-4100	18681
Vector Laboratories	18694
the chromogen to localize peroxidase and a pre-mixed NBT/BCIP solution -LRB- B. 6404 , Sigma , St Louis , MO , USA -RRB- containing levamisole -LRB- SP-500 -RRB- to reveal alkaline phosphatase	18718
peroxidase and a pre-mixed NBT/BCIP solution -LRB- B. 6404 , Sigma , St Louis , MO , USA -RRB-	18744
peroxidase and a pre-mixed NBT/BCIP solution	18744
peroxidase	18744
a pre-mixed NBT/BCIP solution	18759
B. 6404 , Sigma , St Louis , MO , USA	18790
B. 6404	18790
Sigma	18798
St Louis	18805
MO	18814
USA	18818
levamisole	18834
SP-500	18846
alkaline phosphatase	18864
Background staining	18886
additional serial sections incubated without primary antibody	18924
additional serial sections	18924
primary antibody	18969
Muscle fibres	18987
MHC content	19021
their individual patterns of Mab reactivity	19046
their individual patterns	19046
Mab reactivity	19075
Table 1	19107
Seven fibre types	19116
four expressing unique MHC isoforms -LRB- designated I , IIA , IID/X and IIB -RRB- and three additional mixed fibre types co-expressing two MHCs isoforms I + IIA , IIA+IIX / D -LRB- IIAD/X -RRB- and IID/X + IIB -LRB- IID/XB -RRB-	19151
four	19151
unique MHC isoforms -LRB- designated I , IIA , IID/X and IIB -RRB- and three additional mixed fibre types co-expressing two MHCs isoforms I + IIA , IIA+IIX / D -LRB- IIAD/X -RRB- and IID/X + IIB -LRB- IID/XB -RRB-	19167
unique MHC isoforms	19167
I , IIA , IID/X and IIB	19199
I	19199
IIA	19202
IID/X	19207
IIB	19217
three additional mixed fibre types co-expressing two MHCs isoforms I + IIA , IIA+IIX / D -LRB- IIAD/X -RRB- and IID/X + IIB -LRB- IID/XB -RRB-	19226
three additional mixed fibre types	19226
two MHCs isoforms I + IIA , IIA+IIX / D -LRB- IIAD/X -RRB- and IID/X + IIB -LRB- IID/XB -RRB-	19275
two MHCs isoforms I + IIA , IIA+IIX / D -LRB- IIAD/X -RRB- and IID/X	19275
two MHCs isoforms I	19275
two MHCs isoforms	19275
I	19293
IIA , IIA+IIX / D -LRB- IIAD/X -RRB-	19296
IIA	19296
IIA+IIX / D -LRB- IIAD/X -RRB-	19301
IIA+IIX / D	19301
IIA+IIX	19301
D	19309
IIAD/X	19312
IID/X	19324
IIB -LRB- IID/XB -RRB-	19330
IIB	19330
IID/XB	19335
Two additional serial cross-sections	19344
qualitative assessment of myofibrillar ATPase activity	19398
qualitative assessment	19398
myofibrillar ATPase activity	19424
alkaline -LRB- pH 10.45 -RRB- and acid -LRB- pH 4.45 -RRB- pre-incubations	19464
alkaline -LRB- pH 10.45 -RRB-	19464
alkaline	19464
pH 10.45	19474
acid -LRB- pH 4.45 -RRB- pre-incubations	19488
acid	19488
pH 4.45	19494
pre-incubations	19503
a modification -LRB- Nwoye et al. 1982 -RRB- of the Brooke and Kaiser method -LRB- Brooke & Kaiser , 1970 -RRB-	19526
a modification -LRB- Nwoye et al. 1982 -RRB-	19526
a modification	19526
Nwoye et al. 1982	19542
Nwoye	19542
et al. 1982	19548
et al.	19548
1982	19555
the Brooke and Kaiser method -LRB- Brooke & Kaiser , 1970 -RRB-	19564
the Brooke and Kaiser method	19564
Brooke & Kaiser	19594
1970	19611
the staining intensity after alkaline pre-incubation	19631
the staining intensity	19631
alkaline pre-incubation	19660
pure muscle fibres	19685
type I -LRB- white -RRB- , IIB -LRB- grey -RRB- and IIA and IID/X -LRB- black -RRB-	19723
type I -LRB- white -RRB-	19723
type I	19723
IIB -LRB- grey -RRB-	19739
IIB	19739
IIA and IID/X -LRB- black -RRB-	19754
IIA and IID/X	19754
the mATPase reaction after acid pre-incubation	19788
the mATPase reaction	19788
acid pre-incubation	19815
distinction of fibre types	19848
distinction	19848
fibre types	19863
intensity : type I -LRB- black -RRB- , IIA -LRB- white -RRB- and IID/X and IIB -LRB- intermediate intensity -RRB-	19897
intensity	19897
type I -LRB- black -RRB- , IIA -LRB- white -RRB- and IID/X and IIB -LRB- intermediate intensity -RRB-	19908
type I -LRB- black -RRB-	19908
type I	19908
IIA -LRB- white -RRB-	19924
IIA	19924
IID/X and IIB -LRB- intermediate intensity -RRB-	19940
IID/X and IIB	19940
intermediate intensity	19955
a continuum of staining intensities	19994
a continuum	19994
staining intensities	20009
observedwithin fast-twitchsubtypes -LRB- Delp & Duan ,1996 -RRB-	20034
observedwithin fast-twitchsubtypes	20034
Delp & Duan ,1996	20070
Delp	20070
Duan ,1996	20075
Five consecutive cross-sections	20087
each enzyme histochemical assay -LRB- succinate dehydrogenase -LRB- SDH -RRB- and glycerol-3-phosphate dehydrogenase -LRB- GPDH -RRB- -RRB-	20133
each enzyme histochemical assay	20133
succinate dehydrogenase -LRB- SDH -RRB- and glycerol-3-phosphate dehydrogenase -LRB- GPDH -RRB-	20166
succinate	20166
dehydrogenase -LRB- SDH -RRB- and glycerol-3-phosphate dehydrogenase -LRB- GPDH -RRB-	20176
dehydrogenase -LRB- SDH -RRB-	20176
dehydrogenase	20176
SDH	20191
glycerol-3-phosphate dehydrogenase -LRB- GPDH -RRB-	20200
glycerol-3-phosphate dehydrogenase	20200
GPDH	20236
Three of them	20244
Three	20244
them	20253
medium	20276
substrate -LRB- either succinic acid or glycerol-3-phosphate -RRB-	20294
substrate	20294
succinic acid or glycerol-3-phosphate	20312
the other two , incubated in the absence of substrate ,	20352
the other two	20352
the absence of substrate	20380
the absence	20380
substrate	20395
non-specific staining	20431
Mean muscle oxidative capacity was assessed by means of quantitative SDH histochemistry performed in 10 μm thick sections following the procedure	20454
Mean muscle	20454
oxidative capacity	20466
means of quantitative SDH histochemistry performed in 10 μm thick sections following the procedure	20501
means	20501
quantitative SDH histochemistry performed in 10 μm thick sections following the procedure	20510
quantitative SDH histochemistry	20510
10 μm thick sections following the procedure	20555
10 μm thick sections	20555
the procedure	20586
Blanco	20624
et al. -LRB- 1988 -RRB-	20631
et al.	20631
1988	20639
The activity of GPDH , an indirect marker of glycolytic capacity ,	20646
The activity of GPDH	20646
The activity	20646
GPDH	20662
an indirect marker of glycolytic capacity	20668
an indirect marker	20668
glycolytic capacity	20690
14 μm thick sections	20729
Martin et al. -LRB- 1985 -RRB-	20763
Martin et al.	20763
Martin	20763
et al.	20770
1985	20778
staining	20791
sections	20801
2	20832
3 h with a computerized image-processing system -LRB- see below -RRB-	20834
3 h	20834
a computerized image-processing system -LRB- see below -RRB-	20843
a computerized image-processing system	20843
SDH and GPDH activities	20901
at least 15 or 30 min	20940
at least 15	20940
30 min	20955
termination of the reaction within this time	20977
termination	20977
the reaction within this time	20992
the reaction	20992
this time	21012
enzymatic activities	21030
steady-state rates	21070
These activities	21090
optical density per time unit -LRB- OD min − 1 -RRB-	21125
optical density	21125
time unit -LRB- OD min − 1 -RRB-	21145
time unit	21145
OD min − 1	21156
OD min −	21156
1	21163
Quantitative tissue analysis	21167
appropriate staining	21202
a region -LRB- 750 000 μm2 -RRB- of the cross-sections containing between 125 and 175 fibres per muscle sample	21224
a region -LRB- 750 000 μm2 -RRB-	21224
a region	21224
750 000 μm2	21234
750 000	21234
μm2	21242
the cross-sections containing between 125 and 175 fibres per muscle sample	21250
the cross-sections	21250
between 125 and 175 fibres per muscle sample	21280
between 125 and 175 fibres	21280
muscle sample	21311
further analysis	21342
Serial sections	21360
regions free of artefacts	21398
regions	21398
artefacts	21414
They	21425
a Leica DMLS microscope -LRB- Leica Microsistemas , Barcelona , Spain -RRB- , a high-resolution colour charge-coupled device Leica ICCA camera -LRB- Leica Microsistemas , Barcelona , Spain -RRB- , and an eight-bit Matrox Meteor II frame-grabber -LRB- Matrox Electronic Systems Ltd , Barcelona , Spain -RRB- ,	21465
a Leica DMLS microscope	21465
Leica Microsistemas , Barcelona , Spain	21490
Leica Microsistemas , Barcelona	21490
Spain	21522
a high-resolution colour charge-coupled device Leica ICCA camera -LRB- Leica Microsistemas , Barcelona , Spain -RRB-	21530
a high-resolution colour	21530
charge-coupled device Leica ICCA camera -LRB- Leica Microsistemas , Barcelona , Spain -RRB-	21555
charge-coupled device Leica ICCA camera	21555
Leica Microsistemas , Barcelona , Spain	21596
Leica Microsistemas , Barcelona	21596
Spain	21628
an eight-bit Matrox Meteor II frame-grabber -LRB- Matrox Electronic Systems Ltd , Barcelona , Spain -RRB-	21640
an eight-bit Matrox Meteor II frame-grabber	21640
Matrox Electronic Systems Ltd , Barcelona , Spain	21685
Matrox Electronic Systems Ltd	21685
Barcelona , Spain	21716
an image-analysing software -LRB- Visiolog 5 , Noemi , Microptic , Barcelona , Spain -RRB-	21749
an image-analysing software	21749
Visiolog 5	21778
Noemi , Microptic	21790
Barcelona , Spain	21808
Serial sections	21827
the fibres	21877
their immunohistochemical stains	21927
The fibre type distribution of each muscle sample	21961
The fibre type distribution	21961
each muscle sample	21992
immunohistochemistry by counting the relative frequency of the various fibre types	22037
immunohistochemistry	22037
the relative frequency of the various fibre types	22070
the relative frequency	22070
the various fibre types	22096
The same region of the serial sections stained for quantitative SDH and GPDH	22121
The same region	22121
the serial sections stained for quantitative SDH and GPDH	22140
the serial sections	22140
quantitative SDH and GPDH	22172
a grey level -LRB- range of grey level 0 -- 255 -RRB- image	22215
range of grey level 0 -- 255	22229
range of grey level	22229
range	22229
grey level	22238
0 -- 255	22249
each sample analysed	22267
each sample	22267
a mean optical density -LRB- OD -RRB-	22289
a mean optical density	22289
OD	22313
each quantitative histochemical assay	22336
values	22378
OD min − 1	22397
OD min −	22397
1	22404
each enzyme assay	22411
the mean value of the three sections analysed with substrate minus the mean of the two tissue blank sections	22430
the mean value	22430
the three sections analysed with substrate minus the mean of the two tissue blank sections	22448
the three sections	22448
substrate minus the mean of the two tissue blank sections	22481
substrate	22481
the mean of the two tissue blank sections	22497
the mean	22497
the two tissue blank sections	22509
the enzyme activity of a single muscle sample	22561
the enzyme activity	22561
a single muscle sample	22584
a number of factors	22614
a number	22614
factors	22626
the reliability of histochemical enzymeactivity determination	22648
the reliability	22648
histochemical enzymeactivity determination	22667
we	22711
the measurement precision associated with several sources of variability -LRB- thickness of the tissue , image analysis system , etc. -RRB- by repeated measurements	22723
the measurement precision	22723
several sources of variability	22765
several sources	22765
variability	22784
thickness of the tissue , image analysis system , etc.	22797
thickness of the tissue	22797
thickness	22797
the tissue	22810
image analysis system	22822
repeated measurements	22854
the same single fields	22879
three consecutive sections	22905
The coefficient of variation for triplicate measurement of OD in each histochemical assay	22933
The coefficient	22933
variation for triplicate measurement of OD in each histochemical assay	22952
variation	22952
triplicate measurement of OD in each histochemical assay	22966
triplicate measurement	22966
OD in each histochemical assay	22992
OD	22992
each histochemical assay	22998
5 %	23040
The cross-sectional areas of 125 individual muscle fibres per sample	23044
The cross-sectional areas	23044
125 individual muscle fibres per sample	23073
125 individual muscle fibres	23073
sample	23106
the same computerized video display image-analysis system previously described	23147
the same computerized video display image-analysis system	23147
values	23230
each muscle biopsy specimen	23266
Fibre size	23295
the histochemical preparations of SDH	23324
the histochemical preparations	23324
SDH	23358
this procedure	23368
no negative impact onmuscle fibre size -LRB- Snow & Guy , 1980 -RRB-	23387
no negative impact onmuscle fibre size	23387
Snow & Guy	23427
1980	23439
Two-dimensional electrophoresis and evaluation of the relative proportions of myosin light chain -LRB- MLC -RRB- isoforms and variants thereof Muscle homogenization , sample preparation and twodimensional -LRB- 2D -RRB- electrophoresis of proteins were performed essentially as previously described -LRB- Hernando & Manso , 1997 ; Gonzalez et al. 2002 -RRB- , using a pH range of 4 -- 6.5 in the first , isoelectric focusing dimension and 9 -- 20 % acrylamide slab gel gradients for the second dimension .	23446
Two-dimensional electrophoresis and evaluation of the relative proportions of myosin light chain -LRB- MLC -RRB-	23446
Two-dimensional electrophoresis and evaluation	23446
the relative proportions of myosin light chain -LRB- MLC -RRB-	23496
the relative proportions	23496
myosin light chain -LRB- MLC -RRB-	23524
myosin light chain	23524
MLC	23544
isoforms and variants	23549
homogenization , sample preparation and twodimensional -LRB- 2D -RRB- electrophoresis of proteins were performed essentially as previously described -LRB- Hernando & Manso , 1997 ; Gonzalez et al. 2002 -RRB-	23586
homogenization , sample preparation and twodimensional -LRB- 2D -RRB- electrophoresis of proteins were performed essentially as previously described	23586
homogenization , sample preparation and twodimensional	23586
2D	23641
electrophoresis of proteins	23645
electrophoresis	23645
proteins	23664
Hernando & Manso , 1997 ; Gonzalez et al. 2002	23725
Hernando & Manso , 1997 ; Gonzalez et al.	23725
Hernando & Manso , 1997	23725
Hernando & Manso	23725
1997	23743
Gonzalez et al.	23749
Gonzalez	23749
et al.	23758
2002	23765
a pH range of 4 -- 6.5 in the first , isoelectric focusing dimension and 9 -- 20 % acrylamide slab gel gradients	23778
a pH range	23778
4	23792
6.5 in the first , isoelectric focusing dimension and 9	23794
6.5	23794
the first , isoelectric focusing dimension and 9	23801
the first , isoelectric focusing dimension	23801
9	23847
20 % acrylamide slab gel gradients	23849
the second dimension	23887
The resulting 2D electrophoretograms of whole muscle proteins	23909
The resulting 2D electrophoretograms	23909
whole muscle proteins	23949
0.5 % Coomassie	23987
brilliant blue R to determine the relative proportions of MLC isoforms	24002
the relative proportions of MLC isoforms	24032
the relative proportions	24032
MLC isoforms	24060
Three variants of each , the slow -LRB- s -RRB- and fast -LRB- f -RRB- regulatory -LRB- r -RRB- MLCs -LRB- designated 2s , 2s1 , 2s2 and 2f , 2f1 and 2f2 , respectively , from less to more acidic -RRB-	24074
Three variants	24074
each , the slow -LRB- s -RRB- and fast -LRB- f -RRB- regulatory -LRB- r -RRB- MLCs -LRB- designated 2s , 2s1 , 2s2 and 2f , 2f1 and 2f2 , respectively , from less to more acidic -RRB-	24092
each	24092
the slow -LRB- s -RRB-	24098
fast -LRB- f -RRB- regulatory -LRB- r -RRB- MLCs -LRB- designated 2s , 2s1 , 2s2 and 2f , 2f1 and 2f2 , respectively , from less to more acidic -RRB-	24115
fast	24115
f -RRB- regulatory -LRB- r -RRB- MLCs -LRB- designated 2s , 2s1 , 2s2 and 2f , 2f1 and 2f2 , respectively , from less to more acidic	24121
regulatory -LRB- r -RRB-	24124
MLCs -LRB- designated 2s , 2s1 , 2s2 and 2f , 2f1 and 2f2 , respectively ,	24139
MLCs -LRB- designated 2s , 2s1 , 2s2	24139
MLCs -LRB- designated 2s , 2s1 ,	24139
MLCs	24139
designated 2s , 2s1	24145
designated 2s	24145
2s1	24160
2s2	24165
2f , 2f1 and 2f2 , respectively ,	24173
2f , 2f1 and 2f2	24173
less	24209
more acidic	24217
more	24217
as previously reported -LRB- Gonzalez et al. 2002 -RRB-	24244
as previously	24244
Gonzalez et al. 2002	24268
Gonzalez	24268
et al. 2002	24277
et al.	24277
2002	24284
Quantification of proteins in stained gels	24291
Quantification	24291
proteins in stained gels	24309
proteins	24309
gels	24329
densitometry -LRB- Bio-Rad , GS-710 , with Quantity One software v. 4.2.1 -RRB-	24354
densitometry	24354
Bio-Rad , GS-710 , with Quantity One software v. 4.2.1	24368
Bio-Rad , GS-710 ,	24368
Bio-Rad	24368
GS-710	24377
Quantity One software v. 4.2.1	24390
Quantity One software	24390
4.2.1	24414
Optical density measurements	24422
the linear absorption range	24469
Statistical and discriminant analysis of the data Data	24498
Statistical and discriminant analysis	24498
the data Data	24539
means	24571
s.d. Differences among groups	24577
s.d. Differences	24577
groups	24600
one-way analysis of variance -LRB- ANOVA -RRB- using the statistical program SPSS 8.0	24624
one-way analysis	24624
variance -LRB- ANOVA -RRB- using the statistical program SPSS 8.0	24644
ANOVA	24654
the statistical program SPSS	24667
8.0	24696
significance	24706
pair-wise comparisons	24736
a Bonferroni post hoc test , when the homogeneity of variance was accepted -LRB- Levene statistics -RRB- , and a Dunnett 's T3 test when the homogeneity of variance was discarded	24779
a Bonferroni post hoc test , when the homogeneity of variance was accepted -LRB- Levene statistics -RRB-	24779
a Bonferroni post hoc test	24779
the homogeneity of variance	24812
the homogeneity	24812
variance	24831
Levene statistics	24854
a Dunnett 's T3 test when the homogeneity of variance was discarded	24878
a Dunnett 's T3 test	24878
a Dunnett 's	24878
the homogeneity of variance	24903
the homogeneity	24903
variance	24922
Differences	24946
statistically significant at P <	24974
P	25003
Correlations between variables	25012
Correlations	25012
variables	25033
Pearson 's or Spearman 's tests -LRB- for homogeneous or non-homogeneous variances , respectively -RRB-	25063
Pearson 's or Spearman 's tests	25063
Pearson 's or Spearman 's	25063
Pearson 's	25063
Spearman 's	25076
tests	25087
homogeneous or non-homogeneous variances , respectively	25098
homogeneous or non-homogeneous variances	25098
All the data fromthe individualmuscles of all three groups	25155
All the data fromthe individualmuscles	25155
All the data	25155
all three groups	25197
amultivariate , discriminant analysis using the package Statistica for Windows	25231
amultivariate	25231
discriminant analysis using the package Statistica for Windows	25246
discriminant analysis	25246
the package Statistica for Windows	25274
the package Statistica	25274
Windows	25301
This analysis	25310
skeletalmuscles of experimental animals	25341
skeletalmuscles	25341
experimental animals	25360
phenotype	25394
the overall characteristics of group pairs	25416
the overall characteristics	25416
group pairs	25447
their homology	25472
individual muscles	25503
one group or the other	25527
one group	25527
the other	25540
muscles of OEG-transplanted animals	25557
muscles	25557
OEG-transplanted animals	25568
those of non-transplanted and control	25612
those	25612
non-transplanted and control	25621
non-transplanted	25621
control	25642
information	25657
the impact of OEG transplants	25672
the impact	25672
OEG transplants	25686
the relative maintenance of normal skeletal muscle characteristics	25705
the relative maintenance	25705
normal skeletal muscle characteristics	25733
Statistically significant differences between pair of groups -LRB- P < 0.05 -RRB- and the degree of homology of muscles from OEG-transplanted rats with those of control or non-transplanted -LRB- Mahalanobis distances -RRB-	25773
Statistically significant differences between pair of groups -LRB- P < 0.05 -RRB- and the degree of homology of muscles from OEG-transplanted rats with those of control or non-transplanted	25773
Statistically significant differences	25773
pair of groups -LRB- P < 0.05 -RRB- and the degree of homology of muscles from OEG-transplanted rats with those of control or non-transplanted	25819
pair of groups -LRB- P < 0.05 -RRB-	25819
pair	25819
groups -LRB- P < 0.05 -RRB-	25827
groups	25827
P < 0.05	25835
P	25835
< 0.05	25837
<	25837
0.05	25838
the degree of homology of muscles from OEG-transplanted rats with those of control or non-transplanted	25848
the degree	25848
homology of muscles from OEG-transplanted rats with those of control or non-transplanted	25862
homology	25862
muscles from OEG-transplanted rats with those of control or non-transplanted	25874
muscles	25874
OEG-transplanted rats with those of control or non-transplanted	25887
OEG-transplanted rats	25887
those of control or non-transplanted	25914
those	25914
control or non-transplanted	25923
Mahalanobis distances	25952
Fig. 5	25992
each group pair	26003
Results Table 1 .	26021
Results	26021
Table 1	26029
Characteristics of anti-myosin heavy chain -LRB- MHC -RRB- monoclonal antibodies -LRB- MAb -RRB- and clues for the immunohistochemical identification of the MHC isoforms expressed in skeletal muscle fibres Figure 1 .	26038
Characteristics	26038
anti-myosin heavy chain -LRB- MHC -RRB- monoclonal antibodies -LRB- MAb -RRB- and clues for the immunohistochemical identification	26057
anti-myosin heavy chain -LRB- MHC -RRB-	26057
anti-myosin heavy chain	26057
MHC	26082
monoclonal antibodies -LRB- MAb -RRB-	26087
monoclonal antibodies	26087
MAb	26110
clues for the immunohistochemical identification	26119
clues	26119
the immunohistochemical identification	26129
the MHC isoforms	26171
skeletal muscle fibres Figure 1	26201
skeletal muscle fibres	26201
Figure 1	26225
Morphological characteristics of fast - and slow-twitch skeletal muscles of the rat hind	26235
Morphological characteristics	26235
fast - and slow-twitch skeletal muscles of the rat hind	26268
fast - and slow-twitch skeletal muscles	26268
the rat hind	26310
limb following long-term paralysis induced by a complete transversal section of the spinal cord : effect of OEG transplantation The figure represents the absolute and relative -LRB- body weight and muscle-somatic index -RRB- wet weights and mean fibre cross-sectional area -LRB- CSA -RRB- of the slow-twitch SOL and fast-twitch EDL muscles of sham-operated controls -LRB- C , n = 8 -RRB- , spinal cord-transected -LRB- SCT , n = 11 -RRB- and SCT	26323
limb following long-term paralysis induced by a complete transversal section of the spinal cord	26323
limb	26323
long-term paralysis induced by a complete transversal section of the spinal cord	26338
long-term paralysis	26338
a complete transversal section of the spinal cord	26369
a complete transversal section	26369
the spinal cord	26403
effect of OEG transplantation The figure represents the absolute and relative -LRB- body weight and muscle-somatic index -RRB- wet weights and mean fibre cross-sectional area -LRB- CSA -RRB- of the slow-twitch SOL	26420
effect	26420
OEG transplantation	26430
The figure	26450
the absolute and relative -LRB- body weight and muscle-somatic index -RRB- wet weights	26472
the absolute	26472
relative -LRB- body weight and muscle-somatic index -RRB- wet weights	26489
body weight and muscle-somatic index	26499
body weight	26499
muscle-somatic index	26515
fibre cross-sectional area -LRB- CSA -RRB- of the slow-twitch SOL	26558
fibre cross-sectional area -LRB- CSA -RRB-	26558
fibre cross-sectional area	26558
CSA	26586
the slow-twitch SOL	26594
fast-twitch EDL muscles of sham-operated controls -LRB- C , n = 8 -RRB- , spinal cord-transected -LRB- SCT , n = 11 -RRB- and SCT	26618
fast-twitch EDL muscles	26618
sham-operated controls -LRB- C , n = 8 -RRB- , spinal cord-transected -LRB- SCT , n = 11 -RRB- and SCT	26645
sham-operated controls -LRB- C , n = 8 -RRB-	26645
sham-operated controls	26645
C , n = 8	26669
C	26669
n = 8	26672
n	26672
8	26676
spinal cord-transected -LRB- SCT , n = 11 -RRB-	26680
spinal cord-transected	26680
SCT , n = 11	26704
SCT	26704
n = 11	26709
n	26709
11	26713
SCT	26721
OEG-transplanted -LRB- SCT + CT , n = 9 -RRB- rats	26726
SCT + CT	26744
SCT	26744
CT	26750
n = 9	26754
n	26754
= 9	26756
Data	26767
S.D. of the number of animals per group	26784
S.D.	26784
the number of animals per group	26792
the number	26792
animals per group	26806
animals	26806
group	26818
both hind limbs	26847
the number of samples	26894
the number	26894
samples	26908
the number of animals per group	26926
the number	26926
animals per group	26940
animals	26940
group	26952
P < 0.05 , SCT or SCT + CT versus sham-operated controls .	26960
P	26960
< 0.05 , SCT or SCT + CT versus sham-operated controls .	26962
<	26962
0.05 , SCT or SCT + CT versus sham-operated controls .	26964
0.05	26964
SCT or SCT	26970
SCT	26970
SCT	26977
+ CT versus sham-operated controls	26981
+ CT	26981
sham-operated controls	26993
Figure 2 .	27018
Figure	27018
2	27025
Histochemical changes in markers of energy metabolism in SOL and EDL muscles of the rat , induced by a complete spinal cord transection : effect of OEG transplantation Cross-sections of soleus and EDL muscles	27028
Histochemical changes	27028
markers of energy metabolism in SOL and EDL muscles of the rat , induced by a complete spinal cord transection : effect of OEG transplantation Cross-sections of soleus and EDL muscles	27053
markers	27053
energy metabolism in SOL and EDL muscles of the rat , induced by a complete spinal cord transection : effect of OEG transplantation Cross-sections of soleus and EDL muscles	27064
energy metabolism	27064
SOL and EDL muscles of the rat , induced by a complete spinal cord transection : effect of OEG transplantation Cross-sections of soleus and EDL muscles	27085
SOL and EDL muscles	27085
the rat , induced by a complete spinal cord transection : effect of OEG transplantation Cross-sections of soleus and EDL muscles	27108
the rat	27108
a complete spinal cord transection : effect of OEG transplantation Cross-sections of soleus and EDL muscles	27128
a complete spinal cord transection	27128
effect of OEG transplantation Cross-sections of soleus and EDL muscles	27164
effect	27164
OEG transplantation Cross-sections of soleus and EDL muscles	27174
OEG transplantation Cross-sections	27174
soleus and EDL muscles	27212
quantitative glycerol-3-phosphate dehydrogenase -LRB- GPDH -RRB- or succinate dehydrogenase -LRB- SDH -RRB-	27253
quantitative glycerol-3-phosphate dehydrogenase	27253
GPDH	27302
succinate dehydrogenase	27311
SDH	27336
histochemistry , as indicated in the Methods section	27341
histochemistry	27341
the Methods section	27373
A , representative sections of sham-operated controls -LRB- C , n = 8 -RRB- and spinal cord-transected -LRB- SCT , n = 11 -RRB- rats , together with two examples of SCT rats transplanted with OEGs -LRB- SCT + CT , n = 9 -RRB- showing a different degree of functional recovery -LRB- 3 and 7 , good and bad recovery , respectively -LRB- Ramon-Cueto et al. 2000 -RRB- -RRB-	27394
, representative sections of sham-operated controls -LRB- C , n = 8 -RRB- and spinal cord-transected -LRB- SCT , n = 11 -RRB- rats , together with two examples of SCT rats transplanted with OEGs -LRB- SCT + CT , n = 9 -RRB- showing a different degree of functional recovery -LRB- 3 and 7 , good and bad recovery , respectively -LRB- Ramon-Cueto et al. 2000 -RRB- -RRB-	27395
, representative sections of sham-operated controls -LRB- C , n = 8 -RRB- and spinal cord-transected -LRB- SCT , n = 11 -RRB- rats , together with two examples of SCT rats	27395
representative sections of sham-operated controls -LRB- C , n = 8 -RRB- and spinal cord-transected -LRB- SCT , n = 11 -RRB- rats	27397
representative sections	27397
sham-operated controls -LRB- C , n = 8 -RRB- and spinal cord-transected -LRB- SCT , n = 11 -RRB- rats	27424
sham-operated controls -LRB- C , n = 8 -RRB-	27424
sham-operated controls	27424
C , n = 8	27448
C	27448
n = 8	27451
n	27451
8	27455
spinal cord-transected -LRB- SCT , n = 11 -RRB- rats	27462
SCT , n = 11	27486
SCT	27486
n = 11	27491
n	27491
11	27495
two examples of SCT	27519
two examples	27519
SCT	27535
OEGs -LRB- SCT + CT , n = 9 -RRB-	27562
OEGs	27562
SCT + CT	27568
SCT	27568
CT	27574
n = 9	27578
n	27578
= 9	27580
a different degree of functional recovery -LRB- 3 and 7 , good and bad recovery , respectively -LRB- Ramon-Cueto et al. 2000 -RRB- -RRB-	27593
a different degree	27593
functional recovery -LRB- 3 and 7 , good and bad recovery , respectively -LRB- Ramon-Cueto et al. 2000 -RRB- -RRB-	27615
functional recovery	27615
3 and 7 , good and bad recovery , respectively -LRB- Ramon-Cueto et al. 2000 -RRB-	27636
3 and 7	27636
good	27645
bad recovery , respectively -LRB- Ramon-Cueto et al. 2000 -RRB-	27654
bad recovery , respectively	27654
bad recovery	27654
Ramon-Cueto	27682
et al. 2000	27694
et al.	27694
2000	27701
GPDH -LRB- soleus -RRB- or SDH -LRB- EDL -RRB-	27721
GPDH	27721
soleus	27727
SDH	27738
EDL	27743
B , graphic representation of the quantitative histochemistry data for GPDH and SDH in both muscle types .	27749
B	27749
graphic representation of the quantitative histochemistry data for GPDH and SDH in both muscle types	27752
graphic representation	27752
the quantitative histochemistry data for GPDH and SDH in both muscle types	27778
the quantitative histochemistry data	27778
GPDH and SDH	27819
muscle types	27840
Data	27854
S.D. of the number of animals per group	27871
S.D.	27871
the number of animals per group	27879
the number	27879
animals per group	27893
animals	27893
group	27905
2-fold number of samples -LRB- both hind limbs -RRB- per group	27945
2-fold number	27945
samples -LRB- both hind limbs -RRB- per group	27962
samples -LRB- both hind limbs -RRB-	27962
samples	27962
hind limbs	27976
group	27992
P < 0.05 , SCT or SCT + CT versus sham-operated controls .	28000
P	28000
< 0.05 , SCT or SCT + CT versus sham-operated controls .	28002
<	28002
0.05 , SCT or SCT + CT versus sham-operated controls .	28004
0.05	28004
SCT or SCT	28010
SCT	28010
SCT	28017
+ CT versus sham-operated controls	28021
+ CT	28021
sham-operated controls	28033
# P < 0.05 , OEG-transpanted -LRB- SCT + CT -RRB- versus non-transplanted SCT-rats .	28057
# P	28057
< 0.05 , OEG-transpanted -LRB- SCT + CT -RRB- versus non-transplanted SCT-rats	28060
< 0.05 , OEG-transpanted -LRB- SCT + CT -RRB-	28060
< 0.05 , OEG-transpanted	28060
<	28060
0.05	28062
SCT + CT	28085
SCT	28085
CT	28091
non-transplanted SCT-rats	28102
Bar -LRB- situated in the control EDL muscle for SDH histochemistry -RRB-	28129
Bar	28129
the control EDL muscle for SDH histochemistry	28146
the control EDL muscle	28146
SDH histochemistry	28173
1 μm	28203
Figure 3 .	28210
Figure	28210
3	28217
Fibre type transitions in soleus and EDL muscles of the rat	28220
Fibre type transitions	28220
soleus and EDL muscles of the rat	28246
soleus and EDL muscles	28246
the rat	28272
a complete transversal section of the spinal cord	28291
a complete transversal section	28291
the spinal cord	28325
effect of OEG transplantation Fibre typing of soleus and EDL muscles	28342
effect	28342
OEG transplantation Fibre typing of soleus and EDL muscles	28352
OEG transplantation Fibre typing	28352
soleus and EDL muscles	28388
serial cross-sections	28428
those shown in Fig.	28464
those	28464
Fig.	28479
2 , that were probed with monoclonal antibodies directed against different myosin heavy chain -LRB- MHC -RRB- isoforms or stained for myofibrillar ATPase with pre-incubations at pH 4.45 or 10.45 , as indicated in the Methods section	28484
2	28484
monoclonal antibodies directed against different myosin heavy chain -LRB- MHC -RRB- isoforms or stained for myofibrillar ATPase with pre-incubations at pH 4.45 or 10.45 , as indicated in the Methods section	28509
monoclonal antibodies	28509
different myosin heavy chain -LRB- MHC -RRB- isoforms	28548
myofibrillar ATPase	28607
pre-incubations at pH 4.45 or 10.45	28632
pre-incubations	28632
pH 4.45 or 10.45	28651
the Methods section	28685
The antibody BF-F8	28706
MHC-I	28748
BF-35	28759
all MHCs except IIX/D	28765
all MHCs	28765
IIX/D	28781
Myofibrillar ATPase after acid pre-incubation at pH 4.45 denotes three staining intensities : dark -LRB- type I -RRB- , intermediate -LRB- IID/X and IIB -RRB- and light -LRB- IIA -RRB- .	28788
Myofibrillar ATPase after acid pre-incubation at pH 4.45 denotes three staining intensities	28788
Myofibrillar ATPase	28788
acid pre-incubation at pH 4.45	28814
acid pre-incubation	28814
pH 4.45	28837
three staining intensities	28853
dark -LRB- type I -RRB- , intermediate -LRB- IID/X and IIB -RRB- and light -LRB- IIA -RRB-	28881
dark -LRB- type I -RRB-	28881
dark	28881
type I	28887
intermediate -LRB- IID/X and IIB -RRB-	28896
intermediate	28896
IID/X and IIB	28910
IID/X	28910
IIB	28920
light -LRB- IIA -RRB-	28929
light	28929
IIA	28936
Myofibrillar ATPase after alkaline pre-incubation at pH 10.45	28942
Myofibrillar ATPase	28942
alkaline pre-incubation at pH 10.45	28968
alkaline pre-incubation	28968
pH 10.45	28995
three staining intensities corresponding to type I -LRB- light -RRB- , IIA and IID/X -LRB- dark -RRB- and IIB -LRB- intermediate -RRB- fibres	29015
three staining intensities	29015
type I -LRB- light -RRB- , IIA and IID/X -LRB- dark -RRB- and IIB -LRB- intermediate -RRB- fibres	29059
type I -LRB- light -RRB-	29059
type I	29059
light	29067
IIA and IID/X -LRB- dark -RRB-	29075
IIA and IID/X	29075
dark	29090
IIB -LRB- intermediate -RRB- fibres	29100
IIB	29100
fibres	29119
A , representative samples of soleus and EDL muscles of sham-operated -LRB- C , n = 8 -RRB- and SCT -LRB- n = 11 -RRB- together with two examples of SCT rats	29127
representative samples of soleus and EDL muscles	29130
representative samples	29130
soleus and EDL muscles	29156
sham-operated -LRB- C , n = 8 -RRB- and SCT -LRB- n = 11 -RRB-	29182
sham-operated	29182
C , n = 8	29197
C	29197
n = 8	29200
n	29200
8	29204
SCT	29211
n	29216
11	29220
two examples of SCT	29238
two examples	29238
SCT	29254
OEGs -LRB- SCT + CT , n = 9 -RRB-	29281
OEGs	29281
SCT + CT	29287
SCT	29287
CT	29293
n = 9	29297
n	29297
= 9	29299
different level of functional recovery -LRB- 3 and 7 , represent good and bad recovery , respectively -RRB-	29309
different level	29309
functional recovery	29328
3 and 7 ,	29349
3	29349
7	29355
good and bad recovery	29368
B , graphic representation of the proportions of pure -LRB- expressing only one MHC isoform -RRB- and hybrid -LRB- expressing two MHC isoforms -RRB- fibres in both muscle types .	29406
B	29406
graphic representation of the proportions of pure -LRB- expressing only one MHC isoform -RRB- and hybrid -LRB- expressing two MHC isoforms -RRB- fibres in both muscle types	29409
graphic representation	29409
the proportions of pure -LRB- expressing only one MHC isoform -RRB- and hybrid -LRB- expressing two MHC isoforms -RRB- fibres in both muscle types	29435
the proportions of pure	29435
the proportions	29435
pure	29454
only one MHC isoform	29471
hybrid -LRB- expressing two MHC isoforms -RRB- fibres in both muscle types	29497
hybrid -LRB- expressing two MHC isoforms -RRB- fibres	29497
two MHC isoforms	29516
both muscle types	29544
Data	29563
S.D. of the number of animals per group	29580
S.D.	29580
the number of animals per group	29588
the number	29588
animals per group	29602
animals	29602
group	29614
twice the number of samples -LRB- both hind limbs were considered independently -RRB-	29653
twice the number	29653
samples -LRB- both hind limbs were considered independently -RRB-	29673
samples	29673
hind limbs	29687
P	29731
< 0.05 , SCT or SCT + CT versus sham-operated	29733
<	29733
0.05 , SCT or SCT + CT versus sham-operated	29735
0.05 , SCT or SCT	29735
0.05	29735
SCT	29741
SCT	29748
CT versus sham-operated	29754
CT	29754
sham-operated	29764
P <	29780
0.05	29784
SCT + CT versus non-transplanted SCT rats	29790
SCT	29790
CT versus non-transplanted SCT rats	29796
CT	29796
non-transplanted SCT rats	29806
Bars in the SCT panels	29833
Bars	29833
the SCT panels	29841
mATPase histochemistry for SOL	29873
mATPase histochemistry	29873
SOL	29900
pH 4.45	29905
EDL -LRB- pH 10.45 -RRB- muscles	29918
EDL	29918
pH 10.45	29923
1 μm	29950
Figure 4 .	29957
Figure	29957
4	29964
Transitions of essential -LRB- e -RRB- and regulatory -LRB- r -RRB- myosin light chain -LRB- MLC -RRB- isoforms and variants thereof , in soleus and EDL muscles of the rat following a complete transversal section of the spinal cord : effect of OEG transplantation The proportions of e - and rMLC isoforms and of their variants , in soleus or EDL muscles were determined in Coomassie blue-stained two-dimensional -LRB- 2D -RRB- electrophoretograms of whole muscle protein homogenates , as indicated in the Methods section .	29967
Transitions of essential	29967
Transitions	29967
regulatory -LRB- r -RRB- myosin light chain -LRB- MLC -RRB-	30000
regulatory -LRB- r -RRB-	30000
myosin light chain -LRB- MLC -RRB-	30015
myosin	30015
light chain -LRB- MLC -RRB-	30022
light chain	30022
MLC	30035
isoforms and variants	30040
thereof , in soleus and EDL muscles of the rat following a complete transversal section of the spinal cord : effect of OEG transplantation The proportions of e - and rMLC isoforms	30062
thereof , in soleus and EDL muscles	30062
soleus and EDL	30074
the rat following a complete transversal section of the spinal cord : effect of OEG transplantation The proportions of e - and rMLC isoforms	30100
the rat	30100
a complete transversal section of the spinal cord : effect of OEG transplantation The proportions of e - and rMLC isoforms	30118
a complete transversal section of the spinal cord	30118
a complete transversal section	30118
the spinal cord	30152
effect of OEG transplantation The proportions of e	30169
effect of OEG transplantation	30169
effect	30169
OEG transplantation	30179
The proportions of e	30199
The proportions	30199
rMLC isoforms	30225
their variants	30246
soleus or EDL muscles	30265
Coomassie blue-stained two-dimensional -LRB- 2D -RRB- electrophoretograms of whole muscle protein homogenates	30306
Coomassie	30306
blue-stained two-dimensional -LRB- 2D -RRB- electrophoretograms	30316
2D	30346
whole muscle protein homogenates	30373
indicated	30410
the Methods section	30423
Different variants of the slow -LRB- s -RRB- and fast -LRB- f -RRB- rMLC -LRB- denoted 2s , 2s1 and 2s2 and 2f , 2f1 and 2f2 , from less to more acidic , respectively -RRB-	30444
Different variants	30444
the slow -LRB- s -RRB- and fast -LRB- f -RRB- rMLC -LRB- denoted 2s , 2s1 and 2s2 and 2f , 2f1 and 2f2 , from less to more acidic , respectively -RRB-	30466
the slow -LRB- s -RRB- and fast -LRB- f -RRB- rMLC	30466
s	30476
f	30489
2s , 2s1 and 2s2 and 2f , 2f1 and 2f2 ,	30506
2s	30506
2s1 and 2s2 and 2f , 2f1 and 2f2	30510
2s1 and 2s2	30510
2f , 2f1 and 2f2	30526
less to more acidic , respectively	30548
less	30548
more acidic , respectively	30556
more acidic	30556
Gonzalez et al. 2002	30623
Gonzalez	30623
et al. 2002	30632
et al.	30632
2002	30639
The figure	30646
representative 2D patterns	30668
the graphic representation of the percentage distributions of r - and eMLC isoforms -LRB- panels a and b -RRB- and rMLC variants -LRB- panels c and d -RRB- in SOL -LRB- upper panel -RRB- and EDL -LRB- bottom panel -RRB- muscles	30709
the graphic representation of the percentage distributions of r - and eMLC isoforms -LRB- panels a and b -RRB-	30709
the graphic representation	30709
the percentage distributions of r - and eMLC isoforms -LRB- panels a and b -RRB-	30739
the percentage distributions	30739
r - and eMLC isoforms	30771
panels a and b	30793
panels	30793
a and b	30800
rMLC variants -LRB- panels c and d -RRB- in SOL -LRB- upper panel -RRB- and EDL -LRB- bottom panel -RRB- muscles	30813
rMLC variants -LRB- panels c and d -RRB- in SOL -LRB- upper panel -RRB- and EDL -LRB- bottom panel -RRB-	30813
rMLC variants -LRB- panels c and d -RRB-	30813
rMLC variants	30813
panels c and d	30828
SOL -LRB- upper panel -RRB- and EDL -LRB- bottom panel -RRB-	30847
SOL	30847
upper panel	30852
EDL	30869
bottom panel	30874
muscles	30888
C , sham-operated controls -LRB- n = 8 -RRB- ; SCT , spinal cord-transected -LRB- n = 11 -RRB- , SCT + CT , SCT rats transplanted with OEGs -LRB- n = 9 -RRB- .	30897
C , sham-operated controls -LRB- n = 8 -RRB-	30897
C	30897
sham-operated controls -LRB- n = 8 -RRB-	30900
sham-operated controls	30900
n	30924
8	30928
SCT , spinal cord-transected -LRB- n = 11 -RRB- , SCT + CT , SCT rats transplanted with OEGs -LRB- n = 9 -RRB-	30932
SCT , spinal cord-transected -LRB- n = 11 -RRB- , SCT	30932
SCT	30932
spinal cord-transected -LRB- n = 11 -RRB- , SCT	30937
spinal cord-transected	30937
n	30961
11	30965
SCT	30970
CT , SCT rats transplanted with OEGs -LRB- n = 9 -RRB-	30976
CT	30976
SCT rats transplanted with OEGs -LRB- n = 9 -RRB-	30980
SCT rats	30980
OEGs -LRB- n = 9 -RRB-	31007
OEGs	31007
n	31013
9	31017
The 2D patterns of MLCs	31021
The 2D patterns	31021
MLCs	31040
the same muscles used as representative examples in Figs 2 and 3 -LRB- SCT + CT , 3 and 7 , representing two examples of rats with good and bad functional capacity as determined by behavioural tests -RRB-	31059
the same muscles	31059
representative examples in Figs 2 and 3 -LRB- SCT + CT , 3 and 7 , representing two examples of rats with good and bad functional capacity as determined by behavioural tests -RRB-	31084
representative examples	31084
Figs 2 and 3	31111
SCT + CT , 3 and 7 , representing two examples of rats with good and bad functional capacity as determined by behavioural tests	31125
SCT	31125
+ CT , 3 and 7 , representing two examples of rats with good and bad functional capacity as	31129
+ CT , 3 and 7 ,	31129
+ CT	31129
3 and 7	31135
two examples of rats with good and bad functional capacity	31157
two examples	31157
rats with good and bad functional capacity	31173
rats	31173
good and bad functional capacity	31183
behavioural tests	31233
1s , 1f and 3f , fast -LRB- f -RRB- and slow -LRB- s -RRB- isoforms of essential MLCs ; 2s , 2s1 , 2s2 and 2f , 2f1 and 2f2 , charge variants of the slow -LRB- s -RRB- and fast -LRB- f -RRB- regulatory MLC isoforms , from less to more acidic .	31253
1s , 1f and 3f , fast -LRB- f -RRB- and slow -LRB- s -RRB- isoforms of essential MLCs	31253
1s , 1f and 3f , fast -LRB- f -RRB-	31253
1s , 1f and 3f , fast	31253
1s	31253
1f and 3f	31257
f	31274
slow -LRB- s -RRB- isoforms of essential MLCs	31281
slow -LRB- s -RRB- isoforms	31281
s	31287
essential MLCs	31302
2s , 2s1 , 2s2 and 2f , 2f1 and 2f2 , charge variants of the slow -LRB- s -RRB- and fast -LRB- f -RRB- regulatory MLC isoforms , from less to more acidic	31318
2s	31318
2s1 , 2s2 and 2f	31322
2f1 and 2f2	31339
charge variants of the slow -LRB- s -RRB- and fast -LRB- f -RRB- regulatory MLC isoforms	31352
charge variants of the slow -LRB- s -RRB-	31352
charge variants	31352
the slow -LRB- s -RRB-	31371
the slow	31371
-LRB- f -RRB- regulatory MLC isoforms	31393
regulatory	31397
isoforms	31412
less to more acidic	31427
less	31427
more acidic	31435
+ and − in the upper part of the 2D patterns	31448
and − in the upper part of the 2D patterns	31450
and −	31450
the upper part of the 2D patterns	31459
the upper part	31459
the 2D patterns	31477
the sides of basic and acidic isoelectric points	31502
the sides	31502
basic and acidic isoelectric points	31515
Data	31566
S.D. of the number of animals per group	31583
S.D.	31583
the number of animals per group	31591
the number	31591
animals per group	31605
animals	31605
group	31617
twice the number of muscles	31657
twice the number	31657
muscles	31677
P < 0.05 , SCT or SCT + CT versus sham-operated controls .	31687
P	31687
< 0.05 , SCT or SCT + CT versus sham-operated controls .	31689
<	31689
0.05 , SCT or SCT + CT versus sham-operated controls .	31691
0.05	31691
SCT or SCT	31697
SCT	31697
SCT	31704
+ CT versus sham-operated controls	31708
+ CT	31708
sham-operated controls	31720
Figure 5 .	31745
Figure	31745
5	31752
Phenotypic classification of individual hind limb muscles of OEG-transplanted rats in relation to non-transplanted and sham-operated controls by means of multivariate discriminant analysis Individual SOL and EDL muscles of left and right hind limbs of all experimental rats	31755
Phenotypic classification	31755
individual hind limb muscles of OEG-transplanted rats in relation to non-transplanted and sham-operated controls by means of multivariate discriminant analysis Individual SOL and EDL muscles of left and right hind limbs of all experimental rats	31784
individual hind limb muscles	31784
OEG-transplanted rats in relation to non-transplanted and sham-operated controls by means of multivariate discriminant analysis Individual SOL and EDL muscles of left and right hind limbs of all experimental rats	31816
OEG-transplanted rats	31816
relation to non-transplanted and sham-operated controls by means of multivariate discriminant analysis Individual SOL and EDL muscles of left and right hind limbs of all experimental rats	31841
relation	31841
non-transplanted and sham-operated controls	31853
means of multivariate discriminant analysis Individual SOL and EDL muscles of left and right hind limbs of all experimental rats	31900
means	31900
multivariate discriminant analysis Individual SOL and EDL muscles	31909
left and right hind limbs of all experimental rats	31978
left and right hind limbs	31978
all experimental rats	32007
different groups	32050
a function of a cohort of phenotypic characteristics	32070
a function	32070
a cohort of phenotypic characteristics	32084
a cohort	32084
phenotypic characteristics	32096
means of discriminant analysis	32126
means	32126
discriminant analysis	32135
The discriminant model for the SOL	32158
The discriminant model	32158
the SOL	32185
the following variables : wet weight , muscle-somatic index	32202
the following variables	32202
wet weight , muscle-somatic index	32227
wet weight	32227
muscle-somatic index	32239
percentage of fibre types	32261
percentage	32261
fibre types	32275
I	32287
I	32290
+ IIA , IIA , IIAD/X and IIX/D , SDH , GPDH , CSA , fraction of slow rMLC isoform from total rMLC -LRB- rMLCs/rMLCt -RRB- , fraction of slow eMLC isoform from total eMLC -LRB- eMLCs/eMLCt -RRB- , variant 2s/rMLCt , variant 2s/rMLCs , variant 2f/rMLCt and variant 2f/rMLCf	32292
IIA , IIA , IIAD/X and IIX/D	32294
SDH	32322
GPDH	32327
CSA	32333
fraction of slow rMLC isoform from total rMLC -LRB- rMLCs/rMLCt -RRB- , fraction of slow eMLC isoform from total eMLC -LRB- eMLCs/eMLCt -RRB- , variant 2s/rMLCt , variant 2s/rMLCs , variant 2f/rMLCt and variant 2f/rMLCf	32338
fraction	32338
slow rMLC isoform from total rMLC -LRB- rMLCs/rMLCt -RRB- , fraction of slow eMLC isoform from total eMLC -LRB- eMLCs/eMLCt -RRB- , variant 2s/rMLCt , variant 2s/rMLCs , variant 2f/rMLCt and variant 2f/rMLCf	32350
slow rMLC isoform	32350
total rMLC -LRB- rMLCs/rMLCt -RRB- , fraction of slow eMLC isoform from total eMLC -LRB- eMLCs/eMLCt -RRB- , variant 2s/rMLCt , variant 2s/rMLCs , variant 2f/rMLCt and variant 2f/rMLCf	32373
total rMLC	32373
rMLCs/rMLCt	32385
fraction of slow eMLC isoform from total eMLC -LRB- eMLCs/eMLCt -RRB-	32399
fraction	32399
slow eMLC isoform from total eMLC -LRB- eMLCs/eMLCt -RRB-	32411
slow eMLC isoform	32411
total eMLC -LRB- eMLCs/eMLCt -RRB-	32434
total eMLC	32434
eMLCs/eMLCt	32446
variant 2s/rMLCt	32460
variant 2s/rMLCs	32478
variant 2f/rMLCt	32496
variant 2f/rMLCf	32517
The same parameters	32535
the EDL muscle	32580
the percentage of fibre types IIX/DB and IIB	32608
the percentage	32608
fibre types IIX/DB and IIB	32626
fibre types IIX/DB	32626
IIB	32649
types I and IIA	32674
types I	32674
types	32674
I	32680
IIA	32686
Circles	32691
the relative distribution of sham-operated rat control muscles	32709
the relative distribution	32709
sham-operated rat control muscles	32738
all the phenotypic markers mentioned above	32777
all the phenotypic markers	32777
squares	32845
SCT rats	32863
1 -- 9 refer to individual SCT + CT animals , numbered from best -LRB- 1 -RRB- to worst -LRB- 9 -RRB-	32873
1 -- 9	32873
individual SCT	32886
+ CT animals , numbered from best -LRB- 1 -RRB- to worst -LRB- 9 -RRB-	32901
CT animals	32903
best -LRB- 1 -RRB-	32929
best	32929
1	32935
worst -LRB- 9 -RRB-	32941
worst	32941
9	32948
the scores of behavioural tests -LRB- Ramon-Cueto et al. 2000 -RRB-	32974
the scores	32974
behavioural tests -LRB- Ramon-Cueto et al. 2000 -RRB-	32988
behavioural tests	32988
Ramon-Cueto	33007
et al. 2000	33019
et al.	33019
2000	33026
symbols	33049
left and right hind limb muscles , respectively	33067
left and right hind limb muscles	33067
both muscle types	33119
OEG-transplanted animals	33138
an independent phenotypic group , different from both control and SCT animals	33173
an independent phenotypic group	33173
both control and SCT animals	33221
The squares of the Mahalanobis distances between pairs of groups indicative of the relative phenotypic divergences	33251
The squares	33251
the Mahalanobis distances between pairs of groups indicative of the relative phenotypic divergences	33266
the Mahalanobis distances	33266
pairs of groups indicative of the relative phenotypic divergences	33300
pairs	33300
groups indicative of the relative phenotypic divergences	33309
groups	33309
the relative phenotypic divergences	33330
the P values for the statistical significance of the comparisons between pairs of groups	33394
the P values	33394
the statistical significance of the comparisons between pairs of groups	33411
the statistical significance	33411
the comparisons between pairs of groups	33443
the comparisons	33443
pairs of groups	33467
pairs	33467
groups	33476
Figure 6 .	33485
Figure	33485
6	33492
Correlation of data from behaviourally tested functional recovery and expression of selected phenotypic markers of SOL muscle Muscles	33495
Correlation	33495
data from behaviourally	33510
data	33510
functional recovery and expression of selected phenotypic markers of SOL muscle Muscles	33541
functional recovery and expression	33541
selected phenotypic markers of SOL muscle Muscles	33579
selected phenotypic markers	33579
SOL muscle Muscles	33610
anaesthetized animals	33648
1 month	33670
the last test of functional recovery	33684
the last test	33684
functional recovery	33701
8 months	33733
the intervention for SCT and OEG transplantation	33748
the intervention	33748
SCT and OEG transplantation	33769
A , results from behavioural tests -LRB- contact placing , C , and proprioceptive , P , responses -RRB- performed 3 , 5 and 7 months after the intervention , as	33798
behavioural tests -LRB- contact placing , C	33814
behavioural tests	33814
contact placing	33833
C	33850
proprioceptive , P , responses -RRB-	33857
proprioceptive	33857
P	33873
responses	33876
3 , 5 and 7	33897
months	33908
the intervention	33921
Ramon-Cueto et al. 2000	33963
Ramon-Cueto	33963
et al. 2000	33975
et al.	33975
2000	33982
B , L and R	33989
detection of recovery in both , left or right hind limb -LRB- s -RRB- , respectively	34009
detection	34009
recovery in both , left or right hind limb -LRB- s -RRB- , respectively	34022
recovery in both , left	34022
recovery	34022
right hind limb -LRB- s -RRB- , respectively	34048
right hind limb -LRB- s -RRB-	34048
right hind limb	34048
B , percentage of type I fibres	34082
B	34082
percentage of type I fibres	34085
percentage	34085
type I fibres	34099
immunohistochemistry	34125
C , proportion of slow rMLC from the whole rMLC complement ,	34147
C	34147
proportion of slow rMLC from the whole rMLC complement	34150
proportion	34150
slow rMLC from the whole rMLC complement	34164
slow rMLC	34164
the whole rMLC complement	34179
densitometry of Coomassie blue-stained 2D electrophoretograms	34220
densitometry	34220
Coomassie blue-stained 2D electrophoretograms	34236
D , fraction of the less acidic isoelectric point variant -LRB- 2s -RRB- from the slow rMLC isoform , obtained as in C. E ,	34283
D	34283
fraction of the less acidic isoelectric point variant -LRB- 2s -RRB- from the slow rMLC isoform , obtained as in C. E	34286
fraction	34286
the less acidic isoelectric point variant -LRB- 2s -RRB-	34298
the less acidic isoelectric point variant	34298
2s	34341
the slow rMLC isoform , obtained as in C. E	34350
the slow rMLC isoform	34350
C. E	34388
glycerol-3-phosphate dehydrogenase activity -LRB- GPDH -RRB- determined by quantitative histochemistry	34399
glycerol-3-phosphate dehydrogenase activity	34399
GPDH	34444
quantitative histochemistry	34464
Data for left and right hind limb muscles of control -LRB- C , sham-operated animals , n = 8 -RRB- and SCT-rats -LRB- n = 11 -RRB- are	34493
Data	34493
left and right hind limb muscles of control -LRB- C , sham-operated animals , n = 8 -RRB- and SCT-rats -LRB- n = 11 -RRB- are	34502
left and right hind limb muscles of control -LRB- C , sham-operated animals , n = 8 -RRB- and SCT-rats -LRB- n = 11 -RRB-	34502
left and right hind limb muscles	34502
control -LRB- C , sham-operated animals , n = 8 -RRB- and SCT-rats -LRB- n = 11 -RRB-	34538
control	34538
C , sham-operated animals	34547
C	34547
sham-operated animals	34550
n = 8	34573
n	34573
= 8	34575
SCT-rats	34584
n	34594
11	34598
S.D.	34614
all animals of the group	34622
all animals	34622
the group	34637
1 -- 9 refer to the individual muscles of the group of rats with completely transected spinal cord that received OEG transplants , ordered from best -LRB- 1 -RRB- to worst -LRB- 9 -RRB-	34648
1 -- 9	34648
the individual muscles of the group of rats with completely transected spinal cord	34661
the individual muscles	34661
the group of rats with completely transected spinal cord	34687
the group	34687
rats with completely transected spinal cord	34700
rats	34700
completely transected spinal cord	34710
OEG transplants , ordered from best -LRB- 1 -RRB- to worst -LRB- 9 -RRB-	34758
OEG transplants	34758
best -LRB- 1 -RRB-	34788
best	34788
1	34794
worst -LRB- 9 -RRB-	34800
worst	34800
9	34807
previously published scores from functional tests -LRB- Ramon-Cueto et al. 2000 -RRB-	34833
previously published scores	34833
functional tests -LRB- Ramon-Cueto et al. 2000 -RRB-	34866
functional tests	34866
Ramon-Cueto	34884
et al. 2000	34896
et al.	34896
2000	34903
A is a modification of Fig.	34910
is a modification	34912
a modification	34915
1	34938
the above-mentioned reference	34945
The correlations of these parameters with the scores of functional capacity -LRB- as assessed by means of behavioural tests -RRB-	34976
The correlations of these parameters with the scores of functional capacity	34976
The correlations	34976
these parameters with the scores of functional capacity	34996
these parameters	34996
the scores of functional capacity	35018
the scores	35018
functional capacity	35032
means of behavioural tests	35068
means	35068
behavioural tests	35077
the statistical significance of the observation	35124
the statistical significance	35124
the observation	35156
Muscle mass , muscle-somatic index -LRB- MSI -RRB- and fibre cross-sectional area -LRB- CSA -RRB- of paralysed rat SOL and EDL muscles 8 months after SCT : effect of OEG transplantation	35174
Muscle mass	35174
muscle-somatic index -LRB- MSI -RRB- and fibre cross-sectional area -LRB- CSA -RRB- of paralysed rat SOL and EDL muscles 8 months after SCT : effect of OEG transplantation	35187
muscle-somatic index -LRB- MSI -RRB-	35187
muscle-somatic index	35187
MSI	35209
fibre cross-sectional area -LRB- CSA -RRB- of paralysed rat SOL and EDL muscles 8 months after SCT	35218
fibre cross-sectional area -LRB- CSA -RRB- of paralysed rat SOL and EDL muscles 8 months	35218
fibre cross-sectional area -LRB- CSA -RRB-	35218
fibre cross-sectional area	35218
CSA	35246
paralysed rat SOL and EDL muscles	35254
8 months	35288
SCT	35303
effect of OEG transplantation	35308
effect	35308
OEG transplantation	35318
Eight months	35338
a complete spinal cord transection -LRB- SCT -RRB-	35357
a complete spinal cord transection	35357
SCT	35393
the wet weights of paralysed rat SOL and EDL muscles	35399
the wet weights	35399
paralysed rat SOL and EDL muscles	35418
56 % and 76 % of the control values , respectively -LRB- Fig. 1 -RRB-	35468
56 % and 76 % of the control values , respectively	35468
56 % and 76 %	35468
the control values	35483
Fig. 1	35517
The MSI -LRB- wet weight referred to bodyweight -RRB-	35526
The MSI	35526
wet weight referred to bodyweight	35535
wet weight	35535
bodyweight	35558
to66 % and 82 % , respectively , and the mean fibre CSA	35582
to66 % and 82 % , respectively	35582
to66 %	35582
82 % , respectively	35591
82 %	35591
the mean fibre CSA	35614
the mean fibre	35614
CSA	35629
41 % and 58 %	35636
quantitative terms	35672
atrophy	35692
the soleus muscle , mainly formed by slow-twitch fibres with a higher diameter , more than the EDL ,	35709
the soleus muscle	35709
slow-twitch fibres	35745
a higher diameter , more than the EDL	35769
a higher diameter	35769
more than the EDL	35788
more	35788
the EDL	35798
fast-twitch fibres	35829
animals transplanted with OEG immediately after SCT , the mean wet muscle weight and fibre	35852
animals	35852
OEG	35878
SCT , the mean wet muscle weight and fibre	35900
SCT	35900
the mean wet muscle weight	35905
fibre	35936
CSA	35942
non-transplanted animals	35974
differences	36007
statistical significance	36033
Both parameters	36059
transplanted animals than in sham-operated controls -LRB- P < 0.05 -RRB-	36103
transplanted animals	36103
sham-operated controls -LRB- P < 0.05 -RRB-	36132
sham-operated controls	36132
P < 0.05	36156
P	36156
< 0.05	36158
<	36158
0.05	36159
The MSI of the EDL , however ,	36166
The MSI of the EDL	36166
The MSI	36166
the EDL	36177
OEG-transplanted animals	36208
values that were not different from controls though still not different from non-transplanted SCT-animals	36245
values	36245
controls	36281
non-transplanted SCT-animals	36322
Metabolic activity of paralysed rat soleus and EDL muscles 8 months after complete SCT : effect of OEG transplantation Cordotomy had a marked effect on the metabolic properties of both skeletal muscle types , particularly of the soleus -LRB- Fig. 2 -RRB- .	36352
Metabolic activity of paralysed rat soleus and EDL muscles 8 months after complete SCT	36352
Metabolic activity	36352
paralysed rat soleus and EDL muscles 8 months after complete SCT	36374
paralysed rat soleus and EDL muscles	36374
8 months	36411
complete SCT	36426
effect of OEG transplantation Cordotomy had a marked effect on the metabolic properties of both skeletal muscle types , particularly of the soleus -LRB- Fig. 2 -RRB-	36440
effect	36440
OEG transplantation Cordotomy had a marked effect on the metabolic properties of both skeletal muscle types , particularly of the soleus -LRB- Fig. 2 -RRB-	36450
OEG transplantation Cordotomy	36450
a marked effect	36484
the metabolic properties of both skeletal muscle types	36503
the metabolic properties	36503
both skeletal muscle types	36531
the soleus -LRB- Fig. 2 -RRB-	36575
the soleus	36575
Fig. 2	36587
The mean histochemical glycolytic capacity of both muscle types , estimated by the indirect marker glycerol 3-phosphate dehydrogenase -LRB- GPDH -RRB- ,	36596
The mean histochemical glycolytic capacity	36596
both muscle types	36642
the indirect marker glycerol 3-phosphate dehydrogenase -LRB- GPDH -RRB-	36674
the indirect marker glycerol 3-phosphate dehydrogenase	36674
GPDH	36730
150 % -LRB- P < 0.0001 -RRB- and 117 % -LRB- P < 0.0001 -RRB-	36750
150 %	36750
P < 0.0001	36756
P	36756
< 0.0001	36758
<	36758
0.0001	36759
117 %	36771
P < 0.0001	36777
P	36777
< 0.0001	36779
<	36779
0.0001	36780
soleus and EDL muscle	36792
soleus muscle	36832
transplantation of OEG	36847
transplantation	36847
OEG	36866
the GPDH activity	36878
respect	36915
non-transplanted animals -LRB- P < 0.0001 -RRB-	36926
non-transplanted animals	36926
P < 0.0001	36952
P	36952
< 0.0001	36954
<	36954
0.0001	36955
higher -LRB- P < 0.0001 -RRB- than controls	36979
higher -LRB- P < 0.0001 -RRB-	36979
P < 0.0001	36987
P	36987
< 0.0001	36989
<	36989
0.0001	36990
controls	37003
the EDL muscle of OEG-transplanted animals	37031
the EDL muscle	37031
OEG-transplanted animals	37049
GPDH levels	37074
non-transplanted animals	37105
P < 0.0001	37131
P	37131
< 0.0001	37133
<	37133
0.0001	37134
controls -LRB- Fig. 2 -RRB-	37179
controls	37179
Fig. 2	37189
OEG transplantation	37204
the glycolytic activity of the EDL to control values	37251
the glycolytic activity	37251
the EDL to control values	37278
values	37297
Themuscle oxidative capacity , measured by quantitative SDH histochemistry ,	37305
Themuscle oxidative capacity	37305
quantitative SDH histochemistry	37347
the soleus	37402
the EDL of cordotomized animals	37429
the EDL	37429
cordotomized animals	37440
controls but differences	37479
statistical significance -LRB- Fig. 2 -RRB-	37518
statistical significance	37518
Fig. 2	37544
an apparent paradox	37556
the EDL muscle of OEG-transplanted animals	37580
the EDL muscle	37580
OEG-transplanted animals	37598
the mean oxidative capacity	37623
non-transplanted animals	37674
values that were statistically different from both , control and non-transplanted animals -LRB- Fig. 2 -RRB-	37709
values that were statistically different from both	37709
values	37709
control and non-transplanted animals -LRB- Fig. 2 -RRB-	37761
control and non-transplanted animals	37761
Fig. 2	37799
Expression of isoforms of the myosin heavy -LRB- MHC -RRB- and light chains -LRB- MLC -RRB- in paralysed rat soleus and EDL muscles 8 months after SCT : effect of OEG transplants SCT	37808
Expression	37808
isoforms of the myosin heavy -LRB- MHC -RRB- and light chains -LRB- MLC -RRB- in paralysed rat soleus and EDL muscles 8 months after SCT : effect of OEG transplants SCT	37822
isoforms of the myosin heavy -LRB- MHC -RRB-	37822
isoforms	37822
the myosin heavy -LRB- MHC -RRB-	37834
the myosin heavy	37834
MHC	37852
light chains -LRB- MLC -RRB- in paralysed rat soleus and EDL muscles 8 months after SCT : effect of OEG transplants SCT	37861
light chains -LRB- MLC -RRB- in paralysed rat soleus and EDL muscles 8 months after SCT	37861
light chains -LRB- MLC -RRB-	37861
light chains	37861
MLC	37875
paralysed rat soleus and EDL muscles 8 months after SCT	37883
paralysed rat soleus and EDL muscles	37883
8 months	37920
SCT	37935
effect of OEG transplants SCT	37940
effect	37940
OEG transplants SCT	37950
a slow-to-fast fibre type switching	37978
muscle types	38022
the soleus	38039
slow-twitch fibres	38075
its transition	38094
that of the EDL	38131
that	38131
the EDL	38139
fast-twitch fibres -LRB- Fig. 3 -RRB-	38165
fast-twitch fibres	38165
Fig. 3	38185
Eight months	38194
cordotomy	38213
the EDL muscle	38224
a reduced proportion of fibres expressing the MHC isotypes I -LRB- β/slow -RRB- or IIA as compared to controls , while hybrid IID/XB fibres increased	38246
a reduced proportion	38246
fibres expressing the MHC isotypes I -LRB- β/slow -RRB- or IIA as compared to controls , while hybrid IID/XB fibres increased	38270
fibres	38270
the MHC isotypes	38288
I -LRB- β/slow -RRB- or IIA	38305
I -LRB- β/slow -RRB-	38305
IIA	38319
controls , while hybrid IID/XB fibres increased	38338
controls	38338
hybrid IID/XB fibres	38354
Transplantation of OEG immediately after SCT	38386
Transplantation	38386
OEG immediately after SCT	38405
OEG	38405
SCT	38427
no significant effect on fibre type distribution in the EDL muscle	38435
no significant effect	38435
fibre type distribution in the EDL muscle	38460
fibre type distribution	38460
the EDL muscle	38487
the proportion of IID/X fibres	38507
the proportion	38507
IID/X fibres	38525
the paralysed soleus	38561
8 months after SCT , the proportion of fibres expressing MHC-I	38583
8 months	38583
SCT , the proportion of fibres expressing MHC-I	38597
SCT	38597
the proportion of fibres expressing MHC-I	38602
the proportion	38602
fibres expressing MHC-I	38620
fibres	38620
MHC-I	38638
fibres expressing MHC-IIA or IID/X , either alone	38675
fibres	38675
MHC-IIA or IID/X	38693
combination increased -LRB- see Fig. 3 -RRB-	38730
combination	38730
Fig. 3	38757
OEG transplantation the proportion of type	38776
OEG transplantation	38776
the proportion of type	38796
the proportion	38796
type	38814
I fibres in the soleus	38819
I fibres	38819
the soleus	38831
non-transplanted and control animals	38867
both	38938
The proportion of type I+IIA fibres	38944
The proportion	38944
type I+IIA fibres	38962
non-transplanted animals	39007
themnor fromcontrols	39063
The highstandarddeviation of the means	39085
The highstandarddeviation	39085
the means	39114
particularly the fraction of type I fibres	39129
particularly the fraction	39129
type I fibres	39158
the SOL of OEG-transplanted animals	39175
the SOL	39175
OEG-transplanted animals	39186
a high degree of variability in the individual responses	39229
a high degree	39229
variability in the individual responses	39246
variability	39246
the individual responses	39261
most of the parameters tested	39300
most	39300
the parameters tested	39308
the parameters	39308
no significant differences	39330
contralateralmuscles	39379
the fibre type distribution in the EDL muscle of OEG-transplanted rats	39400
the fibre type distribution	39400
the EDL muscle of OEG-transplanted rats	39431
the EDL muscle	39431
OEG-transplanted rats	39449
an exception	39475
the relative abundance of IIAD/X and IID/X fibres	39494
the relative abundance	39494
IIAD/X and IID/X fibres	39520
P < 0.05 and P < 0.001 , respectively	39556
P < 0.05	39556
P <	39556
P	39556
0.05	39559
P < 0.001 , respectively	39568
P	39568
< 0.001 , respectively	39570
<	39570
0.001	39571
that of type IIB fibres	39598
that	39598
type IIB fibres	39606
P < 0.05	39633
P	39633
< 0.05	39635
<	39635
0.05	39636
right hind limb muscles	39667
Spinal cord transection	39692
a marked effect on the expression of myosin light chain -LRB- MLC -RRB- isoforms	39725
a marked effect	39725
the expression of myosin light chain -LRB- MLC -RRB- isoforms	39744
the expression	39744
myosin light chain -LRB- MLC -RRB- isoforms	39762
myosin light chain -LRB- MLC -RRB-	39762
myosin light chain	39762
MLC	39782
isoforms	39787
Eight months	39797
SCT	39816
the proportion of slow -LRB- s -RRB- isoforms of both essential -LRB- e -RRB- and regulatory -LRB- r -RRB- MLCs in paralysed SOL or EDL muscles	39821
the proportion	39821
slow -LRB- s -RRB- isoforms	39839
both essential -LRB- e -RRB- and regulatory -LRB- r -RRB- MLCs	39860
e	39876
r	39895
paralysed SOL or EDL muscles	39906
controls -LRB- Fig. 4a and b panels -RRB-	39953
controls	39953
Fig. 4a and b panels	39963
Fig. 4a	39963
b panels	39975
This effect	39986
the SOL -LRB- Fig. 4 , upper half -RRB- , where the proportion of slow isoforms of rMLCs -LRB- denoted 2s in 2D patterns of Fig. 4 -RRB- was reduced to less than one fifth of control	40035
the SOL -LRB- Fig. 4 , upper half -RRB-	40035
the SOL	40035
Fig. 4	40044
upper half	40052
the proportion of slow isoforms of rMLCs -LRB- denoted 2s in 2D patterns of Fig. 4 -RRB-	40071
the proportion	40071
slow isoforms of rMLCs -LRB- denoted 2s in 2D patterns of Fig. 4 -RRB-	40089
slow isoforms	40089
rMLCs	40106
2s	40121
2D patterns of Fig. 4	40127
2D patterns	40127
Fig. 4	40142
less than one fifth of control	40165
less than one fifth	40165
control	40188
the proportion of MLC isoforms in the EDL muscle -LRB- Fig. 4 , bottom half -RRB-	40221
the proportion	40221
MLC isoforms in the EDL muscle -LRB- Fig. 4 , bottom half -RRB-	40239
MLC isoforms	40239
the EDL muscle -LRB- Fig. 4 , bottom half -RRB-	40255
the EDL muscle	40255
Fig. 4	40271
bottom half	40279
Transplantation of OEG	40293
Transplantation	40293
OEG	40312
the proportion of slow MLC isoforms	40335
the proportion	40335
slow MLC isoforms	40353
non-transplanted animals	40388
differences	40417
statistical significance -LRB- Fig. 4a and b panels -RRB-	40443
statistical significance	40443
Fig. 4a and b panels	40469
Fig. 4a	40469
b panels	40481
previously described -LRB- Gonzalez et al. 2002 and depicted in Fig. 4 , 2D patterns -RRB-	40495
Gonzalez et al. 2002 and depicted in Fig. 4 , 2D patterns	40517
Gonzalez	40517
et al. 2002 and	40526
et al.	40526
2002 and	40533
Fig. 4 , 2D patterns	40554
Fig. 4	40554
2D patterns	40562
both	40576
and	40590
-LRB- s -RRB- rMLC isoforms	40599
-LRB- s -RRB-	40599
rMLC isoforms	40603
different variants	40627
the same molecular weight	40651
slightly different	40681
SOL	40722
the proportion of variant 2s , the less acidic of the variants of the slow rMLC isoform and the most abundantly represented in thismuscle ,	40727
the proportion of variant 2s	40727
the proportion	40727
variant 2s	40745
the less acidic of the variants of the slow rMLC isoform and the most abundantly represented in thismuscle	40757
the less acidic	40757
the variants of the slow rMLC isoform and the most abundantly represented in thismuscle	40776
the variants of the slow rMLC isoform	40776
the variants	40776
the slow rMLC isoform	40792
the most abundantly represented in thismuscle	40818
the most abundantly represented	40818
thismuscle	40853
cordotomy	40895
This variant	40906
EDL muscle	40939
a minor component of the minor -LRB- slow -RRB- isoform	40954
a minor component	40954
the minor -LRB- slow -RRB- isoform	40975
its proportion	41005
SCT animals	41040
a statistically significant manner	41055
Transplantation of OEG	41091
Transplantation	41091
OEG	41110
the proportion of variant 2s	41141
the proportion	41141
variant 2s	41159
the EDL	41173
the control level	41184
the SOL	41215
OEG transplantation	41224
the proportion of this variant	41254
the proportion	41254
this variant	41272
a level that was statistically non-different from both control and non-transplanted animals	41288
a level	41288
both control and non-transplanted animals	41338
both control	41338
non-transplanted animals	41355
The high standard deviation of the data from OEG-transplanted animals	41381
The high standard deviation	41381
the data from OEG-transplanted animals	41412
the data	41412
OEG-transplanted animals	41426
a wide range of variation	41469
a wide range	41469
variation	41485
the individual responses	41498
Global analysis of slow - and fast-twitch skeletal muscles of cordotomized rats following OEG transplantation based on expression of phenotypic markers To establish the degree of similarity between muscles of OEG-transplanted and those of control and non-transplanted cordotomized animals , a multivariate discriminant analysis	41524
Global analysis	41524
slow - and fast-twitch skeletal muscles of cordotomized rats following OEG transplantation based on expression of phenotypic markers To establish the degree of similarity between muscles of OEG-transplanted and those of control and non-transplanted cordotomized animals , a multivariate discriminant analysis	41543
slow - and fast-twitch skeletal muscles	41543
cordotomized rats following OEG transplantation based on expression of phenotypic markers To establish the degree of similarity between muscles of OEG-transplanted and those of control and non-transplanted cordotomized animals , a multivariate discriminant analysis	41585
cordotomized rats	41585
OEG transplantation based on expression of phenotypic markers To establish the degree of similarity between muscles of OEG-transplanted and those of control and non-transplanted cordotomized animals , a multivariate discriminant analysis	41613
OEG transplantation	41613
expression of phenotypic markers	41642
expression	41642
phenotypic markers	41656
the degree of similarity between muscles of OEG-transplanted and those of control and non-transplanted cordotomized animals , a multivariate discriminant analysis	41688
the degree	41688
similarity between muscles of OEG-transplanted and those of control and non-transplanted cordotomized animals , a multivariate discriminant analysis	41702
similarity between muscles of OEG-transplanted and those of control	41702
similarity	41702
muscles of OEG-transplanted and those of control	41721
muscles of OEG-transplanted	41721
muscles	41721
OEG-transplanted	41732
those of control	41753
those	41753
control	41762
non-transplanted cordotomized animals , a multivariate discriminant analysis	41774
non-transplanted cordotomized animals	41774
a multivariate discriminant analysis	41813
all the data available for each muscle , including left and right hind limbs as independent values	41869
all the data	41869
each muscle	41896
left and right hind limbs as independent values	41919
left and right hind limbs	41919
independent values	41948
The discriminant model for the SOL	41968
The discriminant model	41968
the SOL	41995
the following variables : wet weight , muscle-somatic index , percentage of type I , I+IIA , IIA , IIAD/X and IIX fibres , SDH and GPDH activities , fibre CSA , slow rMLC/total rMLC , slow eMLC/total eMLC , variant 2s/total rMLC , variant 2s/slow rMLC , variant 2f/total rMLC and variant 2f/fast rMLC	42012
the following variables	42012
wet weight , muscle-somatic index , percentage of type I , I+IIA , IIA , IIAD/X and IIX fibres , SDH and GPDH activities , fibre CSA , slow rMLC/total rMLC , slow eMLC/total eMLC , variant 2s/total rMLC , variant 2s/slow rMLC , variant 2f/total rMLC and variant 2f/fast rMLC	42037
wet weight	42037
muscle-somatic index	42049
percentage of type I	42071
percentage	42071
type I	42085
I+IIA , IIA , IIAD/X and IIX fibres , SDH and GPDH activities , fibre CSA , slow rMLC/total rMLC , slow eMLC/total eMLC , variant 2s/total rMLC , variant 2s/slow rMLC , variant 2f/total rMLC and variant 2f/fast rMLC	42093
I+IIA	42093
IIA , IIAD/X and IIX fibres	42100
SDH and GPDH activities	42128
fibre CSA	42153
slow rMLC/total rMLC	42164
slow eMLC/total eMLC	42186
variant 2s/total rMLC	42208
variant 2s/slow rMLC	42231
variant 2f/total rMLC	42253
variant 2f/fast rMLC	42279
the EDL muscle	42305
the same parameters	42320
the fraction of type IID/XB and IIB fibres	42363
the fraction	42363
type IID/XB and IIB fibres	42379
that of type I and IIA	42430
that	42430
type I and IIA	42438
type I	42438
IIA	42449
these parameters	42459
the percentages of correctly classified observations	42477
the percentages	42477
correctly classified observations	42496
100 , 90.9 , 77.8 and 89.3 in the SOL and 100 , 95.45 , 94.43 and 96.42 in EDL muscle , for samples of control , non-transplanted , OEG-transplanted and whole group of animals	42535
100 , 90.9	42535
100	42535
90.9	42540
77.8 and 89.3 in the SOL	42546
77.8 and 89.3	42546
the SOL	42563
100 , 95.45 , 94.43 and 96.42 in EDL muscle , for samples of control , non-transplanted , OEG-transplanted and whole group of animals	42575
100	42575
95.45	42580
94.43 and 96.42 in EDL muscle	42587
94.43 and 96.42	42587
EDL muscle	42606
samples of control	42622
samples	42622
control	42633
non-transplanted , OEG-transplanted and whole group of animals	42642
non-transplanted , OEG-transplanted and whole group	42642
animals	42696
None of the 44 individual skeletal muscles -LRB- soleus and EDL ,	42719
None	42719
the 44 individual skeletal muscles -LRB- soleus and EDL ,	42727
the 44 individual skeletal muscles	42727
soleus and EDL	42763
right hind limbs -RRB-	42788
SCT	42811
non-transplanted animals	42816
characteristics of control animal muscle -LRB- and only 3 could be classified as originating from OEG-transplanted animals -RRB-	42851
characteristics	42851
control animal muscle -LRB- and only 3 could be classified as originating from OEG-transplanted animals -RRB-	42870
control animal muscle	42870
only 3	42897
OEG-transplanted animals	42944
OEG-transplanted rats 31 out of 36	42974
OEG-transplanted rats	42974
31	42996
36	43006
muscles	43009
4 as deriving from SCT and only 1 from control animals	43044
4	43044
SCT and only 1 from control animals	43063
SCT	43063
only 1 from control animals	43071
only 1	43071
control animals	43083
a per muscle type basis , contrary to expected	43103
a per muscle type basis , contrary to	43103
a per muscle type	43103
basis	43121
the percentage of correctly classified observations in the EDL	43150
the percentage	43150
correctly classified observations in the EDL	43168
correctly classified observations	43168
the EDL	43205
the SOL	43238
The Mahalanobis distances between group pairs and their statistical significance in both muscle types	43247
The Mahalanobis distances	43247
group pairs and their statistical significance	43281
group pairs	43281
their statistical significance	43297
muscle types	43336
Fig. 5	43366
The data	43374
the differences between the overall phenotypic characteristics of muscles of OEG-transplanted animals and those of both control and non-transplanted	43393
the differences	43393
the overall phenotypic characteristics of muscles of OEG-transplanted animals and those of both control and non-transplanted	43417
the overall phenotypic characteristics	43417
muscles of OEG-transplanted animals and those of both control and non-transplanted	43459
muscles of OEG-transplanted animals	43459
muscles	43459
OEG-transplanted animals	43470
those of both control and non-transplanted	43499
those	43499
both control and non-transplanted	43508
both control	43508
non-transplanted	43525
respect to skeletal muscle phenotype	43554
respect	43554
skeletal muscle phenotype	43565
OEG-transplanted rats	43592
a separate group , situated between control and non-transplanted , with overall properties	43620
a separate group	43620
control and non-transplanted	43655
overall properties	43690
non-transplanted animals	43725
controls	43758
their relative Mahalanobis distances	43783
Correlation of previously published data from functional tests with the expression of morphological , metabolic and contractile activity markers in fast - and slow-twitch skeletal muscle of cordotomized rats following OEG transplantation In general terms , practically all the phenotypic markers measured in this investigation for SOL or EDL muscles correlated very well with previously published data from functional capacity derived frombehavioural tests -LRB- graded from 0 to 4 as previously described in Ramon-Cueto et al. 2000 -RRB- .	43821
Correlation	43821
previously published data	43836
functional tests	43867
the expression	43889
morphological , metabolic and contractile activity markers	43907
fast - and slow-twitch skeletal muscle	43968
cordotomized rats	44009
OEG transplantation In general terms , practically all the phenotypic markers measured in this investigation for SOL or EDL muscles correlated very well with previously published data	44037
OEG transplantation	44037
general terms	44060
practically all the phenotypic markers	44075
this investigation for SOL	44126
this investigation	44126
SOL	44149
EDL muscles	44156
previously published data	44194
functional capacity	44225
frombehavioural tests -LRB- graded from 0 to 4 as previously described in Ramon-Cueto et al. 2000 -RRB-	44253
frombehavioural tests	44253
0 to 4	44288
Ramon-Cueto	44322
et al. 2000	44334
et al.	44334
2000	44341
soleus muscle , wet weight , muscle-somatic index , percentage of fibres expressing only MHC-I -LRB- type I fibres -RRB-	44351
soleus muscle	44351
wet weight , muscle-somatic index , percentage of fibres expressing only MHC-I -LRB- type I fibres -RRB-	44366
wet weight	44366
muscle-somatic index	44378
percentage of fibres expressing only MHC-I -LRB- type I fibres -RRB-	44400
percentage	44400
fibres expressing only MHC-I -LRB- type I fibres -RRB-	44414
fibres	44414
only MHC-I -LRB- type I fibres -RRB-	44432
only MHC-I	44432
type I fibres	44444
type	44444
I fibres	44449
fraction of slow rMLC isoform from total rMLC -LRB- slow rMLC/total rMLC -RRB- , fraction of slow eMLC isoform from total eMLC -LRB- eMLCs/total eMLCt -RRB- , fraction of variant 2s from total rMLC and fraction of variant 2s from slow rMLC	44460
fraction of slow rMLC isoform from total rMLC -LRB- slow rMLC/total rMLC -RRB-	44460
fraction	44460
slow rMLC isoform from total rMLC -LRB- slow rMLC/total rMLC -RRB-	44472
slow rMLC isoform	44472
total rMLC -LRB- slow rMLC/total rMLC -RRB-	44495
total rMLC	44495
slow rMLC/total rMLC	44507
fraction of slow eMLC isoform from total eMLC -LRB- eMLCs/total eMLCt -RRB-	44530
fraction	44530
slow eMLC isoform from total eMLC -LRB- eMLCs/total eMLCt -RRB-	44542
slow eMLC isoform	44542
total eMLC -LRB- eMLCs/total eMLCt -RRB-	44565
total eMLC	44565
eMLCs/total eMLCt	44577
fraction of variant 2s from total rMLC	44597
fraction	44597
variant 2s from total rMLC	44609
variant 2s	44609
total rMLC	44625
fraction of variant 2s from slow rMLC	44640
fraction	44640
variant 2s from slow rMLC	44652
variant 2s	44652
slow rMLC	44668
a positive , statistically significant correlation , while the fraction of type IIAD/X or IID/X fibres , SDH and GPDH activities , fraction of variant 2f from total rMLC and fraction of variant 2f from fast rMLC correlated negatively	44685
a positive , statistically significant correlation	44685
the fraction of type IIAD/X or IID/X fibres , SDH and GPDH activities , fraction of variant 2f from total rMLC and fraction of variant 2f from fast rMLC	44742
the fraction of type IIAD/X or IID/X fibres , SDH and GPDH activities	44742
the fraction	44742
type IIAD/X or IID/X fibres , SDH and GPDH activities	44758
fraction of variant 2f from total rMLC	44812
fraction	44812
variant 2f from total rMLC	44824
variant 2f	44824
total rMLC	44840
fraction of variant 2f from fast rMLC	44855
fraction	44855
variant 2f from fast rMLC	44867
variant 2f	44867
fast rMLC	44883
the basis of the amplitude of the changes induced by SCT and the degree of maintenance of normal values following OEG transplantation	44919
the basis	44919
the amplitude of the changes induced by SCT and the degree of maintenance of normal values following OEG transplantation	44932
the amplitude	44932
the changes induced by SCT and the degree of maintenance of normal values following OEG transplantation	44949
the changes	44949
SCT and the degree of maintenance of normal values following OEG transplantation	44972
SCT	44972
the degree of maintenance of normal values following OEG transplantation	44980
the degree	44980
maintenance of normal values following OEG transplantation	44994
maintenance	44994
normal values following OEG transplantation	45009
normal values	45009
OEG transplantation	45033
four of these parameters	45054
four	45054
these parameters	45062
candidate sensitive markers of paralysed soleus muscle phenotype : -LRB- 1 -RRB- glycolytic activity , as measured by quantitative GPDH histochemistry -LRB- Pearson 's correlation , r = − 0.843 , P < 0.0001 -RRB- ; -LRB- 2 -RRB- proportion of fibres expressing the MHC-I -LRB- β/slow -RRB- as the uniqueMHCisoform -LRB- Spearman 's correlation , r = 0.764 , P < 0.0001 -RRB- ; -LRB- 3 -RRB- fraction of slow isoform from the total rMLC complement -LRB- Spearman 's correlation , r = 0.746 , P < 0.0001 ; and -LRB- 4 -RRB- fraction of the variant 2s from total slow rMLC isoform -LRB- Spearman 's correlation , r = 0.848 , P < 0.0001 -RRB-	45110
candidate sensitive markers of paralysed soleus muscle phenotype : -LRB- 1 -RRB- glycolytic activity , as measured by quantitative GPDH histochemistry -LRB- Pearson 's correlation , r = − 0.843 , P < 0.0001 -RRB-	45110
candidate sensitive markers of paralysed soleus muscle phenotype : -LRB- 1 -RRB- glycolytic activity , as measured by quantitative GPDH histochemistry	45110
candidate sensitive markers of paralysed soleus muscle phenotype	45110
candidate sensitive markers	45110
paralysed soleus muscle phenotype	45141
-LRB- 1 -RRB- glycolytic activity , as measured by quantitative GPDH histochemistry	45176
glycolytic	45180
activity ,	45191
activity	45191
as measured by quantitative GPDH histochemistry	45201
as	45201
quantitative GPDH histochemistry	45216
Pearson 's correlation , r = − 0.843 , P	45250
Pearson 's correlation , r	45250
Pearson 's	45250
− 0.843 , P	45276
− 0.843	45276
P	45284
0.0001	45287
-LRB- 2 -RRB- proportion of fibres expressing the MHC-I -LRB- β/slow -RRB- as the uniqueMHCisoform -LRB- Spearman 's correlation , r = 0.764 , P < 0.0001 -RRB-	45296
proportion	45300
fibres expressing the MHC-I -LRB- β/slow -RRB- as the uniqueMHCisoform -LRB- Spearman 's correlation , r = 0.764 , P < 0.0001 -RRB-	45314
fibres	45314
the MHC-I -LRB- β/slow -RRB- as the uniqueMHCisoform	45332
the MHC-I -LRB- β/slow -RRB-	45332
the MHC-I	45332
β/slow	45343
the uniqueMHCisoform	45354
Spearman 's correlation , r = 0.764 , P	45375
Spearman 's correlation , r	45375
Spearman 's	45375
0.764 , P	45402
0.764	45402
P	45409
0.0001	45412
-LRB- 3 -RRB- fraction of slow isoform from the total rMLC complement -LRB- Spearman 's correlation , r = 0.746 , P < 0.0001 ; and -LRB- 4 -RRB- fraction of the variant 2s from total slow rMLC isoform -LRB- Spearman 's correlation , r = 0.848 , P < 0.0001 -RRB-	45421
fraction	45425
slow isoform from the total rMLC complement -LRB- Spearman 's correlation , r = 0.746 , P < 0.0001 ; and -LRB- 4 -RRB- fraction of the variant 2s from total slow rMLC isoform -LRB- Spearman 's correlation , r = 0.848 , P < 0.0001 -RRB-	45437
slow isoform	45437
the total rMLC complement -LRB- Spearman 's correlation , r = 0.746 , P < 0.0001 ; and -LRB- 4 -RRB- fraction of the variant 2s from total slow rMLC isoform -LRB- Spearman 's correlation , r = 0.848 , P < 0.0001 -RRB-	45455
the total rMLC complement -LRB- Spearman 's correlation , r = 0.746 , P < 0.0001 ;	45455
the total rMLC complement	45455
Spearman 's correlation , r = 0.746 , P < 0.0001	45482
Spearman 's correlation	45482
Spearman 's	45482
r = 0.746	45506
r	45506
0.746	45509
P < 0.0001	45516
P	45516
0.0001	45519
-LRB- 4 -RRB- fraction of the variant 2s from total slow rMLC isoform -LRB- Spearman 's correlation , r = 0.848 , P < 0.0001 -RRB-	45531
fraction	45535
the variant 2s from total slow rMLC isoform -LRB- Spearman 's correlation , r = 0.848 , P < 0.0001 -RRB-	45547
the variant 2s	45547
total slow rMLC isoform -LRB- Spearman 's correlation , r = 0.848 , P < 0.0001 -RRB-	45567
total slow rMLC isoform	45567
Spearman 's correlation , r = 0.848 , P	45592
Spearman 's correlation , r	45592
Spearman 's	45592
0.848 , P	45619
0.848	45619
P	45626
0.0001	45629
Figure 6	45638
the mean values of these parameters in control -LRB- C -RRB- and paralysed -LRB- SCT -RRB- right	45658
mean values of these parameters	45662
mean values	45662
these parameters	45677
control -LRB- C -RRB-	45697
control	45697
C	45706
SCT	45724
hind limb SOL	45744
the individual values obtained for left and right SOL in each of the OEG-transplanted animals , ordered from 1 to 9 according to previously reported time	45772
the individual values	45772
left and right SOL	45807
each of the OEG-transplanted animals , ordered from 1 to 9 according to previously reported time	45829
each	45829
the OEG-transplanted animals , ordered from 1 to 9 according to previously reported time	45837
the OEG-transplanted animals	45837
1 to 9	45880
previously reported time	45900
course and amplitude of recovery of sensory-motor functions -LRB- Ramon-Cueto et al. 2000 -RRB- , represented in Fig. 6A	45925
course and amplitude	45925
recovery of sensory-motor functions -LRB- Ramon-Cueto et al. 2000 -RRB- , represented in Fig. 6A	45949
recovery	45949
sensory-motor functions -LRB- Ramon-Cueto et al. 2000 -RRB- , represented in Fig. 6A	45961
sensory-motor functions -LRB- Ramon-Cueto et al. 2000 -RRB-	45961
sensory-motor functions	45961
Ramon-Cueto	45986
et al. 2000	45998
et al.	45998
2000	46005
Fig. 6A	46027
It	46036
this figure	46058
all four parameters	46075
a good discrimination betweenmuscles	46103
animals that recovered sensory and motor function within the first 3 months after the intervention and those that showed the first signs of recovery at the final part of the 8 month period	46145
animals	46145
sensory and motor function	46168
the first 3 months	46202
the intervention and those that showed the first signs of recovery at the final part of the 8 month period	46226
the intervention	46226
those that showed the first signs of recovery at the final part of the 8 month period	46247
those	46247
the first signs of recovery	46265
the first signs	46265
recovery	46284
the final part of the 8 month period	46296
the final part	46296
the 8 month period	46314
the data of Fig. 6	46338
the data	46338
Fig. 6	46350
it	46357
all four phenotypic markers	46376
rats	46415
1 , 2 and 3	46420
the animals with skeletal muscle characteristics closest to normal , in this order , and rat 9	46434
the animals	46434
skeletal muscle characteristics	46451
normal	46494
this order	46505
rat 9	46521
the farthest	46530
The remaining five animals	46544
slightly different positions	46587
a function of the parameter considered	46619
a function	46619
the parameter considered	46633
the parameter	46633
GPDH activity and the fraction of variant 2s from the slow rMLC isoform	46659
GPDH activity	46659
the fraction of variant 2s from the slow rMLC isoform	46677
the fraction	46677
variant 2s from the slow rMLC isoform	46693
variant 2s	46693
the slow rMLC isoform	46709
the only parameters that provided enough sensitivity to allow animals with similar motor functional capacity to be graded according to expression of a molecular marker	46736
the only parameters	46736
enough sensitivity	46770
animals with similar motor functional capacity	46798
animals with similar motor	46798
animals	46798
similar motor	46811
expression of a molecular marker	46871
expression	46871
a molecular marker	46885
a mean between both hind limb muscles	46917
a mean	46917
both hind limb muscles	46932
both parameters	46956
OEG-transplanted animals	46980
the sequence	47022
1 , 2 , 3 , 4 -LRB- 6 -RRB- , 6 -LRB- 4 -RRB- , 8 , 7 , 5 , 9	47035
1	47035
2	47038
3	47041
4 -LRB- 6 -RRB-	47044
4	47044
6	47046
6 -LRB- 4 -RRB-	47050
6	47050
4	47052
8	47056
7	47059
5	47062
9	47065
Similar conclusions	47068
the analysis of almost the same parameters in the EDL muscle -LRB- not shown -RRB-	47106
the analysis	47106
almost the same parameters in the EDL muscle -LRB- not shown -RRB-	47122
almost the same parameters	47122
the EDL muscle	47152
this muscle	47184
GPDH activity -LRB- Spearman 's correlation r = − 0.604 , P < 0.0001 -RRB- and wet muscle weight -LRB- Pearson 's correlation r = 0.613 , P < 0.0001 -RRB- -LRB- or muscle-somatic index -RRB-	47197
GPDH activity -LRB- Spearman 's correlation r = − 0.604 , P < 0.0001 -RRB- and wet muscle weight -LRB- Pearson 's correlation r = 0.613 , P < 0.0001 -RRB-	47197
GPDH activity -LRB- Spearman 's correlation r = − 0.604 , P < 0.0001 -RRB-	47197
GPDH activity	47197
Spearman 's correlation r = − 0.604 , P	47212
Spearman 's correlation r	47212
Spearman 's	47212
− 0.604 , P	47238
− 0.604	47238
P	47246
0.0001	47249
wet muscle weight -LRB- Pearson 's correlation r = 0.613 , P < 0.0001 -RRB-	47261
wet muscle weight	47261
Pearson 's correlation r = 0.613 , P	47280
Pearson 's correlation r	47280
Pearson 's	47280
0.613 , P	47305
0.613	47305
P	47312
0.0001	47315
the highest discriminatory potential	47356
Discussion The present investigation	47395
Discussion	47395
The present investigation	47406
our knowledge the first study	47438
our knowledge	47438
the first study	47452
the impact of OEG transplantation	47479
the impact	47479
OEG transplantation	47493
completely transected spinal cord on the phenotypic characteristics of fast - and slow-twitch hind limb skeletal muscle	47518
spinal cord	47540
the phenotypic characteristics of fast - and slow-twitch hind limb	47555
the phenotypic characteristics	47555
fast - and slow-twitch hind limb	47589
a variety of phenotypic markers	47649
a variety	47649
phenotypic markers	47662
possible correlations between the relative maintenance of normal muscle characteristics and the functional capacity for locomotion derived from behavioural tests	47694
possible correlations	47694
the relative maintenance of normal muscle characteristics and the functional capacity for locomotion derived from behavioural tests	47724
the relative maintenance of normal muscle characteristics	47724
the relative maintenance	47724
normal muscle characteristics	47752
the functional capacity for locomotion derived from behavioural tests	47786
the functional capacity	47786
locomotion derived from behavioural tests	47814
locomotion	47814
behavioural tests	47838
The main findings of this study	47857
The main findings	47857
this study	47878
-LRB- a -RRB- transplantation of OEG into the transected rat spinal cord	47898
-LRB- a -RRB- transplantation of OEG	47898
transplantation	47902
OEG	47921
the transected rat spinal cord	47930
hind limb	47972
skeletal muscle phenotypes that are generally intermediate between paralysed and control and different from both	47982
skeletal muscle phenotypes	47982
paralysed and control	48049
paralysed	48049
control	48063
-LRB- b -RRB- the expression levels of a variety of phenotypic markers of slowand fast-twitch hind limb skeletal muscle	48105
-LRB- b -RRB- the expression levels of a variety of phenotypic markers of slowand fast-twitch hind limb	48105
the expression levels	48109
a variety of phenotypic markers of slowand fast-twitch hind limb	48134
a variety	48134
phenotypic markers of slowand fast-twitch hind limb	48147
phenotypic markers	48147
slowand fast-twitch hind limb	48169
skeletal muscle	48199
the sensory-motor functional capacity of SCT , OEG-transplanted rats determined by means of behavioural tests	48240
the sensory-motor	48240
capacity of SCT , OEG-transplanted rats determined by means of behavioural tests	48269
capacity of SCT	48269
capacity	48269
SCT	48281
OEG-transplanted rats determined by means of behavioural tests	48286
OEG-transplanted rats	48286
means of behavioural tests	48322
means	48322
behavioural tests	48331
all parameters tested	48356
all parameters	48356
the histochemical glycerol-3-phosphate dehydrogenase activity and the fraction of the less acidic variant -LRB- variant 2s -RRB- of the slow rMLC isoform , in SOL muscle ,	48379
the histochemical glycerol-3-phosphate dehydrogenase activity	48379
the fraction of the less acidic variant -LRB- variant 2s -RRB- of the slow rMLC isoform , in SOL muscle ,	48445
the fraction	48445
the less acidic variant -LRB- variant 2s -RRB- of the slow rMLC isoform , in SOL muscle ,	48461
the less acidic variant -LRB- variant 2s -RRB-	48461
the less acidic variant	48461
variant 2s	48486
the slow rMLC isoform , in SOL muscle ,	48501
the slow rMLC isoform	48501
SOL muscle	48527
the most sensitive phenotypic marker	48552
the degree	48601
a SOLmuscle	48617
normal characteristics following SCT and OEG transplantation	48640
normal characteristics	48640
SCT and OEG transplantation	48673
histochemicalGPDHactivity andmuscleweight -LRB- ormuscle-somatic index -RRB-	48713
histochemicalGPDHactivity andmuscleweight	48713
ormuscle-somatic index	48756
the most sensitive markers in EDL muscle	48784
the most sensitive markers	48784
EDL muscle	48814
It	48826
this study	48848
components of the contractile machinery	48879
components	48879
the contractile machinery	48893
sensitive markers of changes in slow - and fast-twitch skeletal muscle phenotypes in response	48922
sensitive markers	48922
changes in slow - and fast-twitch skeletal muscle phenotypes in response	48943
changes	48943
slow - and fast-twitch skeletal muscle phenotypes in response	48954
slow - and fast-twitch skeletal muscle phenotypes	48954
response	49006
SCT and OEG transplantation	49018
components of the energy metabolism and muscle mass	49056
components	49056
the energy metabolism and muscle mass	49070
The multivariate analysis performed in this study using diverse markers of skeletal muscle morphology , metabolism and molecular diversity of myosin subunits	49109
The multivariate analysis	49109
this study using diverse markers of skeletal muscle morphology , metabolism and molecular diversity of myosin subunits	49148
this study	49148
diverse markers of skeletal muscle morphology , metabolism and molecular diversity of myosin subunits	49165
diverse markers	49165
skeletal muscle morphology , metabolism and molecular diversity of myosin subunits	49184
skeletal muscle morphology , metabolism and molecular diversity	49184
myosin subunits	49250
fast - and slow-twitch skeletal muscle phenotypes of SCT , OEG-transplanted animals	49289
fast - and slow-twitch skeletal muscle phenotypes	49289
SCT , OEG-transplanted animals	49341
SCT	49341
OEG-transplanted animals	49346
those of non-transplanted	49391
those	49391
non-transplanted	49400
controls	49426
account	49448
the high percentage of correctly classified observations obtained in this analysis	49456
the high percentage	49456
correctly classified observations obtained in this analysis	49479
correctly classified observations	49479
this analysis	49525
this result	49540
solid evidence of the impact of OEG transplantation	49561
solid evidence	49561
the impact of OEG transplantation	49579
the impact	49579
OEG transplantation	49593
maintenance of skeletal muscle properties	49616
maintenance	49616
skeletal muscle properties	49631
quantitative terms	49662
the degree to which fibre type-specific protein expression in hind limb skeletalmuscle of OEG-transplanted rats approached normality	49691
the degree	49691
type-specific protein expression in hind limb skeletalmuscle of OEG-transplanted rats	49717
type-specific protein expression	49717
hind limb skeletalmuscle of OEG-transplanted rats	49753
hind limb skeletalmuscle	49753
OEG-transplanted rats	49781
normality	49814
variable fromone animal tothe other	49835
It	49872
3	49903
9 OEG-transplanted animals	49912
The remaining 6 animals , precisely those that showed loss of sensory-motor function 3 months after the intervention ,	49940
The remaining 6 animals	49940
precisely those that showed loss of sensory-motor function 3 months after the intervention	49965
precisely those	49965
loss of sensory-motor function	49993
loss	49993
sensory-motor function	50001
3 months	50024
the intervention	50038
muscle phenotypes	50063
normal individuals	50118
the expression of fibre type-specific characteristics	50137
the expression	50137
fibre type-specific characteristics	50155
proper activation of slow and fast motor neurons -LRB- Schiaffino & Reggiani , 1996 ; Pette & Staron , 2001 -RRB-	50204
proper activation	50204
slow and fast motor neurons -LRB- Schiaffino & Reggiani , 1996 ; Pette & Staron , 2001 -RRB-	50225
slow and fast motor neurons	50225
Schiaffino & Reggiani , 1996 ; Pette & Staron , 2001	50254
Schiaffino & Reggiani	50254
1996 ; Pette & Staron	50277
1996	50277
Pette & Staron	50283
2001	50299
a possible interpretation of these data	50306
a possible interpretation	50306
these data	50335
3	50357
9 animals	50366
OEG transplantation	50376
a functional connectivity of local spinal circuits	50420
a functional connectivity	50420
local spinal circuits	50449
motor pathways	50486
a previous study involving the same rats used in this investigation -LRB- Ramon-Cueto et al. 2000 -RRB-	50505
a previous study	50505
the same rats used in this investigation -LRB- Ramon-Cueto et al. 2000 -RRB-	50532
the same rats	50532
this investigation -LRB- Ramon-Cueto et al. 2000 -RRB-	50554
this investigation	50554
Ramon-Cueto et al. 2000	50574
Ramon-Cueto	50574
et al. 2000	50586
et al.	50586
2000	50593
long distance regeneration of motor pathways within caudal cord stumps and functional recovery	50600
long distance regeneration	50600
motor pathways within caudal cord stumps and functional recovery	50630
motor pathways	50630
caudal cord stumps and functional recovery	50652
caudal cord stumps	50652
functional recovery	50675
this investigation	50712
it	50731
the regenerated axons	50761
functional connections	50795
addition	50822
it	50832
these connections , in the cases that they were formed ,	50852
these connections	50852
the cases that they were formed	50874
the cases	50874
they	50889
normal	50917
appropriate activity patterns	50942
An additional mechanism for OEG transplants to promote a relative maintenance of skeletal muscle characteristics and apparent functional recovery	50984
An additional mechanism	50984
OEG transplants	51012
a relative maintenance of skeletal muscle characteristics and apparent functional recovery	51039
a relative maintenance of skeletal muscle characteristics	51039
a relative maintenance	51039
skeletal muscle characteristics	51065
apparent functional recovery	51101
compensatory adaptations leading to increased neuromuscular activity and motor automatism	51144
compensatory adaptations	51144
increased neuromuscular activity and motor automatism	51180
upper motor neuron pathways	51246
the motor cortex	51277
a main influence	51300
local spinal circuits -LRB- central pattern generators -RRB- that control the coordinated movements associated with locomotion	51320
local spinal circuits -LRB- central pattern generators -RRB-	51320
local spinal circuits	51320
central pattern generators	51343
the coordinated movements associated with locomotion	51384
the coordinated movements	51384
locomotion	51426
Automaticity of movement	51438
Automaticity	51438
movement	51454
sensory information derived from movement , which becomes the only input to control central pattern generation in SCI individuals	51481
sensory information	51481
movement , which becomes the only input to control central pattern generation in SCI individuals	51514
movement	51514
the only input to control central pattern generation in SCI individuals	51538
central pattern generation in SCI individuals	51564
central pattern generation	51564
SCI individuals	51594
months after SCI	51631
months	51631
SCI	51644
the spinal cord circuitry	51649
functional characteristics eventually enabling it to use some of those spinal pathways that are utilized normally -LRB- Edgerton et al. 2006 ; Wolpaw , 2007 -RRB- , which could underlie the functional recovery observed in these animals	51697
functional characteristics	51697
it	51744
some of those spinal pathways that are utilized normally -LRB- Edgerton et al. 2006 ; Wolpaw , 2007 -RRB- , which could underlie the functional recovery observed in these animals	51754
some	51754
those spinal pathways that are utilized normally -LRB- Edgerton et al. 2006 ; Wolpaw , 2007 -RRB- , which could underlie the functional recovery observed in these animals	51762
those spinal pathways that are utilized normally -LRB- Edgerton et al. 2006 ; Wolpaw , 2007 -RRB-	51762
those spinal pathways	51762
Edgerton et al. 2006 ; Wolpaw , 2007	51812
Edgerton	51812
et al. 2006 ; Wolpaw , 2007	51821
et al. 2006	51821
et al.	51821
2006	51828
Wolpaw , 2007	51834
Wolpaw	51834
2007	51842
the functional recovery observed in these animals	51870
the functional recovery	51870
these animals	51906
The rationale for using OEG in regenerative studies of the SC	51921
The rationale	51921
OEG	51945
regenerative studies of the SC	51952
regenerative studies	51952
the SC	51976
their ability to counteract local inhibitory influences for axon growth	51991
local inhibitory influences	52019
axon growth	52051
glial pathways	52077
neurotrophic factors which stimulate neuronal gene expression and axonal growth	52104
neurotrophic factors	52104
neuronal gene expression and axonal growth	52141
neuronal gene expression	52141
axonal growth	52170
OEG	52185
nerve growth factor -LRB- NGF -RRB- , neurotrophin -LRB- NF -RRB- 4/5 , neuroregulin ,	52218
nerve growth factor	52218
NGF	52239
neurotrophin -LRB- NF -RRB- 4/5	52245
neurotrophin	52245
NF	52259
4/5	52263
neuroregulin	52268
brain-derived neurotrophic factor -LRB- BDNF -RRB- and NT-3 -LRB- Ramon-Cueto & Avila , 1998 ; Boruch et al. 2001 -RRB-	52282
brain-derived neurotrophic factor -LRB- BDNF -RRB-	52282
brain-derived neurotrophic factor	52282
BDNF	52317
NT-3 -LRB- Ramon-Cueto & Avila , 1998 ; Boruch et al. 2001 -RRB-	52327
NT-3	52327
Ramon-Cueto & Avila , 1998 ; Boruch et al. 2001	52333
Ramon-Cueto & Avila , 1998 ; Boruch et al.	52333
Ramon-Cueto & Avila , 1998	52333
Ramon-Cueto & Avila	52333
1998	52354
Boruch et al.	52360
Boruch	52360
et al.	52367
2001	52374
some of them	52396
some	52396
them	52404
considerable amounts	52412
addition	52437
the migratory pattern of OEG	52447
the migratory pattern	52447
OEG	52472
these cells	52490
external stimuli originating from injured nerve cells and their processes -LRB- Boruch et al. 2001 -RRB-	52522
external stimuli	52522
injured nerve cells and their processes -LRB- Boruch et al. 2001 -RRB-	52556
injured nerve cells	52556
their processes -LRB- Boruch et al. 2001 -RRB-	52580
their processes	52580
Boruch	52597
et al. 2001	52604
et al.	52604
2001	52611
Slow skeletal muscle fibres	52618
NT-4	52681
an activity-dependent manner	52689
growth and remodelling of adult motoneuron innervation -LRB- Belluardo et al. 2001 -RRB-	52733
growth and remodelling	52733
adult motoneuron innervation -LRB- Belluardo et al. 2001 -RRB-	52759
adult motoneuron innervation	52759
Belluardo	52789
et al. 2001	52799
et al.	52799
2001	52806
Hind limb muscle fibres and lumbar astrocytes	52813
Hind limb muscle fibres	52813
lumbar astrocytes	52841
HSP70 , a stress protein that could also act as a neurotrohic factor critically involved in motoneuron survival -LRB- Robinson et al. 2005 -RRB-	52886
HSP70	52886
a stress protein that could also act as a neurotrohic factor critically involved in motoneuron survival -LRB- Robinson et al. 2005 -RRB-	52893
a stress protein	52893
a neurotrohic factor critically involved	52933
a neurotrohic factor	52933
motoneuron survival -LRB- Robinson et al. 2005 -RRB-	52977
motoneuron survival	52977
Robinson	52998
et al. 2005	53007
et al.	53007
2005	53014
Exercise	53021
the regenerative potential of CNS neurons -LRB- Doyle & Roberts , 2006 -RRB-	53052
the regenerative potential	53052
CNS neurons -LRB- Doyle & Roberts , 2006 -RRB-	53082
CNS neurons	53082
Doyle & Roberts	53095
2006	53112
neurotrophic factor levels and synaptic plasticity -LRB- Ying et al. 2005 -RRB-	53127
neurotrophic factor levels	53127
synaptic plasticity -LRB- Ying et al. 2005 -RRB-	53158
synaptic plasticity	53158
Ying et al. 2005	53179
Ying	53179
et al. 2005	53184
et al.	53184
2005	53191
a permissive cellular environment	53210
axonal growth -LRB- Ghiani et al. 2007 -RRB- following SCI	53248
axonal growth -LRB- Ghiani et al. 2007 -RRB-	53248
axonal growth	53248
Ghiani et al. 2007	53263
Ghiani	53263
et al. 2007	53270
et al.	53270
2007	53277
SCI	53293
these tasks	53314
exercise mimics and possibly	53327
exercise	53327
mimics	53336
the effects of OEG transplants	53368
the effects	53368
OEG transplants	53383
neuronal regeneration and synaptic plasticity	53402
neuronal regeneration	53402
synaptic plasticity	53428
the first 3 months post-surgery	53456
the first 3 months	53456
the rats of this study	53488
the rats	53488
this study	53500
tomove	53524
an open field every day andwere trained to climb onto inclined grids at slopes from 45 to 90 deg to make them familiar with the climbing test -LRB- Ramon-Cueto et al. 2000 -RRB-	53541
an open field every day	53541
an open field	53541
every day	53555
inclined grids	53595
slopes from 45 to 90 deg	53613
slopes	53613
45 to 90 deg	53625
them	53646
the climbing test -LRB- Ramon-Cueto et al. 2000 -RRB-	53665
the climbing test	53665
Ramon-Cueto et al. 2000	53684
Ramon-Cueto	53684
et al. 2000	53696
et al.	53696
2000	53703
neurotrophic factor levelswere not measured	53719
neurotrophic factor levelswere	53719
it	53764
that for some of them -LRB- e.g. BDNF , NF-3 , HSP70 -RRB-	53791
that	53791
some of them -LRB- e.g. BDNF , NF-3 , HSP70 -RRB-	53800
some	53800
them -LRB- e.g. BDNF , NF-3 , HSP70 -RRB-	53808
them	53808
e.g. BDNF , NF-3 , HSP70	53814
e.g. BDNF	53814
NF-3	53825
HSP70	53831
interaction of OEG and exercise	53842
interaction	53842
OEG and exercise	53857
the necessary amounts for tropisms to occur , including adaptive changes in central patterngenerator.OEGtransplants	53888
the necessary amounts	53888
tropisms	53914
adaptive changes in central patterngenerator.OEGtransplants	53943
adaptive changes	53943
central patterngenerator.OEGtransplants	53963
concertwith exercise	54007
a sequence of reciprocal cause and effect leading to relative maintenance of skeletal muscle properties that could underlie the functional recovery previously noticed in the rats of this study , in the absence of authentic regeneration of descending cortical pathways	54043
a sequence	54043
reciprocal cause and effect	54057
relative maintenance of skeletal muscle properties that could underlie the functional recovery previously noticed in the rats of this study , in the absence of authentic regeneration of descending cortical pathways	54096
relative maintenance	54096
skeletal muscle properties	54120
the functional recovery previously noticed in the rats of this study , in the absence of authentic regeneration of descending cortical pathways	54167
the functional recovery	54167
the rats of this study	54213
the rats	54213
this study	54225
the absence of authentic regeneration of descending cortical pathways	54240
the absence	54240
authentic regeneration of descending cortical pathways	54255
authentic regeneration	54255
descending cortical pathways	54281
The variety of skeletal muscle phenotypes	54311
The variety	54311
skeletal muscle phenotypes	54326
OEG-transplanted paraplegic rats , as compared with non-transplanted , could arise from adaptive singularities of the spinal circuitry	54365
OEG-transplanted paraplegic rats	54365
non-transplanted	54416
adaptive singularities of the spinal circuitry	54451
adaptive singularities	54451
the spinal circuitry	54477
different levels of activation of motor neurons	54510
different levels	54510
activation of motor neurons	54530
activation	54530
motor neurons	54544
The migratory behaviour and ability to produce neurotrophins of OEGs	54559
The migratory behaviour and ability	54559
neurotrophins of OEGs	54606
neurotrophins	54606
OEGs	54623
concert with the neurotrophic and synaptogenesic effects of exercise	54632
concert	54632
the neurotrophic and synaptogenesic effects of exercise	54645
the neurotrophic and synaptogenesic effects	54645
exercise	54692
some clues	54710
neuromuscular activity and muscle use	54737
neuromuscular activity	54737
muscle use	54764
OEG-transplanted rats	54793
turn	54819
an increased neuromuscular activity	54825
the formation and maintenance of synaptic sites -LRB- Czeh et al. 1978 ; Landmesser , 1992 -RRB-	54886
the formation and maintenance	54886
synaptic sites -LRB- Czeh et al. 1978 ; Landmesser , 1992 -RRB-	54919
synaptic sites	54919
Czeh et al. 1978 ; Landmesser , 1992	54935
Czeh	54935
et al. 1978 ; Landmesser , 1992	54940
et al. 1978	54940
et al.	54940
1978	54947
Landmesser , 1992	54953
Landmesser	54953
1992	54965
skeletal muscle protein expression -LRB- Talmadge , 2000 -RRB- and mass -LRB- Goldspink , 1999 ; Favier et al. 2008 -RRB-	54984
skeletal muscle protein expression -LRB- Talmadge , 2000 -RRB-	54984
skeletal muscle protein expression	54984
Talmadge	55020
2000	55030
mass -LRB- Goldspink , 1999 ; Favier et al. 2008 -RRB-	55040
mass	55040
Goldspink , 1999 ; Favier et al. 2008	55046
Goldspink , 1999 ; Favier et al.	55046
Goldspink , 1999	55046
Goldspink	55046
1999	55057
Favier et al.	55063
Favier	55063
et al.	55070
2008	55077
this context	55087
the skeletalmuscle of OEG-transplanted animals	55101
the skeletalmuscle	55101
OEG-transplanted animals	55123
an additional opportunity of studying differential gene expression aimed at elucidating the molecular mechanisms leading to relative maintenance of skeletal muscle mass and protein expression patterns	55156
an additional opportunity	55156
differential gene expression aimed at elucidating the molecular mechanisms leading to relative maintenance of skeletal muscle mass and protein expression patterns	55194
differential gene expression	55194
the molecular mechanisms leading to relative maintenance of skeletal muscle mass and protein expression patterns	55244
the molecular mechanisms	55244
relative maintenance of skeletal muscle mass and protein expression patterns	55280
relative maintenance	55280
skeletal muscle mass and protein expression patterns	55304
Satellite cell activation and apoptosis , positive -LRB- e.g. IGF-1 and MGF -RRB- or negative -LRB- e.g. IL-6 and myostatin -RRB- regulatory muscle growth factors , myogenic regulatory factors -LRB- MRFs -RRB- and other transcription factors possibly implicated in skeletal muscle remodelling -LRB- e.g. calcineurin-sensitive transcription factors NF-AT and MEF2 -RRB- , miRNAs and other translation regulatory factors , proteolysis-modulating molecules and signal transduction protein kinases -LRB- e.g. Akt , ERK 1/2 -RRB-	55358
Satellite cell activation and apoptosis	55358
Satellite cell activation	55358
apoptosis	55388
positive -LRB- e.g. IGF-1 and MGF -RRB- or negative -LRB- e.g. IL-6 and myostatin -RRB- regulatory muscle growth factors , myogenic regulatory factors -LRB- MRFs -RRB-	55399
positive -LRB- e.g. IGF-1 and MGF -RRB- or negative -LRB- e.g. IL-6 and myostatin -RRB- regulatory muscle growth factors , myogenic regulatory factors	55399
e.g. IGF-1 and MGF	55409
e.g.	55409
IGF-1 and MGF	55414
e.g. IL-6 and myostatin	55442
e.g.	55442
IL-6 and myostatin	55447
MRFs	55530
other transcription factors possibly implicated in skeletal muscle remodelling -LRB- e.g. calcineurin-sensitive transcription factors NF-AT and MEF2 -RRB- , miRNAs and other translation regulatory factors , proteolysis-modulating molecules and signal transduction protein kinases -LRB- e.g. Akt , ERK 1/2 -RRB-	55540
other transcription factors	55540
skeletal muscle remodelling -LRB- e.g. calcineurin-sensitive transcription factors NF-AT and MEF2 -RRB- , miRNAs and other translation regulatory factors ,	55591
skeletal muscle remodelling	55591
e.g. calcineurin-sensitive transcription factors NF-AT and MEF2	55620
e.g.	55620
calcineurin-sensitive transcription factors NF-AT and MEF2	55625
calcineurin-sensitive transcription factors	55625
NF-AT and MEF2	55669
miRNAs and other translation regulatory factors	55686
miRNAs and other translation	55686
regulatory factors	55715
molecules and signal transduction protein kinases -LRB- e.g. Akt , ERK 1/2 -RRB-	55758
molecules	55758
signal transduction protein kinases -LRB- e.g. Akt , ERK 1/2 -RRB-	55772
signal transduction protein kinases	55772
e.g. Akt , ERK 1/2	55809
e.g. Akt	55809
ERK 1/2	55819
Goldspink , 1999 ; Talmadge , 2000 ; Baldwin & Haddad , 2001 ; Spangenburg & Booth , 2003 ; Koulmann & Bigard , 2006 ; Frost & Lang , 2007 ; Favier et al. 2008 for a review	55833
Goldspink , 1999 ; Talmadge , 2000 ; Baldwin & Haddad , 2001 ; Spangenburg & Booth , 2003 ; Koulmann & Bigard , 2006 ; Frost & Lang , 2007 ; Favier et al. 2008	55833
Goldspink , 1999	55833
Goldspink	55833
1999	55844
Talmadge , 2000	55850
Talmadge	55850
2000	55860
Baldwin & Haddad , 2001	55866
Baldwin & Haddad	55866
2001	55884
Spangenburg & Booth , 2003	55890
Spangenburg & Booth	55890
2003	55911
Koulmann & Bigard , 2006	55917
Koulmann & Bigard	55917
2006	55936
Frost & Lang , 2007	55942
Frost & Lang	55942
2007	55956
Favier et al. 2008	55962
Favier	55962
et al.	55969
2008	55976
a review	55985
some of the events , molecules and pathways by which OEG transplants in concert with exercise could indirectly affect the skeletal muscle phenotype	55999
some	55999
the events , molecules and pathways by which OEG transplants in concert with exercise could indirectly affect the skeletal muscle phenotype	56007
the events , molecules and pathways	56007
OEG transplants in concert with exercise	56051
OEG transplants	56051
concert with exercise	56070
concert	56070
exercise	56083
the skeletal muscle phenotype	56116
agreement with previous reports -LRB- Talmadge et al. 1995 , 1999 ; Roy et al. 1999 -RRB-	56150
agreement	56150
previous reports -LRB- Talmadge et al. 1995 , 1999 ; Roy et al. 1999 -RRB-	56165
previous reports	56165
Talmadge	56183
et al. 1995 , 1999 ; Roy et al. 1999	56192
et al.	56192
1995 , 1999 ; Roy et al. 1999	56199
1995 , 1999	56199
1995	56199
1999	56205
Roy et al. 1999	56211
Roy	56211
et al.	56215
1999	56222
we	56229
a severe atrophy of SOL in response	56241
a severe atrophy	56241
SOL in response	56261
SOL	56261
response	56268
SCT , a dramatic reduction in MHC-I-expressing fibres compensated by an increased number of fibres expressing the fast isoforms IIA and IID/X and a parallel slow-to-fast transition in MLC isoforms -LRB- Lee & Braun , 1990 -RRB- , supporting the contractile changes in response to reduced neuromuscular activity -LRB- Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 , 1994 -RRB- characteristic of paralysed skeletal muscle	56280
SCT	56280
a dramatic reduction in MHC-I-expressing fibres compensated by an increased number of fibres expressing the fast isoforms IIA and IID/X and a parallel slow-to-fast transition in MLC isoforms -LRB- Lee & Braun , 1990 -RRB- , supporting the contractile changes in response to reduced neuromuscular activity -LRB- Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 , 1994 -RRB- characteristic of paralysed skeletal muscle	56285
a dramatic reduction	56285
MHC-I-expressing fibres compensated by an increased number of fibres expressing the fast isoforms IIA and IID/X and a parallel slow-to-fast transition in MLC isoforms -LRB- Lee & Braun , 1990 -RRB- , supporting the contractile changes in response to reduced neuromuscular activity -LRB- Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 , 1994 -RRB- characteristic of paralysed skeletal muscle	56309
MHC-I-expressing fibres	56309
an increased number of fibres expressing the fast isoforms IIA and IID/X and a parallel slow-to-fast transition in MLC isoforms -LRB- Lee & Braun , 1990 -RRB- , supporting the contractile changes in response to reduced neuromuscular activity -LRB- Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 , 1994 -RRB- characteristic of paralysed skeletal muscle	56348
an increased number	56348
fibres expressing the fast isoforms IIA and IID/X and a parallel slow-to-fast transition in MLC isoforms -LRB- Lee & Braun , 1990 -RRB- , supporting the contractile changes in response to reduced neuromuscular activity -LRB- Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 , 1994 -RRB- characteristic of paralysed skeletal muscle	56371
fibres	56371
the fast isoforms IIA and IID/X and a parallel slow-to-fast transition in MLC isoforms -LRB- Lee & Braun , 1990 -RRB-	56389
the fast isoforms IIA and IID/X	56389
the fast isoforms IIA	56389
IID/X	56415
a parallel slow-to-fast transition in MLC isoforms -LRB- Lee & Braun , 1990 -RRB-	56425
a parallel slow-to-fast transition	56425
MLC isoforms -LRB- Lee & Braun , 1990 -RRB-	56463
MLC isoforms	56463
Lee & Braun	56477
1990	56490
the contractile changes in response	56508
the contractile changes	56508
response	56535
reduced neuromuscular activity -LRB- Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 , 1994 -RRB-	56547
reduced neuromuscular activity	56547
Reiser et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 , 1994	56579
Reiser	56579
et al. 1985 ; Sweeney et al. 1986 ; Bottinelli et al. 1991 , 1994	56586
et al. 1985	56586
et al.	56586
1985	56593
Sweeney et al. 1986	56599
Sweeney	56599
et al.	56607
1986	56614
Bottinelli et al. 1991 , 1994	56620
Bottinelli et al.	56620
Bottinelli	56620
et al.	56631
1991 , 1994	56638
1991	56638
1994	56644
characteristic of paralysed skeletal muscle	56650
characteristic	56650
skeletal muscle	56678
the slow-to-fast transformation of myosin subunit isoforms	56708
the slow-to-fast transformation	56708
myosin subunit isoforms	56743
an increased activity of glycolysis -LRB- Talmadge , 2000 ; Otis et al. 2004 -RRB-	56785
an increased activity	56785
glycolysis -LRB- Talmadge , 2000 ; Otis et al. 2004 -RRB-	56810
glycolysis	56810
Talmadge , 2000 ; Otis et al. 2004	56822
Talmadge , 2000 ; Otis et al.	56822
Talmadge , 2000	56822
Talmadge	56822
2000	56832
Otis et al.	56838
Otis	56838
et al.	56843
2004	56850
the EDL muscle -LRB- formed by type IIA , IID/X and IIB fibres , in approximately the same proportion -RRB-	56860
the EDL muscle	56860
type IIA , IID/X and IIB fibres ,	56886
type IIA	56886
IID/X and IIB fibres	56896
approximately the same proportion	56921
fibre type switching	56957
a narrower range of change	56982
a narrower range	56982
change	57002
a slow-to-fast transition	57016
EDL	57057
phenotypic changes in response	57095
phenotypic changes	57095
response	57117
reduced neuromuscular activity than the SOL	57129
reduced neuromuscular activity	57129
the SOL	57165
some markers of the EDL	57205
some markers	57205
the EDL	57221
the extent	57266
a particular muscle	57282
normality asSOLmarkers -LRB- i.e.GPDHactivity , Fig. 2 -RRB-	57313
normality asSOLmarkers	57313
i.e.GPDHactivity	57337
Fig. 2	57355
this conclusion	57391
agreement with observations -LRB- Borisov et al. 2001 -RRB-	57413
agreement	57413
observations -LRB- Borisov et al. 2001 -RRB-	57428
observations	57428
Borisov	57442
et al. 2001	57450
et al.	57450
2001	57457
fast-twitch fibres	57479
partial dedifferentiation	57532
slow-twitch fibres	57563
they	57591
higher phenotypic plasticity	57604
muscle mass and contractility	57640
muscle mass	57640
contractility	57656
a combination of morphological and molecular markers of both slow and fast skeletal muscle , as used in this investigation ,	57700
a combination	57700
morphological and molecular markers of both slow and fast skeletal muscle	57717
morphological and molecular markers	57717
both slow and fast skeletal muscle	57756
this investigation	57803
depiction of a precise figure of the actual skeletal muscle phenotype	57831
depiction	57831
a precise figure of the actual skeletal muscle phenotype	57844
a precise figure	57844
the actual skeletal muscle phenotype	57864
the amplitude of the change induced by SCT as a criteria , the degree of maintenance of normal muscle characteristics following OEG transplantation , the coefficient of correlation with behaviourally tested motor functional capacity and the gradation of their expression levels in animalswith similarmotor functional capacity	57908
the amplitude	57908
the change induced by SCT as a criteria , the degree of maintenance of normal muscle characteristics following OEG transplantation , the coefficient of correlation with behaviourally tested motor functional capacity and the gradation of their expression levels in animalswith similarmotor functional capacity	57925
the change	57925
SCT	57947
a criteria , the degree of maintenance of normal muscle characteristics following OEG transplantation , the coefficient of correlation with behaviourally tested motor functional capacity and the gradation of their expression levels in animalswith similarmotor functional capacity	57954
a criteria	57954
the degree of maintenance of normal muscle characteristics following OEG transplantation , the coefficient of correlation with behaviourally tested motor functional capacity and the gradation of their expression levels in animalswith similarmotor functional capacity	57966
the degree	57966
maintenance of normal muscle characteristics following OEG transplantation , the coefficient of correlation with behaviourally tested motor functional capacity and the gradation of their expression levels in animalswith similarmotor functional capacity	57980
maintenance	57980
normal muscle characteristics following OEG transplantation , the coefficient of correlation with behaviourally tested motor functional capacity and the gradation of their expression levels in animalswith similarmotor functional capacity	57995
normal muscle characteristics	57995
OEG transplantation , the coefficient of correlation with behaviourally tested motor functional capacity and the gradation of their expression levels in animalswith similarmotor functional capacity	58035
OEG transplantation	58035
the coefficient of correlation with behaviourally tested motor functional capacity and the gradation of their expression levels in animalswith similarmotor functional capacity	58056
the coefficient	58056
correlation with behaviourally	58075
correlation	58075
motor functional capacity and the gradation of their expression levels	58113
motor functional capacity	58113
the gradation of their expression levels	58143
the gradation	58143
their expression levels	58160
animalswith similarmotor functional capacity	58187
we	58232
the histochemically assessed GPDH activity as a sensitive phenotypic marker for bothSOLandEDLmuscle -LRB- see Fig. 2 -RRB-	58244
the histochemically assessed GPDH activity	58244
a sensitive phenotypic marker for bothSOLandEDLmuscle -LRB- see Fig. 2 -RRB-	58290
a sensitive phenotypic marker	58290
bothSOLandEDLmuscle	58324
Fig. 2	58349
The fraction of the less acidic variant -LRB- 2s -RRB- of the slowrMLCisoform -LRB- see Fig. 4 and Gonzalez et al. 2002 -RRB- , in the SOL , andmusclewetweight -LRB- ormuscle-somatic index , Fig. 1 -RRB- in the EDL ,	58358
The fraction of the less acidic variant -LRB- 2s -RRB- of the slowrMLCisoform -LRB- see Fig. 4 and Gonzalez et al. 2002 -RRB- , in the SOL	58358
The fraction of the less acidic variant -LRB- 2s -RRB- of the slowrMLCisoform	58358
The fraction	58358
the less acidic variant -LRB- 2s -RRB- of the slowrMLCisoform	58374
the less acidic variant -LRB- 2s -RRB-	58374
the less acidic variant	58374
2s	58399
the slowrMLCisoform	58406
Fig. 4 and Gonzalez et al. 2002	58430
Fig. 4	58430
Gonzalez et al. 2002	58441
Gonzalez	58441
et al.	58450
2002	58457
the SOL	58467
andmusclewetweight -LRB- ormuscle-somatic index , Fig. 1 -RRB- in the EDL	58476
andmusclewetweight -LRB- ormuscle-somatic index , Fig. 1 -RRB-	58476
andmusclewetweight	58476
ormuscle-somatic index	58496
Fig. 1	58520
the EDL	58531
additional sensitive and potentially useful markers	58544
muscle phenotype	58606
SDH activity	58624
SCT animals	58661
a lower proportion of type I and a higher proportion of type IIB fibres -LRB- both contributing to lower muscle oxidative capacity -RRB-	58673
a lower proportion of type I and a higher proportion of type IIB fibres	58673
a lower proportion of type I	58673
a lower proportion	58673
type I	58695
a higher proportion of type IIB fibres	58706
a higher proportion	58706
type IIB fibres	58729
lower muscle oxidative capacity	58767
lower muscle	58767
oxidative capacity	58780
increased proportions of IIA and IIX/D fibres that tended to increase the oxidative capacity -LRB- see Fig. 2 -RRB-	58831
increased proportions	58831
IIA and IIX/D fibres	58856
the oxidative capacity -LRB- see Fig. 2 -RRB-	58901
the oxidative capacity	58901
Fig. 2	58929
Practically all parameters assessed in SOL or EDL muscles	58938
Practically all parameters	58938
SOL or EDL muscles	58977
a good correlation between muscle phenotype	59017
a good correlation	59017
muscle phenotype	59044
functional capacity	59086
they	59141
the degree	59193
a particular skeletal muscle	59209
normality	59249
muscles	59273
animals with similar functional capacity	59286
animals	59286
similar functional capacity	59299
The fraction of the less acidic of the variants -LRB- variant 2s -RRB- of the slow rMLC isoform in the SOL , the muscle-somatic index in the EDL and the histochemical GPDH activity in both muscles ,	59328
The fraction of the less acidic of the variants -LRB- variant 2s -RRB- of the slow rMLC isoform in the SOL	59328
The fraction	59328
the less acidic of the variants -LRB- variant 2s -RRB- of the slow rMLC isoform in the SOL	59344
the less acidic	59344
the variants -LRB- variant 2s -RRB- of the slow rMLC isoform in the SOL	59363
the variants -LRB- variant 2s -RRB-	59363
the variants	59363
variant 2s	59377
the slow rMLC isoform in the SOL	59392
the slow rMLC isoform	59392
the SOL	59417
the muscle-somatic index in the EDL and the histochemical GPDH activity in both muscles	59426
the muscle-somatic index	59426
the EDL and the histochemical GPDH activity	59454
the EDL	59454
the histochemical GPDH activity	59466
muscles	59506
the exceptions	59529
The observation that variant 2s of the slow rMLC was expressed in OEG-transplanted animals at levels statistically non-different from controls	59545
The observation	59545
variant 2s of the slow rMLC	59566
variant 2s	59566
the slow rMLC	59580
OEG-transplanted animals	59611
levels statistically non-different	59639
levels	59639
controls	59679
the notion	59697
it	59713
a sensitive marker of phenotypic changes	59719
a sensitive marker	59719
phenotypic changes	59741
This conclusion	59761
agreement	59783
previous observations made in a model of indirect low-frequency chronic electrical stimulation of fast-twitch muscle -LRB- Gonzalez et al. 2002 -RRB- indicating that changes in the proportion of this variant precede any rearrangement of the sarcomere in the fast-to-slow direction	59798
previous observations	59798
a model of indirect low-frequency	59828
a model	59828
indirect low-frequency	59839
chronic electrical stimulation of fast-twitch muscle -LRB- Gonzalez et al. 2002 -RRB-	59862
chronic electrical stimulation	59862
fast-twitch muscle -LRB- Gonzalez et al. 2002 -RRB-	59896
fast-twitch muscle	59896
Gonzalez	59916
et al. 2002	59925
et al.	59925
2002	59932
changes in the proportion of this variant	59954
changes	59954
the proportion of this variant	59965
the proportion	59965
this variant	59983
any rearrangement of the sarcomere in the fast-to-slow direction	60004
any rearrangement	60004
the sarcomere in the fast-to-slow direction	60025
the sarcomere	60025
the fast-to-slow direction	60042
conclusion	60073
the results reported in this paper	60085
the results	60085
this paper	60109
evidence	60128
8 months	60142
a complete mid-thoracic SCT and simultaneous OEG transplantation , the mean phenotypes of fast - and slow-twitch hind limb	60156
a complete mid-thoracic SCT and simultaneous OEG transplantation	60156
the mean phenotypes of fast - and slow-twitch hind limb	60222
the mean phenotypes	60222
fast - and slow-twitch hind limb	60245
skeletal muscles	60277
those of non-transplanted rats	60313
those	60313
non-transplanted rats	60322
maintenance of skeletalmuscle properties	60356
maintenance	60356
skeletalmuscle properties	60371
the extent to which muscle phenotypes of OEG-transplanted animals approached normality greatly	60407
the extent	60407
muscle phenotypes of OEG-transplanted animals	60427
muscle phenotypes	60427
OEG-transplanted animals	60448
normality	60484
animal	60516
animal	60526
substantive in a few cases	60539
substantive	60539
a few cases	60554
marginal in others	60569
marginal	60569
others	60581
sensory-motor functional capacity previously assessed in the same rats	60606
sensory-motor functional capacity	60606
the same rats	60663
The histochemical glycerol-3-phosphate dehydrogenase activity in SOL and EDL muscle and the fraction of the less acidic variant -LRB- variant 2s -RRB- of the slow rMLC isoform in SOL and muscle weight -LRB- or muscle-somatic index -RRB- in the EDL	60678
The histochemical glycerol-3-phosphate dehydrogenase activity	60678
SOL and EDL muscle and the fraction of the less acidic variant -LRB- variant 2s -RRB- of the slow rMLC isoform in SOL and muscle weight -LRB- or muscle-somatic index -RRB- in the EDL	60743
SOL and EDL muscle	60743
SOL	60743
EDL muscle	60751
the fraction of the less acidic variant -LRB- variant 2s -RRB- of the slow rMLC isoform in SOL and muscle weight -LRB- or muscle-somatic index -RRB- in the EDL	60766
the fraction	60766
the less acidic variant -LRB- variant 2s -RRB- of the slow rMLC isoform in SOL and muscle weight -LRB- or muscle-somatic index -RRB- in the EDL	60782
the less acidic variant -LRB- variant 2s -RRB- of the slow rMLC isoform in SOL	60782
the less acidic variant -LRB- variant 2s -RRB-	60782
the less acidic variant	60782
variant 2s	60807
the slow rMLC isoform in SOL	60822
the slow rMLC isoform	60822
SOL	60847
muscle weight -LRB- or muscle-somatic index -RRB- in the EDL	60855
muscle weight -LRB- or muscle-somatic index -RRB-	60855
muscle weight	60855
the EDL	60898
sight	60916
the most sensitive phenotypic marker	60925
the degree	60974
a skeletal muscle approaches	60990
normal characteristics following SCT and OEG transplantation	61019
normal characteristics	61019
SCT and OEG transplantation	61052
The relatively low proportion of animals that 8 months after OEG transplantation showed patterns of fibre type-specific protein expression close to normality	61081
The relatively low proportion	61081
animals that 8 months after OEG transplantation showed patterns of fibre type-specific protein expression close to normality	61114
animals	61114
8 months after OEG transplantation	61127
8 months	61127
OEG transplantation	61141
patterns of fibre	61168
patterns	61168
fibre	61180
type-specific protein expression close to normality	61186
type-specific protein expression close	61186
normality	61228
OEG transplants	61253
a consistent	61304
long-termmaintenance of normal skeletal muscle characteristics	61333
long-termmaintenance	61333
normal skeletal muscle characteristics	61357
A productive interaction with exercise	61397
A productive interaction	61397
exercise	61427
a possible mechanism underlying OEG-mediated effects on maintenance of skeletal muscle characteristics	61452
a possible mechanism	61452
OEG-mediated effects	61484
maintenance of skeletal muscle characteristics	61508
maintenance	61508
skeletal muscle characteristics	61523
Further work	61556
the molecular events probably involved in transducing OEG and exercise-derived signals into skeletal muscle phenotypic changes	61596
the molecular events	61596
OEG and exercise-derived signals	61650
skeletal muscle phenotypic changes	61688
skeletal muscle	61688
phenotypic changes	61704
